,index,key,score,total_mentions
0,1232,descriptive statistics,78.95555555555494,209.0
1,2777,patients postoperative,61.64999999999975,137.0
2,3465,analysis results,53.999999999999666,189.0
3,3380,patients including,52.64999999999957,351.0
4,816,data regarding,48.23076923076945,285.0
5,1310,resonance energy,32.693023255814175,213.0
6,1957,safe effective,32.11515151515152,757.0
7,388,records patients,31.125000000000036,415.0
8,2129,patients male,30.763636363636593,423.0
9,1343,trend toward,29.439560439560363,285.0
10,2290,acute myocardial,27.4446601941749,382.0
11,1088,patients ra,27.00000000000015,252.0
12,1970,patients demonstrated,22.923076923076962,298.0
13,2184,superior inferior,22.84615384615379,216.0
14,2753,patients early,22.400000000000006,320.0
15,2663,boys girls,19.959322033898097,256.0
16,2931,cerebral perfusion,19.16565656565649,179.0
17,1488,common iliac,17.594594594594675,186.0
18,2347,de novo,17.46826347305394,442.0
19,453,showed mean,17.000000000000096,153.0
20,1610,nerve head,16.39999999999999,164.0
21,842,transthoracic echocardiography,15.828571428571333,554.0
22,2579,patients previously,15.54949494949499,179.0
23,1822,myocardial infarction,15.123599632690402,2076.0
24,2,lesions patients,14.990243902439037,439.0
25,133,older patients,14.674074074074056,283.0
26,3224,patients identified,14.417582417582512,410.0
27,2001,angiography cta,14.245901639344217,395.0
28,1617,years men,14.068965517241187,408.0
29,782,functional brain,13.359595959596023,389.0
30,2225,controls hc,13.14172185430468,242.0
31,2491,analogue scale,13.066666666666542,196.0
32,1770,major complications,12.749397590361237,407.0
33,199,aim compare,12.712101910827975,587.0
34,2864,weeks later,12.548148148148243,154.0
35,1899,calculated using,12.444961240310088,698.0
36,2106,soft tissues,12.443165467625937,376.0
37,254,obtained results,12.397660818713417,200.0
38,1615,prognostic significance,12.288888888888865,158.0
39,1725,receiver operator,12.188235294117677,148.0
40,1660,analyzed patients,11.964912280701816,341.0
41,535,echocardiographic examination,11.828571428571347,138.0
42,464,implant placement,11.8193548387097,229.0
43,149,lipoprotein cholesterol,11.596153846153879,201.0
44,835,bone strength,10.970873786407825,226.0
45,2432,aged years,10.819020049319198,2147.0
46,2040,energy dispersive,10.733333333333418,287.0
47,1659,identify factors,10.589743589743566,295.0
48,141,functional status,10.56874999999998,178.0
49,1265,coherence tomography,10.551739739308438,2767.0
50,2190,lung cancer,10.452134272689579,2402.0
51,3397,different patterns,10.382142857142853,171.0
52,2615,regression model,10.30843913368181,535.0
53,544,hyaluronic acid,10.282352941176482,152.0
54,135,side effects,10.186311787072222,705.0
55,1686,largely unknown,10.122302158273321,335.0
56,2162,acoustic radiation,10.081885856079406,239.0
57,3203,fractional flow,9.874137931034543,249.0
58,1209,global longitudinal,9.274999999999975,371.0
59,2425,staphylococcus aureus,9.173221757322091,406.0
60,448,tomography mdct,9.053846153846148,214.0
61,1071,secondary outcomes,8.894589178356728,304.0
62,1218,functional outcomes,8.88162544169611,457.0
63,92,widely available,8.795180722891613,146.0
64,1653,mitral regurgitation,8.771123872026221,540.0
65,145,used combination,8.744680851063864,137.0
66,3232,knockout mice,8.73267326732673,210.0
67,3525,diagnostic challenge,8.65555555555559,164.0
68,3701,rotator cuff,8.598742970558996,634.0
69,2415,volume total,8.519354838709669,139.0
70,1963,successfully performed,8.42045454545453,195.0
71,2021,patients lesions,8.272727272727263,325.0
72,1390,females mean,8.243601895734589,223.0
73,1033,level trauma,8.177777777777774,138.0
74,740,therapeutic efficacy,8.142857142857148,190.0
75,2351,associated greater,8.10516252390058,471.0
76,1598,coronary arteries,7.9025906735750935,738.0
77,2947,less likely,7.760544217687105,368.0
78,179,investigated effects,7.685889570552155,232.0
79,1197,microscopy showed,7.615077605321466,212.0
80,2481,confocal microscopy,7.53535353535353,1119.0
81,3586,postoperative day,7.523919308357333,214.0
82,296,lv volume,7.482758620689653,217.0
83,2676,liver cancer,7.3999999999999915,148.0
84,1323,lesions detected,7.294736842105221,231.0
85,286,patients multiple,7.234042553191523,340.0
86,3670,survival pfs,7.151181102362268,239.0
87,3637,outpatient clinic,7.149999999999973,143.0
88,1879,frontal parietal,7.080412371134012,202.0
89,1151,reaction time,7.079012345678964,183.0
90,1320,negatively correlated,6.970508054522928,686.0
91,3553,energy transfer,6.9350253807106395,297.0
92,921,area curve,6.773425692695197,1379.0
93,575,provide information,6.772774869109963,308.0
94,1555,aortic arch,6.728828828828808,679.0
95,2904,normal control,6.676041666666693,221.0
96,3244,resynchronization therapy,6.633644859813049,169.0
97,3039,patients reported,6.615945330296132,274.0
98,292,studies shown,6.576470588235329,559.0
99,303,surgical resection,6.565707133917375,860.0
100,1713,found groups,6.555223880596986,183.0
101,938,angiography patients,6.551219512195119,158.0
102,2647,examination showed,6.526315789473639,310.0
103,1541,tomography angiography,6.380106571936077,898.0
104,1095,parameters patients,6.379069767441893,211.0
105,2556,patients found,6.284258416742472,356.0
106,1270,aim review,6.274876847290651,193.0
107,2939,tested hypothesis,6.164609053497954,214.0
108,3529,reserve ffr,6.12972972972973,162.0
109,2671,used reference,6.112195121951229,179.0
110,2778,radiation force,6.112081513828239,247.0
111,2518,newly formed,6.066666666666676,156.0
112,2957,surgical treatment,6.051890587288797,1003.0
113,1833,much less,5.999999999999997,156.0
114,428,detected using,5.924064171123016,191.0
115,290,acuity bcva,5.859119496855374,274.0
116,2838,aortic repair,5.813373860182361,219.0
117,3167,ex vivo,5.7471172962226404,1314.0
118,2399,patients chronic,5.683898305084768,706.0
119,3335,tomography findings,5.6045454545454705,137.0
120,2317,suspected coronary,5.600000000000007,140.0
121,2453,paper presents,5.586754966887404,222.0
122,241,regression models,5.466176470588226,756.0
123,887,host cell,5.459154929577452,204.0
124,2536,lumen area,5.437735849056603,131.0
125,3256,ligament acl,5.428571428571419,240.0
126,3211,safety profile,5.410869565217379,131.0
127,1875,blood cell,5.370930232558126,298.0
128,2732,women aged,5.3561403508771965,284.0
129,318,vascular access,5.34597156398103,240.0
130,1483,frontal cortex,5.344444444444453,444.0
131,3217,peripheral nerve,5.286274509803927,337.0
132,3074,hounsfield units,5.208791208791206,270.0
133,315,clinically relevant,5.1342648037259,728.0
134,140,optical coherence,5.106377151799704,2777.0
135,3470,coronary artery,5.102201457284468,4031.0
136,3638,patients aged,5.092378752886827,675.0
137,2848,endovascular treatment,5.065734794106543,583.0
138,2606,patients receiving,5.054365079365067,542.0
139,2659,visual analogue,5.040559440559483,212.0
140,1729,methods used,5.037500000000034,403.0
141,3489,bone graft,4.864285714285725,227.0
142,2636,temporal lobe,4.843077509045902,865.0
143,387,objective investigate,4.816216216216204,198.0
144,2534,technical success,4.796337361405252,879.0
145,2990,associated high,4.791451469278711,472.0
146,73,rate patients,4.705912596401032,339.0
147,3502,current evidence,4.704294478527598,142.0
148,2698,institutes health,4.691768826619953,285.0
149,138,cells vitro,4.6163009404388635,199.0
150,2623,breast cancers,4.606118546845124,219.0
151,44,fusiform gyrus,4.605744125326363,196.0
152,2863,events mace,4.564102564102559,178.0
153,309,cardiovascular factors,4.559766763848394,460.0
154,2524,women men,4.558154645873942,575.0
155,1301,imaging results,4.558150851581472,323.0
156,3627,myocardial ischemia,4.450549450549449,300.0
157,1129,characteristic curves,4.435582822085903,482.0
158,2056,retrospective chart,4.427067669172919,256.0
159,1258,focused ultrasound,4.3283236994219525,234.0
160,2993,patients healthy,4.3280334728033445,862.0
161,2195,patients based,4.316981132075472,176.0
162,2926,four different,4.311340206185563,306.0
163,3442,lv systolic,4.2947496947497035,409.0
164,1306,patients presenting,4.291383219954655,757.0
165,2674,end points,4.290960451977399,310.0
166,1583,groups vs,4.28700906344412,165.0
167,1431,ventricular septal,4.281385281385289,230.0
168,206,key role,4.269918699187015,404.0
169,184,proximal femur,4.257352941176458,193.0
170,1601,structural changes,4.251908396946561,557.0
171,3527,least years,4.244919786096273,189.0
172,2769,open surgical,4.241463414634145,188.0
173,3049,randomized controlled,4.227044025157252,611.0
174,1624,predictive value,4.198902247778336,2975.0
175,1593,surgical techniques,4.196208530805693,233.0
176,944,new bone,4.181229773462791,380.0
177,874,imaging agent,4.137313432835805,126.0
178,1630,classified according,4.119547657512114,250.0
179,3105,determine optimal,4.108474576271177,202.0
180,957,artery disease,4.108121410992609,1715.0
181,3285,coronary angiography,4.094810863239577,1732.0
182,587,review discuss,4.086486486486483,168.0
183,1080,patients bilateral,4.07272727272727,160.0
184,264,conducted patients,4.061538461538432,264.0
185,3669,disease control,4.044444444444422,182.0
186,664,depressive disorder,4.016740872662492,358.0
187,787,observed patients,3.9973509933775,1006.0
188,3168,especially patients,3.9188976377952733,237.0
189,843,lobe epilepsy,3.9114635904830415,274.0
190,3702,higher prevalence,3.8995633187772882,329.0
191,1947,studies confirmed,3.858015267175556,133.0
192,3384,min min,3.7963190184049087,238.0
193,2279,present patients,3.79313304721033,491.0
194,2617,congestive heart,3.7874015748031313,185.0
195,17,normal controls,3.7821122740247346,375.0
196,1982,patients undergone,3.7789215686274606,593.0
197,594,national institutes,3.755769230769219,279.0
198,3587,fiber layer,3.726262626262632,434.0
199,126,laboratory tests,3.7169398907103814,179.0
200,1275,patients admitted,3.6981943250214884,391.0
201,2858,high sensitivity,3.68095952023988,792.0
202,3241,cell viability,3.680210157618212,553.0
203,1371,cognitive deficits,3.627863777089777,217.0
204,1969,treated using,3.5860627177700324,166.0
205,3490,target vessel,3.5724770642201786,177.0
206,3305,human subjects,3.5698774080560414,208.0
207,814,patients median,3.5691489361701985,610.0
208,2618,wild type,3.563292547274751,281.0
209,2987,detection rates,3.514211886304927,272.0
210,300,single institution,3.512735326688814,244.0
211,1908,disease characterized,3.4973262032085493,218.0
212,850,articular cartilage,3.4882860665844584,345.0
213,1207,left ventricular,3.4720866563504393,4630.0
214,2042,data collected,3.4702380952380856,795.0
215,2527,older years,3.4565217391304217,265.0
216,1128,image processing,3.45591524426133,466.0
217,3139,microscope sem,3.4477611940298614,154.0
218,3420,imaging method,3.444748858447473,328.0
219,2427,female mice,3.439024390243899,141.0
220,3443,underwent magnetic,3.4295857988165697,252.0
221,2173,first reported,3.411392405063296,245.0
222,1818,recurrence rate,3.4054054054054013,252.0
223,152,imaging revealed,3.381136638452226,451.0
224,1464,multivariate regression,3.3695652173912913,310.0
225,2818,university hospital,3.367523680649528,541.0
226,2759,dilated cardiomyopathy,3.315492957746468,214.0
227,1141,using data,3.31506849315069,330.0
228,1321,disease activity,3.310139165009932,675.0
229,1290,degenerative changes,3.3057101024890265,213.0
230,3291,endovascular aneurysm,3.3055167055167014,239.0
231,442,dense breasts,3.2976034858387795,176.0
232,3336,lesion volume,3.27425237053246,335.0
233,323,time initial,3.2342245989304774,144.0
234,95,endothelial cell,3.212499999999998,257.0
235,131,provide overview,3.2068965517241352,165.0
236,2412,microcomputed tomography,3.177777777777766,143.0
237,2454,different groups,3.1687409551374865,644.0
238,2862,major challenge,3.1468277945619283,168.0
239,2441,malignant lesions,3.12582781456954,360.0
240,2132,treatment treatment,3.1111111111111143,140.0
241,1109,rv dysfunction,3.1019920318725025,229.0
242,2543,pain score,3.090347490347483,174.0
243,969,breast lesions,3.0898336414047938,398.0
244,391,mutation carriers,3.0820143884892053,153.0
245,2885,neural basis,3.081481481481479,208.0
246,3653,provides first,3.07032967032965,127.0
247,30,complications occurred,3.0666666666666753,322.0
248,2805,cardiac arrest,3.0557398805573985,307.0
249,2693,nitric oxide,3.0459770114942684,265.0
250,3024,imaging showed,3.03536647872885,470.0
251,2007,findings associated,3.0227642276422806,143.0
252,1309,syndrome acs,3.0166666666666657,181.0
253,1790,associated lower,3.0066489361701967,665.0
254,640,scoring system,3.0015037593984917,499.0
255,888,patients men,2.9902636916835648,546.0
256,2440,chest pain,2.9902636916835643,567.0
257,759,prospective studies,2.945303408146307,412.0
258,1868,time years,2.909698996655521,150.0
259,1695,male presented,2.903592120509849,187.0
260,2742,scale score,2.8996108949416435,414.0
261,489,data demonstrate,2.862849533954727,250.0
262,243,however little,2.861261261261264,397.0
263,3371,outcomes patients,2.8575197889182,760.0
264,2717,years older,2.8571428571428537,300.0
265,790,force impulse,2.79226856561546,188.0
266,2499,cataract surgery,2.756452775775056,236.0
267,1805,groups patients,2.7562500000000147,567.0
268,1816,patients stage,2.7458582408198065,233.0
269,3569,using dynamic,2.739130434782608,180.0
270,209,vitro vivo,2.7115449343655316,760.0
271,2046,evaluated whether,2.7081081081081066,167.0
272,1666,studies included,2.7022149302707126,270.0
273,2972,physical properties,2.679867986798681,203.0
274,246,groups similar,2.6735751295336745,172.0
275,1803,review current,2.661764705882363,181.0
276,1462,brain activation,2.66050882420353,457.0
277,3187,potential complications,2.6551724137931,154.0
278,2757,deep vein,2.654301499605365,177.0
279,3311,common type,2.651162790697682,114.0
280,1432,many patients,2.6221948212083896,217.0
281,1736,higher frequency,2.612962962962962,166.0
282,1809,routine use,2.6122370936902475,207.0
283,1013,sciatic nerve,2.6072874493927096,161.0
284,2230,cardiac dysfunction,2.589723320158106,312.0
285,3648,cardiovascular disease,2.5641677255399995,1009.0
286,2906,coronary computed,2.558062375580623,257.0
287,2204,time months,2.557928802589,304.0
288,886,system used,2.554545454545452,281.0
289,691,left ventricle,2.5512088869527383,723.0
290,77,months patients,2.5306372549019516,826.0
291,665,artery stenosis,2.5253164556962084,570.0
292,1339,events patients,2.523623445825923,192.0
293,2719,subgroup patients,2.51338582677166,228.0
294,2134,classification system,2.5084337349397288,347.0
295,2907,invasive coronary,2.496341463414626,178.0
296,999,difference found,2.492424242424252,470.0
297,2130,unknown whether,2.488888888888904,224.0
298,1269,patients presented,2.487341772151907,655.0
299,2410,value patients,2.4802631578947376,145.0
300,1977,cases without,2.457702582368658,184.0
301,377,liver function,2.4529058116232423,240.0
302,3591,coil embolization,2.4524145415084115,243.0
303,529,smooth muscle,2.4447761194029884,364.0
304,1599,patients respectively,2.440763863385983,583.0
305,3445,medical center,2.436464088397784,343.0
306,1705,macular thickness,2.4331807780320442,343.0
307,3426,syndrome patients,2.4181818181818246,133.0
308,3029,cox proportional,2.416542948038176,422.0
309,2779,article review,2.415444015444001,184.0
310,1070,injury severity,2.4062499999999973,140.0
311,2398,aim describe,2.3877551020408108,195.0
312,1236,peripheral quantitative,2.3795918367346944,159.0
313,3665,patients af,2.3559127439724414,180.0
314,1340,disability index,2.3429487179487167,215.0
315,1554,anterior posterior,2.330131004366812,667.0
316,1373,minimally invasive,2.3267973856209037,1068.0
317,729,lung volume,2.3118942731277548,256.0
318,574,stent placement,2.296284329563812,309.0
319,2379,ischemic stroke,2.2898950208198965,1425.0
320,3377,readily available,2.271717171717174,173.0
321,1580,eyes healthy,2.2546409807355543,157.0
322,3649,mean patients,2.2467181467181447,253.0
323,2651,prospective multicenter,2.2342710997442463,208.0
324,1348,neuroimaging findings,2.2289473684210503,154.0
325,3216,benign malignant,2.221941594317284,828.0
326,3267,independent factor,2.194679564691659,363.0
327,2629,images reviewed,2.190201729106627,152.0
328,370,data exist,2.1712418300653593,151.0
329,2704,analysis mean,2.1676056338028142,162.0
330,927,patients showed,2.1668138041733433,1317.0
331,1234,balloon angioplasty,2.1660256410256444,218.0
332,634,infarction mi,2.161743067345783,269.0
333,2756,resonance cmr,2.1567049808429135,433.0
334,102,transcranial doppler,2.1380471380471344,254.0
335,2455,used obtain,2.137931034482761,155.0
336,2937,bone density,2.1278637770897864,474.0
337,3112,valve repair,2.1229336437718302,194.0
338,718,model model,2.1176470588235334,120.0
339,2808,femoral head,2.102663217166336,497.0
340,1901,identify potential,2.099999999999996,132.0
341,2413,neurologic deficits,2.096728558797521,167.0
342,136,medical treatment,2.0953642384105864,339.0
343,156,patients left,2.088957055214721,227.0
344,1962,animal studies,2.0810810810810905,154.0
345,2326,occurred patients,2.0803678811460964,754.0
346,2421,fractures treated,2.0769230769230753,165.0
347,2690,provides useful,2.0545454545453903,113.0
348,559,glioblastoma multiforme,2.036363636363626,112.0
349,304,located within,2.016348773841952,148.0
350,2380,logistic regression,2.011178836710023,2629.0
351,693,trauma patients,2.009868421052628,235.0
352,1381,long axis,2.003773584905665,177.0
353,904,acute appendicitis,1.9962596259625949,211.0
354,3383,acute chronic,1.995744680851063,268.0
355,297,consisted patients,1.984615384615379,213.0
356,3600,patients clinically,1.979356568364611,321.0
357,1791,left frontal,1.9746898263027308,173.0
358,2754,normal subjects,1.967592592592594,250.0
359,2622,stay days,1.9636363636363663,144.0
360,2598,superior mesenteric,1.962913907284765,228.0
361,2087,used treat,1.962644853442399,244.0
362,2641,retrospective review,1.9597245309903026,1058.0
363,498,plane systolic,1.9322033898305153,190.0
364,1131,fraction lvef,1.9278350515463902,330.0
365,3592,analysis conducted,1.9254349627174834,332.0
366,2807,situ hybridization,1.921917808219176,183.0
367,316,patients control,1.9157894736842105,364.0
368,2679,therapeutic strategies,1.8961334344200143,205.0
369,3001,studies identified,1.8910891089108892,191.0
370,3249,acl reconstruction,1.8866391995291323,341.0
371,1600,choroidal thickness,1.886476868327402,589.0
372,3507,health organization,1.8754521963824329,191.0
373,1281,median period,1.8753738783649034,171.0
374,2839,review literature,1.8659430122116674,573.0
375,2116,left side,1.8597568777991036,338.0
376,2117,ventricular mass,1.857689110556936,302.0
377,3018,lesions found,1.8557823129251723,124.0
378,2227,thyroid carcinoma,1.8529411764705879,231.0
379,611,posterior parietal,1.847971781305118,169.0
380,2222,renal artery,1.8426035502958529,346.0
381,2685,months months,1.8419679463287377,706.0
382,54,wt mice,1.8378378378378357,238.0
383,3394,quantitative image,1.8375000000000072,126.0
384,2613,years old,1.8342254934760804,1075.0
385,1960,systematic review,1.8333333333333348,572.0
386,363,patients using,1.8289276807980073,386.0
387,2411,patients categorized,1.826148409893994,152.0
388,51,cardiac computed,1.8231805929919134,178.0
389,2280,cerebral amyloid,1.8174757281553435,144.0
390,70,regression analysis,1.8148936170212524,2559.0
391,1122,cells using,1.805930807248764,189.0
392,865,progressive disease,1.7962264150943454,136.0
393,789,within years,1.793762183235868,214.0
394,536,multicenter randomized,1.789830508474571,132.0
395,1251,arterial blood,1.7885462555066072,280.0
396,1905,autosomal dominant,1.7881619937694697,246.0
397,3240,subclavian artery,1.7754266211604146,289.0
398,40,treatment option,1.769341102644556,387.0
399,2169,previously published,1.7625107480653461,277.0
400,1405,preserved ejection,1.760808709175736,153.0
401,3643,thoracic aorta,1.7607594936708848,214.0
402,1042,patients enrolled,1.757240437158467,677.0
403,3220,value respectively,1.7540145985401476,178.0
404,2118,fundus autofluorescence,1.7347931873479256,155.0
405,194,volume index,1.73052362707535,271.0
406,3019,respectively difference,1.7296354992076062,321.0
407,3318,ultrasound guidance,1.7281636131231273,312.0
408,823,understanding mechanisms,1.7234042553191546,135.0
409,2633,bladder cancer,1.7212543554006983,190.0
410,1742,lv ejection,1.7179125528913946,420.0
411,2915,previously shown,1.7142857142857129,180.0
412,1378,imaging technologies,1.7111111111111024,154.0
413,2122,findings suggest,1.7080351114112147,1736.0
414,1538,older adults,1.7045634920634911,968.0
415,1519,physical examination,1.7041256157635392,675.0
416,50,major depressive,1.6896551724137916,385.0
417,522,pulmonary function,1.676507276507273,336.0
418,2086,patients often,1.6739549839228354,137.0
419,1978,article describes,1.6717423133235711,173.0
420,3002,tomography showed,1.6591362126245808,227.0
421,1150,patients newly,1.6573529411764683,161.0
422,1611,nucleus accumbens,1.6553620531622355,210.0
423,1302,associated higher,1.6382978723404311,924.0
424,2059,january december,1.6330034924330616,905.0
425,2189,breast tissue,1.6280474649406673,343.0
426,613,purpose investigate,1.6240802675585315,607.0
427,3124,radiation oncologists,1.6146496815286635,169.0
428,1825,response evaluation,1.6116788321167888,192.0
429,1865,cardiac resynchronization,1.598130841121493,171.0
430,1749,water content,1.5957446808510656,225.0
431,3589,good agreement,1.5938413564607274,470.0
432,2822,imaging used,1.5931485518530044,522.0
433,592,range median,1.591150442477875,203.0
434,3254,occurred cases,1.5887133182844262,153.0
435,2235,regions involved,1.5855832241153376,263.0
436,2057,stroke scale,1.582089552238808,265.0
437,310,endovascular repair,1.5787579802669744,203.0
438,2097,analysis software,1.5666666666666704,141.0
439,2737,several factors,1.5652173913043452,180.0
440,1072,response therapy,1.5648241206030096,173.0
441,72,using multivariate,1.564285714285705,146.0
442,3583,multivariable logistic,1.5606188466948026,292.0
443,2391,femoral artery,1.558862366683594,298.0
444,2971,obtained different,1.555251141552512,131.0
445,224,structural integrity,1.55339805825243,160.0
446,996,iliac artery,1.5501416430594896,288.0
447,3084,hypertrophy lvh,1.5499999999999996,155.0
448,2755,higher rates,1.5469026548672553,228.0
449,2515,open repair,1.543241224794623,164.0
450,438,daily practice,1.5428571428571687,144.0
451,804,selected patients,1.541283292978206,439.0
452,456,review performed,1.5354838709677414,238.0
453,1184,navigation system,1.535248041775456,245.0
454,1137,well tolerated,1.5304990757855828,276.0
455,2766,subjects underwent,1.5294117647058818,442.0
456,1997,af patients,1.5232876712328747,139.0
457,2373,tomography patients,1.5217391304347812,175.0
458,2935,cardiac remodeling,1.5186440677966082,168.0
459,2390,investigate association,1.5118685331710287,276.0
460,3628,important information,1.5111111111111104,136.0
461,2459,acute stroke,1.506690140845069,389.0
462,402,including patients,1.496678966789664,312.0
463,2782,play role,1.4962264150943367,488.0
464,350,low dose,1.4925266903914645,233.0
465,2248,human body,1.490196078431373,180.0
466,3413,scale vas,1.4806426931905121,236.0
467,306,intracerebral hemorrhage,1.4802083333333302,406.0
468,1493,prospective observational,1.4784313725490215,464.0
469,2626,medical images,1.4672853828306265,204.0
470,1574,together results,1.4620253164556907,385.0
471,1873,weeks months,1.4613583138173285,208.0
472,153,surgical management,1.4566346495908906,347.0
473,1489,twenty patients,1.4563284696301302,311.0
474,1019,systolic excursion,1.451851851851857,196.0
475,964,interquartile range,1.4454280530048906,848.0
476,2240,odds ratios,1.4437499999999992,266.0
477,1890,using quantitative,1.4434504792332281,251.0
478,738,based data,1.4409356725146167,154.0
479,1812,well suited,1.438775510204083,141.0
480,2520,clinically useful,1.4352250489236837,193.0
481,1221,prefrontal cortex,1.4292694169163151,1824.0
482,396,pulmonary vascular,1.4276387377584305,160.0
483,2677,conventional methods,1.4212765957446878,167.0
484,431,randomized trials,1.4168539325842708,194.0
485,1975,studies suggest,1.4111498257839759,405.0
486,1691,late gadolinium,1.4070080862533678,290.0
487,3535,patients suspected,1.3931781516478459,775.0
488,2786,strain gls,1.3900990099009907,162.0
489,1689,orbitofrontal cortex,1.3784969829950604,359.0
490,1764,ii iii,1.3775692163303581,358.0
491,2105,particularly patients,1.3722222222222202,152.0
492,1576,limited data,1.3701657458563499,310.0
493,1634,abdominal wall,1.368115942028987,236.0
494,2406,designed synthesized,1.3677419354838751,159.0
495,769,data support,1.3616490891658697,263.0
496,1342,radiofrequency ablation,1.3606299212598454,288.0
497,2559,proximal distal,1.358024691358025,275.0
498,1471,lower limbs,1.3494623655913978,251.0
499,1949,four groups,1.3473560517038825,441.0
500,2014,tumor growth,1.3446237472396791,501.0
501,468,neoadjuvant chemotherapy,1.339805825242718,230.0
502,2234,innate immune,1.3367088607594975,132.0
503,3354,children aged,1.3366873065015492,314.0
504,1904,relatively high,1.3360269360269312,248.0
505,320,wall shear,1.3347181008902058,173.0
506,3094,rarely reported,1.3184079601990049,159.0
507,2911,frequency bands,1.3176672384219568,167.0
508,773,improved patients,1.314828897338407,133.0
509,2483,implantation tavi,1.3107438016528905,183.0
510,855,right atrium,1.3078189300411571,227.0
511,222,overall patients,1.3050554870530182,252.0
512,2936,cardiac surgery,1.301078402798019,240.0
513,163,amino acid,1.2993766696349036,456.0
514,3053,present investigated,1.294704528012278,241.0
515,1116,young adults,1.293025871766027,605.0
516,3488,aortic aneurysm,1.2918355529820469,485.0
517,1632,ventricular hypertrophy,1.2910735351946527,288.0
518,1077,neural substrates,1.2902457185405796,152.0
519,1350,functional magnetic,1.290084550345883,2098.0
520,404,studies evaluating,1.2894736842105239,140.0
521,1346,different brain,1.2859618717504333,210.0
522,1154,reconstructed using,1.2747967479674809,224.0
523,1271,soft tissue,1.273492888487752,1877.0
524,1026,classified groups,1.269016697588124,180.0
525,3316,cord compression,1.2640776699029137,217.0
526,3183,carbon nanotubes,1.261194029850747,169.0
527,482,without use,1.2582037996545785,235.0
528,713,coefficient icc,1.2581632653061197,274.0
529,956,complete response,1.2563548266865425,318.0
530,146,tumor cells,1.2545506582713217,707.0
531,2224,studies conducted,1.2542372881355919,185.0
532,588,structural functional,1.2455052095953478,659.0
533,731,changes brain,1.2450980392156847,381.0
534,3239,doppler ultrasound,1.245013723696254,504.0
535,3431,learning curve,1.2437499999999988,199.0
536,688,texture analysis,1.2394534585824097,177.0
537,2711,respectively median,1.2380952380952386,182.0
538,235,plasminogen activator,1.2365663322185063,282.0
539,1127,therapeutic interventions,1.2267123287671224,199.0
540,1426,independent predictors,1.224844720496894,870.0
541,2215,bone resorption,1.2247422680412436,297.0
542,1256,frontal regions,1.2243243243243265,151.0
543,3286,cell lung,1.2236842105263124,465.0
544,3579,using modified,1.219844357976653,285.0
545,1684,tomography performed,1.218181818181829,201.0
546,1834,values higher,1.2080691642651287,262.0
547,410,high accuracy,1.2071428571428573,286.0
548,852,structural connectivity,1.205633802816901,212.0
549,2438,systolic velocity,1.2015463917525762,259.0
550,384,fellow eyes,1.197122302158272,192.0
551,1171,surgical intervention,1.1964338781575017,671.0
552,2658,controls underwent,1.1938303341902299,258.0
553,2823,public health,1.1920028060329733,288.0
554,3356,normal range,1.186471067644661,251.0
555,1229,still unknown,1.1856532877882142,178.0
556,3454,default mode,1.1853881278538734,649.0
557,3143,photodynamic therapy,1.1828679008471912,309.0
558,3342,treatment efficacy,1.1803607214428877,155.0
559,579,proportion patients,1.1766871165644215,411.0
560,2883,combined use,1.1752442996742651,164.0
561,3230,healthy young,1.1699233716475088,197.0
562,392,hypertensive patients,1.168284789644014,361.0
563,413,peak systolic,1.1669855151680768,350.0
564,3386,chart review,1.1658268049968248,437.0
565,846,close proximity,1.1653964984552005,138.0
566,1620,pearson coefficient,1.1638513513513555,265.0
567,3594,surface roughness,1.1629715612304115,233.0
568,533,achieved patients,1.1619280048810163,414.0
569,1735,conducted using,1.1590909090909085,270.0
570,2643,investigate effects,1.1583081570996991,213.0
571,3432,without history,1.1555555555555546,204.0
572,2741,results present,1.150496360026473,212.0
573,2081,central peripheral,1.1465587044534393,177.0
574,2696,median days,1.146222430783668,207.0
575,343,change time,1.1456483126110135,129.0
576,3314,using optical,1.1391304347826106,393.0
577,3375,bypass graft,1.1355311355311364,150.0
578,3195,mechanisms underlying,1.1337288431338333,637.0
579,1338,local recurrence,1.1320992848127887,414.0
580,1479,years later,1.1317002881844354,187.0
581,638,current guidelines,1.1258894362342644,187.0
582,368,total lung,1.1250000000000002,126.0
583,1898,intellectual disability,1.120309050772629,203.0
584,3048,investigated using,1.119489559164736,386.0
585,2542,aim determine,1.1176215132787706,656.0
586,3321,lesions using,1.1165644171779114,182.0
587,3125,independent factors,1.1153419593345633,431.0
588,1717,month months,1.0999999999999983,154.0
589,465,literature review,1.098495070057082,504.0
590,469,infarction stemi,1.0950495049504971,316.0
591,169,groups different,1.090797546012268,127.0
592,2546,mechanism action,1.0883720930232623,156.0
593,2748,value predictive,1.0874524714828888,598.0
594,2620,annular plane,1.087370600414076,202.0
595,899,patients women,1.0789473684210567,287.0
596,2855,thickness measurements,1.0742358078602623,205.0
597,3238,intraocular pressure,1.0713375796178317,319.0
598,2562,oxygen species,1.0681985294117629,447.0
599,690,brain abnormalities,1.0644981412639396,249.0
600,772,vitamin deficiency,1.0643652561247232,177.0
601,2420,rate higher,1.0562500000000001,169.0
602,660,repair evar,1.0562499999999995,169.0
603,2794,outcomes included,1.0521831735889222,260.0
604,41,cuff tears,1.0464809384164222,183.0
605,123,best knowledge,1.0462984723854287,424.0
606,2063,type type,1.0460767946577687,241.0
607,1410,admitted hospital,1.0343029845107676,351.0
608,2552,studies demonstrated,1.02944162436549,507.0
609,3055,days respectively,1.0280561122244505,135.0
610,2012,using scanner,1.0280193236714976,152.0
611,232,computer tomography,1.0261011419249593,185.0
612,760,patients range,1.0256541161454995,164.0
613,48,foot ankle,1.0225147211638395,328.0
614,8,subchondral bone,1.0213123092573753,291.0
615,3419,lower mean,1.019939577039274,211.0
616,1886,membrane potential,1.0187577128753595,203.0
617,3172,value sensitivity,1.018745493871666,157.0
618,3299,remained unchanged,1.0115186420127296,235.0
619,955,angiography performed,1.0064102564102568,157.0
620,1490,criteria patients,1.002328288707799,205.0
621,2509,years included,0.9987293519695073,262.0
622,417,months surgery,0.9926073926073973,552.0
623,228,cortical bone,0.9922854387656747,686.0
624,1566,model using,0.990506838294447,228.0
625,116,coronary interventions,0.9893805309734522,129.0
626,3117,third trimester,0.9882352941176467,168.0
627,941,high dose,0.9859154929577463,200.0
628,677,using fluorescence,0.9858585858585834,244.0
629,2368,assess association,0.9853658536585398,202.0
630,3514,surgical approaches,0.9840445269016687,156.0
631,1731,developed method,0.9796334012220013,185.0
632,2953,estrogen receptor,0.9776119402985078,131.0
633,3674,values calculated,0.976190476190474,205.0
634,1015,factors associated,0.9718309859154908,966.0
635,554,chronic liver,0.9683544303797463,180.0
636,2075,neural mechanisms,0.9670433145009449,395.0
637,2201,assess influence,0.957835820895521,151.0
638,150,image data,0.9559190031152666,323.0
639,2074,endothelial dysfunction,0.9555555555555565,258.0
640,2115,image segmentation,0.952631578947365,181.0
641,1045,procedural success,0.9521023765996353,248.0
642,1439,open surgery,0.9517550410754297,236.0
643,317,vessel disease,0.950112107623318,339.0
644,2365,nerve fiber,0.95008870490834,554.0
645,104,patients large,0.9483146067415748,211.0
646,1784,superparamagnetic iron,0.9454545454545502,156.0
647,687,internal fixation,0.9454545454545452,234.0
648,3207,worse outcomes,0.944262295081969,128.0
649,480,dorsolateral prefrontal,0.9437713575644593,490.0
650,2004,neurodegenerative diseases,0.9388042203985922,286.0
651,1428,patients requiring,0.9374485596707817,201.0
652,3658,patients moderate,0.9346405228758168,195.0
653,3243,healthy individuals,0.934443288241413,449.0
654,1866,long term,0.9316455696202516,368.0
655,2955,patients evaluated,0.9289258653988989,613.0
656,1945,total occlusion,0.9205175600739378,166.0
657,386,respectively however,0.917938931297709,185.0
658,3438,levels higher,0.9175487465181063,243.0
659,1785,confirmed presence,0.913953488372093,131.0
660,3416,cognitive function,0.9121118012422357,356.0
661,1153,cardiovascular events,0.9118203309692671,532.0
662,3396,media thickness,0.9105613701236897,145.0
663,1943,sensitivity predictive,0.9103448275862017,176.0
664,1475,inferior temporal,0.9082191780821909,153.0
665,779,using multiple,0.9062499999999993,145.0
666,2439,brain volume,0.9057295645530935,312.0
667,1777,disc degeneration,0.902119116662949,277.0
668,3064,high degree,0.8956381260096935,252.0
669,2662,heart catheterization,0.8953367875647676,144.0
670,2523,endothelial cells,0.8914691943127939,594.0
671,1747,achieved cases,0.8908827785817679,162.0
672,1525,image analysis,0.8906466977890475,866.0
673,2055,volume changes,0.8882882882882889,174.0
674,190,patients cervical,0.8857644991212639,168.0
675,358,better understanding,0.8773738469886073,539.0
676,1813,greater activation,0.8753623188405788,151.0
677,3675,respectively multivariate,0.8741542625169122,170.0
678,1098,volume reduction,0.8735632183908061,190.0
679,1308,collected patients,0.8732824427480892,208.0
680,1823,days patients,0.8683158896289243,234.0
681,562,patients history,0.8676171079429756,355.0
682,3071,blood vessel,0.8651685393258408,231.0
683,1605,survival time,0.8651102464332027,145.0
684,812,cava ivc,0.8642857142857103,121.0
685,341,systolic dysfunction,0.8635235732009916,348.0
686,3606,level iii,0.8631268436578218,209.0
687,1028,left right,0.8624022458391726,1024.0
688,1326,identify predictors,0.8560943643512453,142.0
689,720,cortical areas,0.8551483420593365,350.0
690,2416,tomography scan,0.8542372881355902,784.0
691,1241,associated reduced,0.8490358126721764,402.0
692,3284,arterial hypertension,0.847659802086118,299.0
693,2571,cases controls,0.8473118279569917,197.0
694,662,data using,0.8432432432432458,182.0
695,1672,arterial stiffness,0.8428043093744968,359.0
696,2508,artery pressure,0.8418604651162789,181.0
697,2457,patients undergo,0.8413284132841299,285.0
698,612,different levels,0.8404907975460122,274.0
699,1288,patients followed,0.8403183023872649,576.0
700,709,angiography showed,0.839267886855241,194.0
701,3289,associated presence,0.836900958466454,338.0
702,1240,cardiac structure,0.8359293873312561,161.0
703,2010,underwent preoperative,0.8315832988838368,214.0
704,868,investigated relationship,0.8293906810035849,178.0
705,1757,aortic aneurysms,0.8278860569715104,251.0
706,3528,cm range,0.8267223382045922,180.0
707,1079,health stroke,0.8259013980868269,244.0
708,1484,treatment strategy,0.8258366318819725,225.0
709,457,valve implantation,0.8255639097744275,366.0
710,419,quantified using,0.8250111259457032,299.0
711,2852,john sons,0.824659680736461,593.0
712,32,current literature,0.8241379310344833,239.0
713,346,hydrogen peroxide,0.8235294117647055,160.0
714,2335,survival rate,0.8225300092336087,524.0
715,1553,compare diagnostic,0.8222222222222251,259.0
716,1112,sons ltd,0.8207186889189613,557.0
717,2780,cardiopulmonary bypass,0.8184931506849269,239.0
718,1934,patients findings,0.8178770949720668,244.0
719,2764,within first,0.81707818930041,209.0
720,1470,eyes patients,0.8167711131005706,595.0
721,703,patients unilateral,0.8145350682323064,313.0
722,936,optical properties,0.8101796407185637,246.0
723,708,based computed,0.8074074074074122,109.0
724,981,cell death,0.8073089700996687,810.0
725,1664,vascular endothelial,0.8062953995157376,370.0
726,3543,preterm birth,0.8061244979919684,651.0
727,261,coronary atherosclerosis,0.80576759966073,250.0
728,2817,neurological deficits,0.8047650562541366,320.0
729,2286,pleural effusion,0.8012738853503171,259.0
730,1547,analysis performed,0.800309902803209,1671.0
731,1894,abdominal aortic,0.8001704407109811,557.0
732,2350,based imaging,0.794117647058823,180.0
733,2179,alcohol consumption,0.7920714684533771,173.0
734,1856,ultrasound performed,0.7902877697841723,169.0
735,2577,reported literature,0.7891653432151041,379.0
736,1758,necrosis factor,0.786554621848745,156.0
737,1134,median nerve,0.7837809917355374,281.0
738,1762,invasive breast,0.783670520231214,187.0
739,2570,shear wave,0.7828682303258567,607.0
740,1892,mean months,0.7822665749024988,793.0
741,1372,majority patients,0.7808496291301409,386.0
742,1925,knee oa,0.7805803571428569,269.0
743,2113,patients included,0.7785784797630819,1434.0
744,2186,observed groups,0.774260591526779,167.0
745,803,pressure gradient,0.7739600216099386,247.0
746,3164,zeta potential,0.7737517831669002,339.0
747,3176,population patients,0.7734915924826893,230.0
748,2229,observed cases,0.7699313786650019,187.0
749,726,chronic total,0.7678467788740577,189.0
750,1815,reported patients,0.7640759930915225,316.0
751,1919,dose index,0.7632653061224484,187.0
752,1998,vivo studies,0.7622114868491672,284.0
753,82,knee osteoarthritis,0.7619339045287633,249.0
754,2963,patients malignant,0.7616398243045392,153.0
755,473,unstable angina,0.7611111111111146,137.0
756,3429,using mr,0.7602484472049666,136.0
757,3204,controlled trial,0.7576530612244893,405.0
758,1748,salivary glands,0.7565891472868199,152.0
759,2360,hippocampal volume,0.755710830421928,444.0
760,2283,parameters including,0.7551050317537842,377.0
761,2015,hodgkin lymphoma,0.7538461538461516,224.0
762,1771,range range,0.753303964757704,285.0
763,928,patients tumor,0.7515151515151542,124.0
764,961,breast cancer,0.7514451760487174,3985.0
765,324,spearman rank,0.7499999999999992,174.0
766,3690,disease pd,0.7477622890682352,392.0
767,2842,giant cell,0.7473214285714285,186.0
768,1685,useful information,0.7466774063632695,206.0
769,383,formula see,0.7398170749639748,1324.0
770,312,proportional hazard,0.739534883720931,159.0
771,3301,disorder mdd,0.7382488479262687,267.0
772,1354,acute ischemic,0.7361260053619296,523.0
773,2100,microstructural changes,0.7333333333333337,198.0
774,260,scans performed,0.7331461218165977,416.0
775,593,resection performed,0.7314121037464008,141.0
776,839,mean diameter,0.7266811279826472,201.0
777,2363,patients received,0.720084229696661,1543.0
778,127,fluorescent protein,0.7170731707317095,357.0
779,1133,signs symptoms,0.7151631477927064,253.0
780,817,could predict,0.7144343302990904,201.0
781,3444,analyses used,0.7142857142857137,175.0
782,985,external beam,0.7137980085348504,193.0
783,3392,quantitative qualitative,0.7132075471698135,171.0
784,2336,december patients,0.7118335500650195,238.0
785,3153,aortic regurgitation,0.7109826589595368,246.0
786,1626,left heart,0.7109425785482131,193.0
787,1279,phase contrast,0.7097882083571825,248.0
788,3495,new zealand,0.7088929219600714,279.0
789,700,anatomical landmarks,0.708641975308642,164.0
790,2465,descending aorta,0.708001180986123,218.0
791,2869,underwent surgery,0.7028802880288018,411.0
792,1592,functional network,0.7023489932885917,161.0
793,3671,cerebral cortex,0.7014925373134336,235.0
794,2070,episodic memory,0.7010020974131896,320.0
795,3471,duplex ultrasound,0.698591549295774,248.0
796,2865,independently associated,0.6962506040535557,1189.0
797,3662,treatment patients,0.6957420421661963,765.0
798,119,major adverse,0.694994892747702,486.0
799,578,neurological symptoms,0.6944444444444423,250.0
800,2697,text formula,0.6939579090291936,269.0
801,972,common complication,0.6937097573055961,149.0
802,29,important implications,0.6890894175553736,200.0
803,445,little known,0.687914139057378,1053.0
804,1459,provide important,0.68720930232558,197.0
805,3547,see text,0.68714090684637,1329.0
806,1383,volume patients,0.6857966834895457,164.0
807,2916,poor prognosis,0.6852667063256014,467.0
808,2834,higher mortality,0.6849927149101501,164.0
809,2377,present cases,0.6832568807339442,331.0
810,2715,could detected,0.6829438437390999,178.0
811,1974,associated adverse,0.6826398852223818,183.0
812,168,assess effect,0.6798789712556723,214.0
813,2085,connective tissue,0.6798609253811196,410.0
814,2760,plays role,0.6781414994720171,247.0
815,841,angiography ccta,0.6760563380281687,208.0
816,3609,ganglion cell,0.6742312365641645,284.0
817,1228,range mean,0.6731770833333345,235.0
818,1444,new insight,0.6731006160164253,149.0
819,2503,knowledge first,0.6727874276261367,581.0
820,1099,depressive symptoms,0.6723367697594506,364.0
821,2003,patients referred,0.6666066606660653,529.0
822,1649,structural abnormalities,0.6662871600253004,229.0
823,2991,flow reserve,0.6661991584852739,375.0
824,1391,multivariate cox,0.6639074863055382,202.0
825,1016,cardiovascular magnetic,0.6598656382184622,260.0
826,2061,recorded patients,0.6597597597597594,169.0
827,1043,aneurysm repair,0.6591016548463352,328.0
828,385,method applied,0.658602963410945,242.0
829,1984,stenosis patients,0.657432432432433,139.0
830,1591,association found,0.6573529411764683,149.0
831,657,mean distance,0.657107231920199,155.0
832,911,acute coronary,0.651731927710843,577.0
833,2950,initial imaging,0.6491803278688517,132.0
834,3373,nucleic acid,0.6472868217054255,167.0
835,1006,tricuspid annular,0.6468613628734464,235.0
836,37,added value,0.6347949080622327,204.0
837,3210,mdd patients,0.6338646459367642,311.0
838,625,inversely associated,0.6327868852459028,193.0
839,406,anterior segment,0.6301484424001671,274.0
840,1461,grading system,0.6300519872547373,221.0
841,872,multidetector computed,0.6287060839760048,253.0
842,265,cell cultures,0.6282685512367513,127.0
843,2551,inclusion criteria,0.6278776558487013,996.0
844,446,collagen fibrils,0.6268041237113388,152.0
845,882,vascular disease,0.6242214532871976,246.0
846,550,treatment outcomes,0.6230515916575238,258.0
847,3615,time required,0.6230366492146597,221.0
848,900,analysis method,0.6215827338129495,162.0
849,2456,histopathological examination,0.6214504596527065,234.0
850,1914,years underwent,0.6202117420596739,537.0
851,3280,management patients,0.6193225985563562,507.0
852,1316,better understand,0.6181506849315086,361.0
853,2688,material properties,0.6174343734522068,271.0
854,2580,cbct images,0.6163624511082134,305.0
855,357,specificity predictive,0.615015669709769,868.0
856,1676,shed light,0.6140845070422458,218.0
857,3391,treatment response,0.6133854645814174,635.0
858,1907,electron microscopic,0.6108757870635374,184.0
859,3242,consistent previous,0.6108374384236485,124.0
860,1075,previous research,0.6100456621004563,167.0
861,1862,assess accuracy,0.6086956521739112,170.0
862,2714,remains controversial,0.6085227272727283,252.0
863,3475,brain stem,0.6078431372549017,155.0
864,272,used compare,0.607212326521693,567.0
865,3613,used quantify,0.6067264573991029,246.0
866,335,still unclear,0.6032992411745295,223.0
867,3387,obstructive pulmonary,0.6029106029106027,174.0
868,3352,treatment options,0.602799848656829,569.0
869,3127,using visual,0.6011121408711767,141.0
870,2285,versus versus,0.6009458500827608,291.0
871,2525,complications observed,0.6003811944091485,189.0
872,1964,images taken,0.598639455782315,176.0
873,2540,male mean,0.5981768459434822,193.0
874,1253,patients least,0.5978593272171256,255.0
875,2893,inflammatory markers,0.5974326059050058,179.0
876,3699,breast imaging,0.5966455460305602,348.0
877,460,flow cbf,0.5963842975206608,251.0
878,2825,method could,0.5952531645569609,171.0
879,3360,success rate,0.595109993314443,1005.0
880,1627,small animal,0.5923986486486482,167.0
881,220,young adult,0.5919439579684753,130.0
882,3451,bone regeneration,0.5918513223731242,345.0
883,75,proportional hazards,0.5899441340782104,288.0
884,2197,weight kg,0.5878549988455323,190.0
885,422,feasibility using,0.5873417721518999,232.0
886,2920,cartilage damage,0.5856677524429967,186.0
887,807,cell carcinoma,0.5840108401084015,862.0
888,2426,right ventricle,0.5834754483975304,451.0
889,960,cruciate ligament,0.5831265508684875,423.0
890,3401,fluorescently labeled,0.5830985915492953,138.0
891,2490,objective compare,0.5829545454545455,189.0
892,483,patients operated,0.5806451612903224,180.0
893,1364,ascending aorta,0.5747410624791152,549.0
894,1864,temporal cortex,0.5726239669421482,241.0
895,3566,imaging agents,0.5709726443768991,221.0
896,2890,peripapillary retinal,0.5702127659574474,134.0
897,1347,patients experienced,0.5679049034175336,546.0
898,1663,subjects aged,0.5668228678537945,144.0
899,2821,vs ml,0.5663588390501317,159.0
900,215,groups however,0.5633074935400595,218.0
901,49,prospectively collected,0.5620253164556929,222.0
902,2970,excluded patients,0.5607843137254875,143.0
903,1734,surgical technique,0.5585106382978733,300.0
904,1196,january march,0.5580908032596034,141.0
905,2831,relative controls,0.557198443579765,179.0
906,405,level iv,0.5566460219151963,254.0
907,2423,tumor tissue,0.5552033080634041,212.0
908,2678,prospective randomized,0.55088118249005,255.0
909,1437,examination performed,0.5506883604505656,200.0
910,1533,median range,0.5491990846681912,300.0
911,1492,surface morphology,0.5488833746898262,158.0
912,3006,skull base,0.5484232112176458,532.0
913,796,residual tumor,0.5482200647249157,242.0
914,2008,muscle volume,0.5451697127937326,174.0
915,2053,cortical surface,0.5418764302059503,224.0
916,2114,level dependent,0.5403508771929817,154.0
917,2030,vein thrombosis,0.5350368754544508,326.0
918,915,technique allows,0.5346153846153834,139.0
919,1924,urinary tract,0.5314117811669229,422.0
920,1640,left subclavian,0.5305683563748099,157.0
921,1788,oct images,0.5278510473235059,252.0
922,1586,regions associated,0.5275340200941115,244.0
923,3651,cancer mortality,0.5270833333333336,161.0
924,2656,natural history,0.5265060240963859,391.0
925,2502,venous thrombosis,0.5263003232441963,199.0
926,2031,sensitivity specificity,0.5251688896587673,5053.0
927,1633,success achieved,0.5249999999999981,182.0
928,2828,fatty acid,0.5247102366806271,296.0
929,2078,taken together,0.5245139475908714,730.0
930,2487,median time,0.5242381489841966,563.0
931,1010,blunt trauma,0.5234899328859081,130.0
932,262,cancer treatment,0.5205479452054768,285.0
933,193,adverse cardiac,0.520321185917233,324.0
934,3083,without known,0.5195009848982273,172.0
935,565,salivary gland,0.5186827105763148,195.0
936,2772,muscle thickness,0.5178147268408557,218.0
937,2545,skeletal muscle,0.5170568561872899,773.0
938,3046,atrial appendage,0.5168443496801709,202.0
939,3518,retrospectively identified,0.5156626506024096,214.0
940,362,patients known,0.5156250000000006,132.0
941,908,cartilage thickness,0.5150720838794239,131.0
942,207,foreign body,0.5146879596553895,331.0
943,3302,liver lesions,0.514089347079039,204.0
944,472,atrial septal,0.5087371083868466,304.0
945,1046,anterior wall,0.5079754601226949,138.0
946,750,sought determine,0.506854838709683,419.0
947,3042,changes observed,0.506626612475702,235.0
948,3246,men mean,0.5061174216504716,451.0
949,3067,outcomes assessed,0.5050228310502282,158.0
950,2274,however role,0.5046439628482964,163.0
951,851,real data,0.5024630541871933,170.0
952,2035,software used,0.5019490254872544,186.0
953,100,determine whether,0.5011984021304715,1882.0
954,2149,biopsy performed,0.49995235826584083,159.0
955,785,tumor resection,0.499899979995999,255.0
956,132,care patients,0.4985507246376817,172.0
957,903,activation left,0.49830508474576274,147.0
958,1741,controls using,0.49772727272727246,146.0
959,1361,bone disease,0.49477786438035865,138.0
960,653,web science,0.49454949944382687,171.0
961,546,blood volume,0.4928409947249447,436.0
962,3041,longitudinal strain,0.49234659922800494,685.0
963,1709,prospectively enrolled,0.49206349206349154,310.0
964,118,values obtained,0.49135577797997954,300.0
965,2903,tissue damage,0.48734052993130256,191.0
966,242,ultrasound imaging,0.48637083993660896,682.0
967,1073,ductus arteriosus,0.48372093023255736,176.0
968,3646,oxidative stress,0.48239473409257544,855.0
969,12,escherichia coli,0.48214537755821957,488.0
970,2810,cognitive control,0.4814065660494791,442.0
971,3061,heart failure,0.4800175669740902,2186.0
972,2064,particularly important,0.47972972972972905,142.0
973,3072,imaging tests,0.479096045197739,212.0
974,2655,natriuretic peptide,0.47869163308840945,306.0
975,3400,brain metastases,0.47839506172839474,186.0
976,2781,twin pregnancies,0.4770718232044203,157.0
977,142,regions interest,0.4733767096003178,775.0
978,3576,healthy adults,0.47185430463576167,300.0
979,249,work provides,0.470175438596493,134.0
980,512,brain development,0.4698205546492655,288.0
981,395,chronic inflammatory,0.46837294332723967,183.0
982,1981,stereotactic body,0.4676959619952496,179.0
983,3704,brain lesions,0.46563573883161613,271.0
984,2604,spectroscopy mrs,0.46563192904656414,150.0
985,1222,months range,0.46527594401901035,881.0
986,484,anterior cruciate,0.4644329896907206,318.0
987,2843,findings present,0.4637681159420277,128.0
988,182,aimed identify,0.4619085805934236,192.0
989,1976,young modulus,0.4614147909967841,205.0
990,3524,low back,0.4591821183642364,393.0
991,762,support use,0.45844980940279506,164.0
992,3142,osteoarthritis oa,0.4578146611341687,331.0
993,1584,reactive oxygen,0.45690789473684146,463.0
994,2297,ultrasound examination,0.4553278688524602,404.0
995,1508,vascular factors,0.45494505494505477,184.0
996,2801,present review,0.454054054054054,147.0
997,3655,predictive values,0.4512445763873012,520.0
998,2850,epithelial cell,0.44987277353689675,156.0
999,3549,binding affinity,0.44897959183673475,165.0
1000,3421,performed single,0.44722222222222535,161.0
1001,892,septal defect,0.44518087528459405,419.0
1002,1457,local anesthetic,0.4446650124069484,128.0
1003,333,aimed assess,0.4439721509710525,466.0
1004,2072,magnetic field,0.4413518886679918,555.0
1005,3463,different concentrations,0.4413492927094673,156.0
1006,586,using system,0.4379391100702592,187.0
1007,2634,studies examined,0.4372469635627529,180.0
1008,1478,spin echo,0.43658536585365626,179.0
1009,2609,breast density,0.4358796296296288,538.0
1010,3376,brain network,0.4342409240924086,277.0
1011,2565,mice treated,0.43343139876972464,219.0
1012,1135,deep brain,0.43024439918533525,325.0
1013,2611,electroencephalography eeg,0.4297842235585422,243.0
1014,3381,disease duration,0.4282542200067969,461.0
1015,1752,together data,0.4273314866112658,178.0
1016,798,series patients,0.42609727164886907,449.0
1017,4,microscopy revealed,0.4253632760898283,210.0
1018,1755,echocardiography tte,0.4234442836468885,133.0
1019,655,vs vs,0.42145820983995397,474.0
1020,3550,initial treatment,0.42075471698113265,223.0
1021,3288,cortical thinning,0.4194768876459946,250.0
1022,540,support hypothesis,0.4192546583850952,225.0
1023,69,groups differences,0.4181541273225702,208.0
1024,1701,functional recovery,0.41719197707736316,208.0
1025,3194,early late,0.4171779141104295,340.0
1026,1690,low levels,0.41606872157655417,179.0
1027,3276,first years,0.41269841269841234,130.0
1028,1668,immune response,0.41025641025641,260.0
1029,3275,cortical regions,0.4095439785401662,392.0
1030,1759,scores patients,0.40762564991334466,147.0
1031,355,blood flow,0.40741139911264873,3065.0
1032,1535,analysis patients,0.4071495766698034,541.0
1033,615,peak velocity,0.40555555555555495,146.0
1034,3044,data showed,0.4054127198917476,214.0
1035,2372,central nervous,0.4026315789473721,1003.0
1036,1277,patients persistent,0.40192030724915945,182.0
1037,2270,average years,0.4017794330643492,511.0
1038,2994,frequently used,0.4015267175572512,263.0
1039,1557,respectively overall,0.40147965474722513,148.0
1040,3206,auditory cortex,0.4004282655246247,187.0
1041,267,class iii,0.400125628140704,245.0
1042,1646,algorithm based,0.4000000000000003,136.0
1043,2013,patients present,0.3980752405949251,325.0
1044,771,initial presentation,0.39754601226993846,162.0
1045,38,symptomatic patients,0.39458832624661827,352.0
1046,3088,molecular mechanisms,0.3941260066319276,320.0
1047,3575,response rate,0.3935379644588043,203.0
1048,1528,showed normal,0.39222596527597847,176.0
1049,1108,health care,0.38947368421052553,514.0
1050,1454,differences among,0.38938428874734676,262.0
1051,1167,months postoperatively,0.38864673086670076,426.0
1052,2278,aim assess,0.388624369649352,789.0
1053,3150,patients diabetes,0.388439306358381,192.0
1054,605,characteristics patients,0.38817005545286576,300.0
1055,780,imaging dti,0.3881619937694702,623.0
1056,2198,well described,0.3867583834909729,173.0
1057,52,spinal canal,0.3825708061002179,439.0
1058,1893,immune cells,0.38235294117647095,130.0
1059,1954,median duration,0.3811074918566771,195.0
1060,257,women years,0.3803133668191021,285.0
1061,3137,interstitial lung,0.37923387096774164,209.0
1062,1273,surgical interventions,0.3782964534707487,160.0
1063,1619,intensive care,0.37769740807715524,482.0
1064,1145,diagnostic yield,0.3766584766584769,511.0
1065,3343,color doppler,0.37636152954808516,464.0
1066,289,results highlight,0.3761301989150089,208.0
1067,2294,included studies,0.3757309941520471,257.0
1068,2177,alone combination,0.375199419869471,199.0
1069,3516,mean adc,0.3749999999999988,174.0
1070,2888,transcription factor,0.3740811557255159,284.0
1071,3015,using functional,0.3730005094243575,523.0
1072,2447,preoperative magnetic,0.372420734776044,148.0
1073,1681,lower levels,0.3723653395784537,159.0
1074,1687,transforming growth,0.3721518987341786,147.0
1075,2978,left temporal,0.3719714964370547,174.0
1076,1048,beam computed,0.3714705265366056,466.0
1077,233,adverse outcomes,0.37066743883017206,251.0
1078,2349,blood samples,0.370382695507487,371.0
1079,485,absorbed dose,0.3700633837152608,165.0
1080,1443,world health,0.3699386503067497,201.0
1081,3676,copyright john,0.36982248520710137,375.0
1082,3165,developmental delay,0.36821877309682155,159.0
1083,2094,classification accuracy,0.36734693877550845,210.0
1084,329,fat pad,0.36561100978278915,175.0
1085,507,volume cm,0.36519410977242267,124.0
1086,3372,graphene oxide,0.36486486486486536,270.0
1087,2154,bold signal,0.3643652561247221,409.0
1088,2790,morphological functional,0.36344086021505534,169.0
1089,2127,showed complete,0.3628111273792112,177.0
1090,2020,disease onset,0.3622828784119117,146.0
1091,3461,patients improved,0.36059113300492435,122.0
1092,3307,patients affected,0.3566521528785687,194.0
1093,621,compare results,0.3558359621451101,188.0
1094,1398,foreign bodies,0.3546174142480214,224.0
1095,2768,cerebral blood,0.3536302623550947,966.0
1096,302,intervertebral disc,0.35046530178144114,269.0
1097,2616,tests used,0.3467741935483862,215.0
1098,1107,emergency medicine,0.34659820282413334,150.0
1099,113,highlights importance,0.34480151228733474,144.0
1100,511,department ed,0.34434322656479543,217.0
1101,526,end point,0.3438816163915779,477.0
1102,3078,analysis identified,0.3432989690721659,333.0
1103,966,could used,0.3428812131423854,814.0
1104,1767,diseases including,0.34193548387096717,159.0
1105,2648,mineral content,0.3409493161705559,163.0
1106,2554,preoperatively postoperatively,0.33933649289099493,179.0
1107,1192,range patients,0.33854907539118034,238.0
1108,3593,neural responses,0.33746612466124654,293.0
1109,1403,cochrane library,0.33723849372384873,169.0
1110,2517,vascular complications,0.33706712270200895,146.0
1111,871,eye movement,0.336507936507937,212.0
1112,1532,little information,0.334963325183374,137.0
1113,906,regurgitation mr,0.33441502988898497,178.0
1114,166,matched healthy,0.3333333333333328,235.0
1115,3076,showed higher,0.3330568720379143,937.0
1116,3537,preterm infants,0.3316209034543844,432.0
1117,3339,cases diagnosed,0.3304197814836113,169.0
1118,3025,rnfl thickness,0.32997072783887427,658.0
1119,3341,hazard hr,0.32927033827229507,453.0
1120,1031,confounding factors,0.32897196261681044,176.0
1121,2824,transit time,0.3285601888276944,261.0
1122,890,difference observed,0.3277644230769227,303.0
1123,2358,epilepsy surgery,0.3266644136532611,179.0
1124,809,multivariate logistic,0.3259668508287253,590.0
1125,1797,procedure patients,0.3233979135618484,155.0
1126,1259,independent prognostic,0.3231633881975116,175.0
1127,3320,liver stiffness,0.32290703292152634,471.0
1128,1696,acute aortic,0.32249047013977167,141.0
1129,3378,patients single,0.3208092485549132,185.0
1130,2653,carlo simulation,0.3207920792079205,126.0
1131,2784,five patients,0.3196658097686411,829.0
1132,3011,functional networks,0.3195258889582044,197.0
1133,2304,asymptomatic patients,0.31910112359550985,426.0
1134,1594,class ii,0.3181615711682524,291.0
1135,582,difference mean,0.31803278688524594,194.0
1136,339,ventricular diastolic,0.3179524152847875,147.0
1137,1295,lung disease,0.31748753117206996,485.0
1138,1106,motor area,0.31742313323572396,271.0
1139,2681,survival months,0.3169179229480732,172.0
1140,3034,individual patients,0.31611295681063123,173.0
1141,2016,spontaneous preterm,0.3159019960268661,283.0
1142,503,findings consistent,0.31537376586741916,172.0
1143,211,ad patients,0.3145463274123856,252.0
1144,1956,cognitive functions,0.31256830601092905,286.0
1145,3253,versus respectively,0.3122252970861142,274.0
1146,371,literature regarding,0.3116972477064224,151.0
1147,2605,rankin scale,0.3116438356164387,273.0
1148,1312,feasibility safety,0.310296191819465,200.0
1149,1845,tissue volume,0.3081812831077099,154.0
1150,697,stent graft,0.3078062326442462,344.0
1151,2142,relatively common,0.3070312500000004,131.0
1152,27,gm volume,0.3070063694267515,241.0
1153,1831,mean time,0.3057692307692316,530.0
1154,3366,task performance,0.30547945205479515,223.0
1155,1420,high prevalence,0.30546190155091,302.0
1156,103,determine incidence,0.30410447761194087,163.0
1157,3574,decision making,0.3035264483627197,482.0
1158,53,following surgery,0.3034662691017513,177.0
1159,327,range iqr,0.30307262569832444,217.0
1160,3598,however whether,0.30256835128417514,166.0
1161,1181,early phase,0.3015706806282721,144.0
1162,984,novel therapeutic,0.30149679258731255,141.0
1163,1722,survival analysis,0.30070921985815563,212.0
1164,2259,studies required,0.2992443324937031,198.0
1165,2166,typically developing,0.2989455184534269,189.0
1166,2815,quantitative computed,0.29736842105264333,226.0
1167,1912,pulmonary vein,0.29464285714285665,210.0
1168,2539,silver nanoparticles,0.294552169898427,319.0
1169,2151,literature search,0.2942839582052839,266.0
1170,1838,vertebral fractures,0.29364527347454983,172.0
1171,1716,screening mammography,0.2931442080378264,248.0
1172,1827,upper extremity,0.29189562813202036,206.0
1173,2827,second third,0.2917345750873107,179.0
1174,2856,open reduction,0.29142322972657186,215.0
1175,1091,abdomen pelvis,0.29133398247322206,136.0
1176,1427,using magnetic,0.2910003040437806,563.0
1177,1084,based findings,0.2908011869436198,245.0
1178,195,among different,0.28974641675854484,292.0
1179,240,volume fraction,0.28950749464667896,338.0
1180,875,critical role,0.2883338602592484,304.0
1181,2024,neuroendocrine tumors,0.2841870824053454,174.0
1182,2783,patients whose,0.2837971464896167,245.0
1183,2217,structural magnetic,0.2828854314002835,200.0
1184,3158,groups based,0.2815215757029016,302.0
1185,2494,magnetoencephalography meg,0.28070175438596434,160.0
1186,3017,posterior wall,0.28068181818181853,209.0
1187,2687,quality assessment,0.28050314465408915,223.0
1188,859,cystic lesions,0.2801447308909998,163.0
1189,2054,using either,0.28002028397565887,251.0
1190,478,disc herniation,0.2799077227287707,196.0
1191,1993,axial length,0.279363101958189,312.0
1192,291,control participants,0.2772511848341242,234.0
1193,551,cells cells,0.27674714104193165,198.0
1194,2141,anterior chamber,0.2761052952535826,289.0
1195,1760,cortical subcortical,0.2751677852348996,205.0
1196,2111,artery calcium,0.2747358309317962,220.0
1197,1786,hemorrhage ich,0.27408993576017043,128.0
1198,531,retrospective patients,0.27378318584070793,275.0
1199,1360,groups difference,0.2723279648609097,186.0
1200,2734,patients complete,0.27193558007754276,291.0
1201,3449,parietal regions,0.2713947990543746,164.0
1202,1379,paper present,0.2713936430317838,185.0
1203,1429,retrospective included,0.27120181405895705,299.0
1204,2722,incidental findings,0.2705035971223022,188.0
1205,1510,high specificity,0.2699345248628562,263.0
1206,1238,chronic inflammation,0.2689275893675529,163.0
1207,35,even though,0.2683486238532071,390.0
1208,1806,manual segmentation,0.26829268292682856,190.0
1209,3458,shear stress,0.2682873465418736,356.0
1210,3322,cardiac involvement,0.26812418014866635,146.0
1211,3517,connectivity analysis,0.2666666666666674,183.0
1212,3523,frequently observed,0.26598569969356584,186.0
1213,3546,tibial plateau,0.2592964824120605,258.0
1214,3190,chest radiography,0.25918310122441346,235.0
1215,2944,interobserver variability,0.258959537572254,224.0
1216,1105,could lead,0.2585160202360873,219.0
1217,3483,using model,0.2580246913580236,209.0
1218,933,lung adenocarcinoma,0.2576301615798925,205.0
1219,2793,measurements obtained,0.2574380165289253,356.0
1220,1280,cavernous sinus,0.2573529411764707,175.0
1221,1412,gadolinium enhancement,0.2573341448569689,302.0
1222,3221,associated low,0.25714285714285695,117.0
1223,3596,thirty patients,0.25689201053555777,209.0
1224,3237,acute phase,0.25657336726039026,275.0
1225,2498,imaging confirmed,0.2565656565656555,127.0
1226,3536,trial patients,0.25386715195632337,155.0
1227,2992,radial artery,0.25266787062879614,285.0
1228,3189,screening program,0.25229960578186583,160.0
1229,2306,wave elastography,0.2521440823327614,294.0
1230,1125,patients controls,0.25201435979258296,1053.0
1231,3255,brain atrophy,0.2519948519948524,267.0
1232,1995,diagnostic imaging,0.2515815085158146,517.0
1233,1814,sinus rhythm,0.2513011152416357,182.0
1234,974,traumatic brain,0.25043344249662663,500.0
1235,1117,pericardial effusion,0.24935064935064966,192.0
1236,455,adverse effects,0.2491981310771568,429.0
1237,2761,differ groups,0.24735812133072319,316.0
1238,1283,taken account,0.24687859057832245,293.0
1239,3347,modified rankin,0.2455284552845518,302.0
1240,808,artery patients,0.24520123839009433,132.0
1241,1226,system based,0.2439393939393933,161.0
1242,2675,diagnostic evaluation,0.24114475321443396,153.0
1243,3634,glucose metabolism,0.2407006222631939,373.0
1244,1793,accuracy sensitivity,0.240589198036012,245.0
1245,3521,uterine artery,0.24012409513960692,258.0
1246,2601,relaxation time,0.23899253731343298,427.0
1247,811,found cases,0.2388724035608313,161.0
1248,3198,medical therapy,0.23828124999999925,305.0
1249,3548,vertebral artery,0.23800653367623548,439.0
1250,2205,percutaneous coronary,0.2373004354136418,981.0
1251,3268,spinal stenosis,0.23705103969754268,198.0
1252,1047,median survival,0.23671497584541143,245.0
1253,1317,chest radiograph,0.2347578347578345,206.0
1254,1933,weeks range,0.2333333333333336,119.0
1255,2381,h h,0.2329711719542223,187.0
1256,2319,randomized trial,0.23273222184416475,380.0
1257,707,back pain,0.23241385388208285,694.0
1258,819,diastolic dysfunction,0.23211482395156044,575.0
1259,3462,visual analog,0.23200220324979362,351.0
1260,3365,identified cases,0.23169955442393367,140.0
1261,2067,chronic obstructive,0.2305134835611373,208.0
1262,83,weeks treatment,0.23037249283667588,134.0
1263,1233,cell surface,0.22976434927153588,379.0
1264,230,reviewed medical,0.22851239669421528,158.0
1265,279,state art,0.22758620689655124,143.0
1266,2702,grade iii,0.2271468144044318,164.0
1267,2387,mortality morbidity,0.22602739726027335,165.0
1268,840,right side,0.22453923117430213,328.0
1269,598,verbal memory,0.22429906542056077,120.0
1270,1837,showed reduced,0.22407862407862414,228.0
1271,2836,cases mean,0.22293814432989614,173.0
1272,3601,using techniques,0.2220472440944877,141.0
1273,1589,measured patients,0.22180731889469757,165.0
1274,922,biomechanical properties,0.22172284644194826,148.0
1275,667,inferior parietal,0.21985815602836836,465.0
1276,3619,fluorescent proteins,0.21937587331159764,157.0
1277,1792,patients coronary,0.21926466119720547,328.0
1278,1877,plexiform layer,0.21844660194174736,150.0
1279,764,red blood,0.2176997759522033,265.0
1280,2275,depth imaging,0.2167664670658682,181.0
1281,633,aim identify,0.21641468682505346,167.0
1282,3412,postmenopausal women,0.2146915792167919,466.0
1283,2809,rv function,0.21416151014333842,279.0
1284,450,care unit,0.21347855684138795,392.0
1285,2324,patients completed,0.2127450980392155,217.0
1286,1994,currently available,0.21088435374149725,310.0
1287,1563,systolic function,0.2093903293622995,498.0
1288,722,patients similar,0.2074766355140187,148.0
1289,1474,medial temporal,0.2072607260726073,314.0
1290,2331,living cells,0.20539192272992648,523.0
1291,2444,present man,0.20373250388802297,131.0
1292,3399,preoperative planning,0.2036054521471495,302.0
1293,3257,limb ischemia,0.20343969223806288,155.0
1294,1972,disease chd,0.2024691358024673,164.0
1295,212,higher mean,0.2018018018018009,224.0
1296,710,normal abnormal,0.198969072164949,193.0
1297,2835,studies reported,0.19792247276412447,434.0
1298,1113,results confirmed,0.19742336739227023,202.0
1299,2469,young patients,0.1973700688791482,197.0
1300,1848,using cardiac,0.1973094170403585,132.0
1301,3225,enhanced depth,0.1970323264440908,169.0
1302,3540,cell count,0.1961538461538464,255.0
1303,3404,months later,0.19568733153638626,363.0
1304,3023,period patients,0.19448535708169276,334.0
1305,1100,lumbar spine,0.1944194419441916,936.0
1306,898,new approach,0.19362224039247677,296.0
1307,2482,vital capacity,0.19230769230769154,150.0
1308,1867,cell population,0.19190404797601213,128.0
1309,1562,tissue sections,0.18996282527881006,146.0
1310,2384,artery dissection,0.18931750741839753,174.0
1311,976,fourteen patients,0.18922716627634673,202.0
1312,3681,found higher,0.18874931731294362,216.0
1313,704,surgery performed,0.18874262369496034,297.0
1314,18,plain radiographs,0.1885913853317809,270.0
1315,1094,matter wm,0.18857730142416693,338.0
1316,2932,used estimate,0.1883920076118008,330.0
1317,3374,mean total,0.18776978417266202,174.0
1318,11,success rates,0.1858075750979539,388.0
1319,1491,pulmonary disease,0.18571428571428553,259.0
1320,1353,low sensitivity,0.18458523840627042,157.0
1321,2244,results support,0.18282950423216393,378.0
1322,3309,findings revealed,0.1822660098522173,185.0
1323,1476,intracranial pressure,0.17811984606926895,180.0
1324,2530,solid tumors,0.1780199818346963,280.0
1325,948,arterial spin,0.17768560763168834,306.0
1326,93,visual field,0.17763326773337898,519.0
1327,954,coronary intervention,0.17733168622606596,957.0
1328,679,changes patients,0.17361761949390836,195.0
1329,3626,pd patients,0.17298136645962314,557.0
1330,19,effects observed,0.17291666666666747,166.0
1331,2323,optimal treatment,0.1720067453625621,170.0
1332,3100,reconstruction using,0.17173913043478276,158.0
1333,901,brain region,0.17122473246135542,180.0
1334,2252,investigated whether,0.16943946762221826,662.0
1335,1846,cells showed,0.1684901531728661,165.0
1336,895,patients likely,0.16829268292682867,138.0
1337,608,analog scale,0.16690814256737188,320.0
1338,1913,young children,0.16599190283400847,205.0
1339,2232,characteristic analysis,0.1657269288416239,430.0
1340,1991,reconstruction algorithm,0.16545265348595217,159.0
1341,2507,mean mean,0.1648936170212776,155.0
1342,1276,angiography revealed,0.16482340349625413,154.0
1343,1369,support vector,0.16432748538011643,281.0
1344,3616,reference values,0.16426512968300006,285.0
1345,3096,recent developments,0.16381909547738677,163.0
1346,2878,jugular vein,0.16279688390651714,252.0
1347,2325,average months,0.16156282998944055,153.0
1348,2082,ventricular ejection,0.15995174909529442,663.0
1349,505,univariate multivariate,0.1597690086621741,415.0
1350,1931,studies performed,0.15934028946482623,526.0
1351,3560,higher number,0.15904936014625218,174.0
1352,1859,however remains,0.15842185128983086,174.0
1353,2650,animal model,0.15822536317236197,403.0
1354,1268,hip fracture,0.15680880330123748,190.0
1355,1860,analyses using,0.15670840787119847,146.0
1356,1173,demographic characteristics,0.15641025641025724,183.0
1357,334,determine association,0.15555555555555609,171.0
1358,2621,beneficial effects,0.15506607929515437,176.0
1359,1406,early postoperative,0.15468750000000006,231.0
1360,3667,small vessel,0.15230927129661168,318.0
1361,1639,respectively conclusion,0.15172018348623845,147.0
1362,694,patients years,0.14986751987202118,1153.0
1363,1883,inner outer,0.14909819639278682,124.0
1364,3003,patients could,0.1479058635819698,206.0
1365,2513,stromal cells,0.1477042642396973,314.0
1366,269,levels serum,0.14742268041236953,143.0
1367,400,postoperative period,0.14729524223332585,226.0
1368,1477,mice bearing,0.14725274725274762,134.0
1369,2147,occipital cortex,0.14472843450479206,151.0
1370,1025,improve outcomes,0.14212454212454265,194.0
1371,26,kappa statistics,0.14137931034482815,123.0
1372,2669,bone defects,0.14135814690160337,210.0
1373,2516,coronary sinus,0.141356255969437,148.0
1374,2493,demonstrated higher,0.1412280701754364,161.0
1375,1802,data consecutive,0.13996316758747665,152.0
1376,2079,acquisition time,0.13872809608190553,271.0
1377,699,imaging positron,0.13829321663019717,158.0
1378,167,cardiac hypertrophy,0.13728425232931094,214.0
1379,606,stemi patients,0.13699374830116906,280.0
1380,1172,machine learning,0.13609455701231615,403.0
1381,2261,oct imaging,0.13581321725366025,156.0
1382,1250,flow cytometry,0.13459167655729565,651.0
1383,2357,using analysis,0.13430531732418488,261.0
1384,3531,contrast agents,0.133470514972654,948.0
1385,970,specific brain,0.13319530710835076,193.0
1386,2813,operating room,0.1324786324786327,310.0
1387,3610,pancreatic duct,0.13211009174311913,240.0
1388,3457,hepatocellular carcinoma,0.13207009965146513,708.0
1389,3147,direct comparison,0.1316455696202529,156.0
1390,1194,gestational weeks,0.12817258883248767,202.0
1391,307,imaging demonstrated,0.12784717119764868,174.0
1392,2859,parkinson disease,0.1269500043575517,874.0
1393,689,retinal layers,0.12615062761506257,201.0
1394,844,cingulate cortex,0.12594484836575692,874.0
1395,433,fiber tracts,0.12593737920371073,181.0
1396,1799,carotid plaque,0.12476092393703103,240.0
1397,1597,disease however,0.12390057361376648,216.0
1398,3138,gene expression,0.12263535551206872,940.0
1399,2532,saphenous vein,0.12222222222222225,223.0
1400,1404,myocardial function,0.12198649951784,230.0
1401,356,cancer res,0.11815017404276483,132.0
1402,2196,patients required,0.11564625850340084,425.0
1403,732,value npv,0.11551312649164587,242.0
1404,210,brain changes,0.11534764498558175,216.0
1405,3694,frontal temporal,0.11524222134698663,209.0
1406,2881,identified using,0.11524016604071961,265.0
1407,2488,experimental data,0.11330600074543401,304.0
1408,1973,neural activation,0.11019108280254722,173.0
1409,3700,prediction model,0.10935073004038544,160.0
1410,1588,patients selected,0.1080291970802912,148.0
1411,3539,medical history,0.10716510903426767,344.0
1412,3077,multiple linear,0.106106870229008,278.0
1413,980,emotion regulation,0.10607940446650052,285.0
1414,2446,type b,0.10570342205323206,278.0
1415,1836,internal jugular,0.10514861995753697,283.0
1416,725,inflammatory bowel,0.10457516339869351,160.0
1417,3293,fdg uptake,0.10456704420898824,477.0
1418,508,drug delivery,0.10422826157123485,897.0
1419,85,core biopsy,0.10283018867924511,218.0
1420,1069,state functional,0.10262127146730944,262.0
1421,1779,obtained patients,0.10091743119265917,473.0
1422,514,cancer therapy,0.10029673590504497,247.0
1423,282,animal models,0.10022026431717698,455.0
1424,3467,individual differences,0.0986446983789532,464.0
1425,379,mortality rates,0.0975426423821914,241.0
1426,585,preoperative evaluation,0.09695926563396476,169.0
1427,1414,ability detect,0.09612403100775038,186.0
1428,117,nervous system,0.0955947136563857,1302.0
1429,2135,carried using,0.09417833456153296,213.0
1430,2599,endoscopic ultrasound,0.09354838709677421,203.0
1431,2750,patients lung,0.09347258485639712,179.0
1432,2940,amino acids,0.09146154752090482,353.0
1433,2773,valve surgery,0.09021739130434776,166.0
1434,1140,review patients,0.08986568986569037,368.0
1435,3186,layer thickness,0.08978817578248464,284.0
1436,1003,cognitive decline,0.08975979772439852,355.0
1437,2567,cell layer,0.08870523415977981,161.0
1438,3140,first second,0.08842874543240017,363.0
1439,2073,female male,0.08827831587270238,319.0
1440,1102,outer retinal,0.08688845401174161,222.0
1441,1577,factors including,0.08659049909801542,288.0
1442,2025,surgical excision,0.08581436077057872,245.0
1443,2404,developed using,0.08493975903614484,141.0
1444,331,aimed examine,0.08433048433048304,148.0
1445,2443,lower extremities,0.08416610398379479,277.0
1446,879,anisotropy fa,0.08385308385308593,605.0
1447,815,studies used,0.08351454598883343,203.0
1448,3310,calcium score,0.08299711815561986,208.0
1449,3070,followed months,0.08296199213630412,211.0
1450,3588,parietal cortex,0.08292682926829625,459.0
1451,2233,post hoc,0.0822190611664299,289.0
1452,495,within weeks,0.08172484599589519,199.0
1453,1839,tomography scans,0.08048954797212719,901.0
1454,3014,using image,0.07861507128309451,193.0
1455,1334,end diastolic,0.07813411078717185,134.0
1456,2795,investigate influence,0.07725540025412989,152.0
1457,1036,muscle strength,0.0770207654024371,204.0
1458,214,psychiatric disorders,0.07686729514140649,265.0
1459,2264,rates patients,0.0761670761670763,155.0
1460,1645,efficacy safety,0.07586083213773337,423.0
1461,1669,fluorescent imaging,0.0743609604957402,160.0
1462,2458,scan patients,0.07432024169184133,123.0
1463,2642,early stages,0.07419100236779815,470.0
1464,1794,routine practice,0.07377938517179108,204.0
1465,1254,quality assurance,0.07350993377483432,222.0
1466,1602,data provide,0.07250922509225098,262.0
1467,1870,across multiple,0.07171964140179299,176.0
1468,2077,performed consecutive,0.07159904534606493,150.0
1469,447,last decade,0.07117942654448686,172.0
1470,1921,arterial phase,0.07111521588547684,220.0
1471,449,detailed analysis,0.07028423772609907,136.0
1472,553,successfully used,0.06877770740975285,181.0
1473,1763,somatosensory cortex,0.0683728448275862,282.0
1474,2376,supine position,0.06753006475485707,219.0
1475,2409,contrast media,0.06705710102489054,229.0
1476,1841,endoplasmic reticulum,0.06669785720969429,324.0
1477,2359,electron microscope,0.06644429619746557,498.0
1478,509,recurrence rates,0.06487358795051085,201.0
1479,2071,results suggested,0.06437571592210838,281.0
1480,3602,sd sd,0.0631399317406145,185.0
1481,2268,evaluation treatment,0.06294937637564275,143.0
1482,2630,connectivity left,0.06250917094644158,142.0
1483,861,gene delivery,0.062039045553145176,209.0
1484,415,sentinel lymph,0.06152130269908545,197.0
1485,1697,analysis based,0.05951035781544287,158.0
1486,2052,cm cm,0.0590614725515592,468.0
1487,2652,free wall,0.058988819629959215,271.0
1488,676,use ultrasound,0.05649432534678472,224.0
1489,1655,injury tbi,0.055489614243322855,187.0
1490,2209,tumor volume,0.05515080297688766,704.0
1491,1097,improved accuracy,0.05510623714873225,134.0
1492,3099,ultrasound examinations,0.05495417603320073,227.0
1493,1703,patients mild,0.05446009389671364,290.0
1494,337,structural features,0.05332548557975264,151.0
1495,101,patients developed,0.05287162162161993,626.0
1496,942,laser irradiation,0.052161243322001095,179.0
1497,1609,however patients,0.05125535823637482,279.0
1498,1204,superior parietal,0.051024042742653646,191.0
1499,3215,surgical outcomes,0.050456720313179576,290.0
1500,2929,assessment performed,0.05013939523911639,167.0
1501,643,hearing loss,0.049493861727330335,383.0
1502,1060,model developed,0.04939550949913684,143.0
1503,496,resting state,0.04916857512695446,823.0
1504,806,value ppv,0.048473282442748115,254.0
1505,1329,layer rnfl,0.04827828531271938,229.0
1506,162,days later,0.047727272727272514,168.0
1507,2263,flip angle,0.046066886481394544,163.0
1508,2414,duration years,0.04534883720930225,156.0
1509,1507,ultrasound used,0.04372574385510936,169.0
1510,1665,ventricular assist,0.043521594684385725,131.0
1511,2735,pulmonary nodules,0.04179785039626556,275.0
1512,187,large number,0.03945606263521223,383.0
1513,3504,functional changes,0.03903462749213007,186.0
1514,435,every months,0.03808374978459386,221.0
1515,2739,brain stimulation,0.038013740897683564,308.0
1516,564,hip joint,0.0379187455452602,266.0
1517,2110,level evidence,0.03748290013679706,274.0
1518,3494,abnormal findings,0.037267080745341345,210.0
1519,2531,months mean,0.03708320349018354,357.0
1520,620,demonstrated high,0.036630036630036764,150.0
1521,452,remains challenge,0.036574074074073835,158.0
1522,1458,arteriovenous fistula,0.036421119190641914,192.0
1523,311,bone remodeling,0.03594351732990917,140.0
1524,2269,patients atrial,0.03522696384887216,216.0
1525,3473,left upper,0.034858387799564135,160.0
1526,424,hcc patients,0.03482466747279461,144.0
1527,1422,differences patients,0.03402571711177038,172.0
1528,181,correlated well,0.03229166666666559,186.0
1529,1530,procedure time,0.031071570840526013,390.0
1530,967,fa values,0.030908736349453857,317.0
1531,648,anterior descending,0.029888268156423797,428.0
1532,2301,atherosclerotic plaque,0.02885048835461987,192.0
1533,3417,survival patients,0.0283779560370869,454.0
1534,3173,carpal tunnel,0.027942421676545422,165.0
1535,795,incidence rate,0.02729754322111054,150.0
1536,154,surgery years,0.027152988855116265,134.0
1537,3688,carotid arteries,0.026372401493619097,338.0
1538,1198,lv dysfunction,0.025809795283752372,166.0
1539,2984,nerve root,0.0255319148936174,192.0
1540,1751,investigate potential,0.02539208364451018,170.0
1541,1861,delivery systems,0.02534837425348401,191.0
1542,934,spin labeling,0.025184911242603903,227.0
1543,3469,patients symptomatic,0.02388331814038357,393.0
1544,909,using confocal,0.021230942970074163,188.0
1545,2393,conventional imaging,0.020908802033683952,329.0
1546,521,performed months,0.020787850023730597,219.0
1547,2253,myocardial dysfunction,0.02056202878684014,150.0
1548,618,thyroid cancer,0.019897067850229055,301.0
1549,745,used patients,0.019630071599046384,329.0
1550,1485,surgically treated,0.018412348401323084,167.0
1551,1021,revealed differences,0.018071727992547866,194.0
1552,369,morphological changes,0.017847411444141637,393.0
1553,1920,complete resolution,0.016477328855082757,278.0
1554,2588,inversely correlated,0.015527950310559115,225.0
1555,1138,together findings,0.014168136390358427,241.0
1556,144,years male,0.012315050067253277,412.0
1557,3319,atrial la,0.012032816773016946,198.0
1558,2009,tomographic angiography,0.010883648613630807,210.0
1559,595,studies including,0.008067358527511665,206.0
1560,3629,operating characteristic,0.007356535439433879,1821.0
1561,3411,pulmonary venous,0.006104345211246744,203.0
1562,2561,cell density,0.005822129024299576,236.0
1563,656,vivo imaging,1.956823729498034e-14,501.0
1564,1733,scans patients,1.2772511809235293e-14,355.0
1565,436,mode network,4.928099809711596e-15,514.0
1566,2470,mean values,4.01935502962838e-15,369.0
1567,571,complications including,3.5071605764016404e-15,139.0
1568,2321,directly related,2.8878305164780746e-15,128.0
1569,2216,cardiovascular diseases,2.369558315584045e-15,257.0
1570,439,cell type,2.1782920143850156e-15,141.0
1571,1255,single center,2.1416498391159134e-15,215.0
1572,1776,provide detailed,1.780439742660249e-15,154.0
1573,705,analyses conducted,9.608278076262024e-16,157.0
1574,3506,among subjects,8.468312880773295e-16,157.0
1575,2798,connectivity fc,8.017850424412049e-16,237.0
1576,1387,findings included,7.030789435315342e-16,127.0
1577,2251,patients hips,6.654321183008621e-16,169.0
1578,1832,without compromising,6.187374117221375e-16,157.0
1579,3330,associated development,4.922467585868231e-16,157.0
1580,3133,safety efficacy,4.611950160250911e-16,521.0
1581,1313,plays key,3.780306128365387e-16,157.0
1582,3692,using echocardiography,3.4965711659035307e-16,172.0
1583,1248,fine needle,2.287633519352993e-16,236.0
1584,366,impairment mci,2.2007821733816587e-16,191.0
1585,34,evaluated using,0,1340.0
1586,696,white matter,0,4245.0
1587,2799,response treatment,0,288.0
1588,1336,first time,0,1522.0
1589,3512,computed tomography,0,10700.0
1590,2564,endothelial function,0,268.0
1591,462,imaging evaluation,0.0,169.0
1592,3292,purpose determine,0,542.0
1593,252,underlying mechanisms,0,335.0
1594,727,data available,0,461.0
1595,2640,consecutive series,0,231.0
1596,2156,different regions,0,192.0
1597,1652,test hypothesis,0,385.0
1598,1503,different conditions,-4.1237271418900833e-16,162.0
1599,2804,spectroscopy xps,-4.1746009175107465e-16,146.0
1600,271,body surface,-6.876752172875472e-16,306.0
1601,3632,total cases,-1.1099319296570937e-15,204.0
1602,201,liver fibrosis,-0.005016545969017986,523.0
1603,673,patients pd,-0.00508839210550936,272.0
1604,2867,patients abnormal,-0.005219136835061609,234.0
1605,1453,knee pain,-0.00743220622698354,222.0
1606,2044,operation time,-0.008976102584029595,231.0
1607,591,patients patients,-0.0091994142544753,2293.0
1608,1126,posterior fossa,-0.009435829759155,286.0
1609,1307,wave velocity,-0.010371650821088981,420.0
1610,2037,interobserver agreement,-0.010800970873786338,534.0
1611,2036,tracer uptake,-0.012115563839701518,195.0
1612,476,atherosclerotic plaques,-0.012370645390631178,261.0
1613,2998,records reviewed,-0.013118527042577544,171.0
1614,3157,symptom onset,-0.013240418118466888,228.0
1615,654,patients metastatic,-0.014295925661186667,200.0
1616,3141,accuracy respectively,-0.01538461538461549,159.0
1617,2974,inner ear,-0.01627609714529184,191.0
1618,3398,likely due,-0.016521340064249216,180.0
1619,716,chronic pain,-0.017342879872713227,218.0
1620,2159,years female,-0.018723800652072357,201.0
1621,1880,gastrointestinal tract,-0.01967054263565883,203.0
1622,1352,united states,-0.019989985748950063,519.0
1623,365,alveolar bone,-0.021138853251751837,306.0
1624,3672,time surgery,-0.021266427718040794,178.0
1625,45,stent implantation,-0.021701904595492018,207.0
1626,3418,extracellular matrix,-0.02460567823343809,468.0
1627,486,nasal cavity,-0.02567400445213953,173.0
1628,2461,physical activity,-0.02728860064854063,547.0
1629,3264,therapeutic strategy,-0.02857142857142765,133.0
1630,1642,u test,-0.03022295623451735,183.0
1631,1380,domain optical,-0.031250000000000784,370.0
1632,2788,used detect,-0.03168044077134914,345.0
1633,1820,aneurysm sac,-0.03169164882226981,148.0
1634,459,used create,-0.03322109988776655,148.0
1635,1548,findings provide,-0.03364922757367316,432.0
1636,2533,medial prefrontal,-0.03397880891486997,465.0
1637,3480,mice showed,-0.03461908323538836,180.0
1638,3466,small molecules,-0.03518267929634593,130.0
1639,1552,facet joint,-0.03538268506900873,188.0
1640,2123,diagnostic test,-0.03538511118272645,183.0
1641,10,analyzed data,-0.03609022556391061,168.0
1642,3379,measurements taken,-0.03621274990569622,160.0
1643,3111,independent component,-0.036904761904762336,186.0
1644,412,patients groups,-0.03720782318333712,702.0
1645,2738,propensity score,-0.03756050338818983,194.0
1646,2574,hela cells,-0.03760071620411805,210.0
1647,3382,american society,-0.037749624221601684,293.0
1648,109,correlated negatively,-0.03793626707131906,125.0
1649,1278,closely associated,-0.038169425511197154,196.0
1650,3355,atherosclerotic disease,-0.038566912539515136,183.0
1651,90,transcatheter aortic,-0.03918757467144692,492.0
1652,2731,patients cases,-0.039950678175092555,162.0
1653,2762,tomography used,-0.04064436183395356,164.0
1654,2157,could serve,-0.040667361835243686,195.0
1655,3218,stable patients,-0.04086021505376166,133.0
1656,3123,using diffusion,-0.042663378545004765,173.0
1657,381,slice thickness,-0.04277320799059985,182.0
1658,1058,ionizing radiation,-0.04308579936720569,463.0
1659,183,temporal bone,-0.04321622813464638,294.0
1660,1076,direct indirect,-0.04340567612687794,130.0
1661,188,oral cavity,-0.04362661467219094,179.0
1662,3424,lung tissue,-0.04512946979038157,183.0
1663,1284,quantitative assessment,-0.04537941397445157,302.0
1664,1765,performed retrospective,-0.047390109890109826,345.0
1665,3436,investigate feasibility,-0.04747998115873773,168.0
1666,786,progenitor cells,-0.04794952681387996,152.0
1667,1103,network connectivity,-0.04827844311377209,215.0
1668,258,specific activity,-0.04832605531295487,166.0
1669,2045,provide evidence,-0.04832713754646836,442.0
1670,1287,ejection fraction,-0.04929945381145167,2076.0
1671,1315,american college,-0.04932126696832609,218.0
1672,3456,pituitary gland,-0.0502705361534678,219.0
1673,2917,neurological deficit,-0.05028936340051875,180.0
1674,2930,control patients,-0.05048902011441275,456.0
1675,2909,blood supply,-0.05119549929676644,182.0
1676,1022,prior surgery,-0.05129682997118117,178.0
1677,3130,replacement tavr,-0.052728954671600145,171.0
1678,1772,coronary stenosis,-0.052760736196319546,215.0
1679,2830,associated worse,-0.053604691272851154,259.0
1680,2193,cognitively normal,-0.05365486058779188,178.0
1681,3678,closely related,-0.05400495458298862,327.0
1682,3344,pseudomonas aeruginosa,-0.054128440366972265,177.0
1683,3193,review article,-0.05422535211267605,154.0
1684,3677,subretinal fluid,-0.05436507936507914,137.0
1685,2214,neck cancer,-0.05525888089157123,238.0
1686,1670,bone volume,-0.05705761700540805,306.0
1687,57,treatment modality,-0.05884476534295903,163.0
1688,1720,across different,-0.05912305516265826,209.0
1689,1468,upper limb,-0.05931103344982565,198.0
1690,159,echocardiographic parameters,-0.05943562610229219,337.0
1691,644,images analyzed,-0.060443037974683436,191.0
1692,889,identifying patients,-0.06080305927342324,159.0
1693,3304,due lack,-0.063821892393321,172.0
1694,3128,reliable method,-0.06395806028833587,244.0
1695,751,disease ckd,-0.06497844827586233,201.0
1696,517,transesophageal echocardiography,-0.06516651665166477,362.0
1697,221,retinal detachment,-0.06557486631016038,218.0
1698,1298,time peak,-0.06626984126984063,167.0
1699,701,left coronary,-0.06664707610931461,162.0
1700,3472,pulmonary embolism,-0.0670354409210779,579.0
1701,68,vivo experiments,-0.06756756756756661,175.0
1702,1038,neurological disorders,-0.06843177189409257,168.0
1703,1787,much higher,-0.06907514450867135,239.0
1704,2789,surgical planning,-0.07020348837209348,322.0
1705,204,blood oxygen,-0.07057232987832174,261.0
1706,1272,lumbar spinal,-0.07095830285296242,194.0
1707,2981,screw placement,-0.0727083874318354,200.0
1708,2684,using conventional,-0.07354555433589467,335.0
1709,2610,false lumen,-0.07366720516962844,152.0
1710,2095,oxide nanoparticles,-0.07409293443666422,291.0
1711,2500,overweight obese,-0.07506339814032116,148.0
1712,1421,years years,-0.0752851711026606,627.0
1713,624,limiting membrane,-0.07532937225523136,162.0
1714,429,stroke patients,-0.07677048204721296,774.0
1715,758,high diagnostic,-0.0775431861804228,202.0
1716,1220,bone turnover,-0.07818396226415121,221.0
1717,989,model based,-0.07873443983402466,253.0
1718,14,histological examination,-0.08033573141486794,268.0
1719,2721,cross sectional,-0.08103448275862087,141.0
1720,273,within hours,-0.08252527336496811,400.0
1721,2708,patients idiopathic,-0.08355978260869526,205.0
1722,2767,patients treatment,-0.0837070254110621,168.0
1723,1637,doppler ultrasonography,-0.085166034700678,218.0
1724,1415,using software,-0.08523206751054935,202.0
1725,1575,cells treated,-0.08529411764705792,174.0
1726,1545,different methods,-0.0856375284149626,296.0
1727,1561,proposed algorithm,-0.08569622919738742,226.0
1728,3295,disease associated,-0.08577405857740654,205.0
1729,1472,evaluated patients,-0.08651986674250409,484.0
1730,1504,posterior cingulate,-0.08675889328063063,439.0
1731,99,common patients,-0.08695652173913004,250.0
1732,380,surgical removal,-0.08711656441717762,142.0
1733,2328,spatial statistics,-0.08952319169639902,276.0
1734,1959,automated segmentation,-0.08959711365003034,149.0
1735,1305,women underwent,-0.08998599439775908,257.0
1736,3389,anatomical structures,-0.09073032044068026,333.0
1737,375,antiplatelet therapy,-0.09075777485764323,148.0
1738,1004,tricuspid valve,-0.0918344094189138,279.0
1739,1526,protein kinase,-0.0923639689071782,202.0
1740,3247,portal venous,-0.09308510638297814,175.0
1741,1451,green icg,-0.0930917327293322,137.0
1742,3573,time first,-0.09319271332694132,162.0
1743,491,abdominal pain,-0.09359531306045991,618.0
1744,1775,observed using,-0.09387755102040903,138.0
1745,2758,analyzed retrospectively,-0.09480122324159009,155.0
1746,2701,expression level,-0.09669669669669582,161.0
1747,2959,fluoroscopic guidance,-0.09867549668874054,149.0
1748,2276,cell culture,-0.09912126537785587,376.0
1749,2861,time consuming,-0.0999999999999995,172.0
1750,2486,retinal thickness,-0.10098285386326128,414.0
1751,3151,used analysis,-0.10308008213552619,251.0
1752,1916,bone formation,-0.10322328069946561,791.0
1753,3618,prognostic information,-0.10430696945967183,222.0
1754,1078,cancellous bone,-0.10506688285366853,144.0
1755,1826,years respectively,-0.10553410553410711,410.0
1756,139,rv systolic,-0.1063291139240507,168.0
1757,129,ms ms,-0.10645994832041147,206.0
1758,2975,diabetic macular,-0.10651066238913,166.0
1759,1714,imaging biomarkers,-0.1065789473684212,243.0
1760,2370,patients different,-0.1073807968647944,274.0
1761,1631,number studies,-0.10756972111553803,135.0
1762,2155,cognitive impairment,-0.10950836266593018,952.0
1763,427,nude mice,-0.10986842105263135,167.0
1764,430,renal failure,-0.11123723041997718,294.0
1765,680,aortic diameter,-0.11328125000000007,145.0
1766,558,associated disease,-0.11370967741935435,141.0
1767,1987,multidisciplinary approach,-0.11497584541062764,153.0
1768,2334,peripheral blood,-0.116295025728987,339.0
1769,58,conservative management,-0.11765987241325665,199.0
1770,1178,birth weight,-0.11816255778120191,409.0
1771,1657,achilles tendon,-0.11829405162738456,357.0
1772,1911,mean range,-0.1183978068839474,299.0
1773,715,abdominal ultrasound,-0.11845794392523326,169.0
1774,3664,successful patients,-0.11864406779661048,175.0
1775,185,neural network,-0.11869449378330393,243.0
1776,2242,useful predicting,-0.1195599022004891,163.0
1777,1744,length stay,-0.12144973786186418,296.0
1778,3388,rectal cancer,-0.12213247172859266,378.0
1779,2608,pulmonary valve,-0.12220297887080055,196.0
1780,1936,recent studies,-0.12366114897760506,635.0
1781,376,head circumference,-0.12426470588235286,169.0
1782,3697,determine prevalence,-0.12436182746432731,250.0
1783,2236,imaging examinations,-0.12472963229992808,173.0
1784,3265,knee flexion,-0.12526400116524652,200.0
1785,627,caudate nucleus,-0.12553710370456428,235.0
1786,2814,underwent surgical,-0.12554965883244898,414.0
1787,2946,hepatitis c,-0.12631578947368616,244.0
1788,2744,microscopic examination,-0.12698412698412664,170.0
1789,200,retinal vein,-0.12971675468074892,193.0
1790,330,patients less,-0.1317073170731714,171.0
1791,3258,doppler echocardiography,-0.13184357541899436,236.0
1792,3079,osteogenic differentiation,-0.1320574162679424,184.0
1793,516,showed improvement,-0.132734530938123,266.0
1794,2680,aim examine,-0.13399715504978715,157.0
1795,728,patients assigned,-0.13443231947991607,193.0
1796,2596,brain tissue,-0.13515441850983584,510.0
1797,2140,connectivity within,-0.1359154929577462,193.0
1798,3059,cac score,-0.13600317208564602,245.0
1799,1636,data indicate,-0.13608903020667462,428.0
1800,1896,method measuring,-0.1363184079601985,137.0
1801,25,six months,-0.13742000673627514,408.0
1802,2921,similar results,-0.13746770025839727,342.0
1803,1368,examination patients,-0.1380846325167033,155.0
1804,2614,pulmonary fibrosis,-0.13872721458266746,241.0
1805,695,findings patients,-0.13947422216770872,461.0
1806,1482,lung injury,-0.14034896401308633,198.0
1807,2005,children adults,-0.14172015404364485,184.0
1808,916,plasma membrane,-0.14182349830466348,556.0
1809,794,wide variety,-0.14200178731009788,227.0
1810,107,χ test,-0.14285714285714257,160.0
1811,2541,months following,-0.1441550575408843,170.0
1812,1402,medical students,-0.14436642401597605,249.0
1813,1014,infants born,-0.14456521739130423,133.0
1814,965,nm nm,-0.14500326583932063,185.0
1815,2305,humeral head,-0.14558254747729324,250.0
1816,3580,cancer cell,-0.14559386973180025,570.0
1817,763,cellular level,-0.1467811158798281,133.0
1818,403,hiv infection,-0.1482517482517483,212.0
1819,2137,grade ii,-0.14836795252225443,250.0
1820,998,tricuspid regurgitation,-0.1488731845751487,273.0
1821,1850,findings highlight,-0.15019721272679418,168.0
1822,3511,elevation myocardial,-0.15292283710054336,327.0
1823,2161,time minutes,-0.15376401494927872,288.0
1824,3538,cortical area,-0.15405405405405487,133.0
1825,2136,cognitive processes,-0.15412087912087863,187.0
1826,3578,blood cells,-0.15614194722474908,286.0
1827,2582,electrical stimulation,-0.15629139072847756,236.0
1828,3693,years mean,-0.156914455249712,952.0
1829,1573,interest rois,-0.15754001684920066,187.0
1830,248,laboratory data,-0.15754923413566754,144.0
1831,2960,foveal thickness,-0.15759071834115,168.0
1832,2485,growth restriction,-0.157974300831445,209.0
1833,2348,participants included,-0.1581427581427577,163.0
1834,3414,herein present,-0.1586872586872583,137.0
1835,857,growth rate,-0.15896414342629545,266.0
1836,1168,echocardiography tee,-0.1594827586206894,185.0
1837,1843,cingulate gyrus,-0.16097560975609754,176.0
1838,3332,multiple logistic,-0.16159420289855073,223.0
1839,2548,determine relationship,-0.16198347107438107,196.0
1840,1056,longitudinal studies,-0.16485225505443174,212.0
1841,990,patients first,-0.1669747381392485,271.0
1842,3290,therapeutic target,-0.1671781187458299,179.0
1843,497,venous drainage,-0.16723894162795386,180.0
1844,2479,normal tissue,-0.16746411483253598,175.0
1845,2682,functional structural,-0.16772151898734197,265.0
1846,3303,diabetic retinopathy,-0.168467652681356,364.0
1847,3565,vein occlusion,-0.16935483870967835,210.0
1848,1199,wilcoxon test,-0.16959444805898982,230.0
1849,2101,test used,-0.17084639498431975,545.0
1850,3334,adult male,-0.1733800350262681,165.0
1851,2587,respectively addition,-0.17391304347826056,160.0
1852,619,adjusted odds,-0.17627388535031802,246.0
1853,2098,intracranial aneurysms,-0.17673938298696265,326.0
1854,2428,high resolution,-0.1784204671857626,802.0
1855,1393,performed compare,-0.17914110429447822,146.0
1856,525,seven cases,-0.18053777208706778,141.0
1857,3191,hypertension diabetes,-0.1811206182721499,193.0
1858,2188,provide new,-0.18123569794050318,396.0
1859,2125,pain patients,-0.18152173913043496,167.0
1860,1200,doppler sonography,-0.18252564556066447,172.0
1861,2330,met criteria,-0.1836501901140673,161.0
1862,3317,cardiac disease,-0.1837606837606834,172.0
1863,2112,carotid atherosclerosis,-0.1842491918895089,209.0
1864,2880,results demonstrated,-0.18475902094372984,523.0
1865,114,lean mass,-0.18486005534732175,334.0
1866,3108,image reconstruction,-0.1856153181793122,555.0
1867,2841,children years,-0.18627022299956256,284.0
1868,549,pain scores,-0.18678875081752713,204.0
1869,6,intravenous injection,-0.18749999999999983,165.0
1870,3036,tested using,-0.1875507442489877,231.0
1871,1595,volume loss,-0.1882808375857822,214.0
1872,2452,within h,-0.18843086222819205,362.0
1873,2557,rating scale,-0.1884490972181386,433.0
1874,425,ra patients,-0.1891115644625779,446.0
1875,3250,internal external,-0.18977272727272673,167.0
1876,2484,globus pallidus,-0.18989921866153303,195.0
1877,1331,subset patients,-0.19021134593993427,285.0
1878,765,system patients,-0.19032846715328447,149.0
1879,1261,thirteen patients,-0.19085290482076572,193.0
1880,724,new method,-0.1916534935188109,433.0
1881,2182,information regarding,-0.19356725146199424,331.0
1882,2985,review conducted,-0.19448416751787484,136.0
1883,1274,lv function,-0.19659318637274728,327.0
1884,1941,previously demonstrated,-0.19716494845360846,153.0
1885,284,shoulder arthroplasty,-0.19720279720279651,141.0
1886,1819,provides new,-0.1972465581977469,197.0
1887,1104,ventricular rv,-0.1974322396576308,346.0
1888,646,cases patients,-0.19839553540286,316.0
1889,2705,groups b,-0.19870129870129877,204.0
1890,2667,higher patients,-0.19943181818181804,741.0
1891,295,cutoff values,-0.2023121387283232,266.0
1892,1314,validated using,-0.20238095238094858,170.0
1893,3229,events occurred,-0.20423280423280374,193.0
1894,2395,cell morphology,-0.2044028800794504,233.0
1895,1766,using fmri,-0.20700389105058284,266.0
1896,792,analysis methods,-0.20719602977667448,167.0
1897,3440,minor complications,-0.20839813374805688,134.0
1898,2180,resonance angiography,-0.20919460767369485,356.0
1899,2065,cox regression,-0.21003098373354054,493.0
1900,1466,early diastolic,-0.2109452736318394,212.0
1901,2995,cognitive performance,-0.2116053661980875,311.0
1902,2150,propose new,-0.21170018281535624,193.0
1903,2369,rate per,-0.21212121212121302,170.0
1904,1739,weight gain,-0.2135265700483093,153.0
1905,1358,connectivity right,-0.2140703517587943,142.0
1906,2178,thyroid nodules,-0.21504424778760955,567.0
1907,2272,range months,-0.215062424486509,890.0
1908,173,upper lower,-0.21541064688272846,331.0
1909,610,first trimester,-0.21693121693121745,246.0
1910,1170,mild cognitive,-0.22073214932946705,435.0
1911,172,partial least,-0.2208132322536182,178.0
1912,1847,cone beam,-0.2211678832116763,606.0
1913,2433,brain regions,-0.222751045603629,2003.0
1914,791,cases reported,-0.22392974753018396,340.0
1915,902,however limited,-0.2244978337928317,150.0
1916,1505,vivo vitro,-0.22738386308068492,155.0
1917,1262,artery mca,-0.22778864970645757,194.0
1918,198,patients lower,-0.22779156327543465,306.0
1919,3283,method based,-0.2281475917754195,450.0
1920,3170,included consecutive,-0.2288659793814425,222.0
1921,1322,data used,-0.22887266828872654,249.0
1922,1938,pattern analysis,-0.22987012987012959,177.0
1923,2896,mean change,-0.2323024054982814,208.0
1924,1835,among women,-0.23274811895377961,406.0
1925,305,examine whether,-0.23304940374787106,228.0
1926,1539,retrospectively analyzed,-0.23307086614173161,740.0
1927,2303,hepatic artery,-0.23322271736038655,251.0
1928,636,patients high,-0.23484162895927016,692.0
1929,1407,showed better,-0.23487885133113925,302.0
1930,2583,signal changes,-0.23625077591558016,173.0
1931,2968,hypertension ph,-0.23651452282157673,171.0
1932,308,height weight,-0.2368479467258594,194.0
1933,278,results confirm,-0.23694267515923573,186.0
1934,1857,pulmonary arterial,-0.23701298701298665,365.0
1935,2996,levels patients,-0.23725998962117237,254.0
1936,2526,brain functional,-0.23749183540169783,202.0
1937,2183,calcium phosphate,-0.23845405501017064,221.0
1938,20,gastric cancer,-0.2385608856088561,431.0
1939,174,cellular uptake,-0.24017082242733068,379.0
1940,170,effective method,-0.2406250000000005,231.0
1941,2892,disease ad,-0.2406250000000007,616.0
1942,3073,successfully treated,-0.24064837905236755,386.0
1943,3562,time period,-0.24091778202676878,210.0
1944,1529,contact angle,-0.2411876872786712,233.0
1945,1783,aimed compare,-0.24166994879873957,236.0
1946,409,insular cortex,-0.24247635425623415,188.0
1947,3262,estimated using,-0.244155844155841,376.0
1948,1606,ppv npv,-0.2443723263018144,251.0
1949,534,fluorescence intensity,-0.24440868865647583,217.0
1950,2250,medical imaging,-0.2452050074652577,427.0
1951,2160,surface properties,-0.24609964771011628,163.0
1952,983,values patients,-0.24615384615384547,192.0
1953,515,positively associated,-0.2465505417638177,428.0
1954,1285,complications related,-0.2465753424657529,180.0
1955,2806,high mortality,-0.24659090909090683,217.0
1956,1928,type iii,-0.24778092540132204,328.0
1957,2724,higher control,-0.24836244541484737,175.0
1958,3080,oxygen saturation,-0.2488479262672808,270.0
1959,0,cerebrospinal fluid,-0.2496311596341104,940.0
1960,1654,test test,-0.2506097560975602,137.0
1961,3245,central role,-0.25270219903093505,226.0
1962,2851,less frequently,-0.2540453074433661,157.0
1963,1294,right left,-0.25524375607246874,870.0
1964,1902,vivo using,-0.255474452554744,175.0
1965,3020,structural heart,-0.2558282208588951,139.0
1966,2400,biodistribution studies,-0.2569819819819818,163.0
1967,1355,compare accuracy,-0.25714285714285673,161.0
1968,1219,aqueous solution,-0.25781250000000044,220.0
1969,1257,intraclass coefficient,-0.25795482147194554,531.0
1970,1286,studies revealed,-0.2584967320261432,339.0
1971,401,mr image,-0.2587385019710904,179.0
1972,1235,fully automated,-0.2599358183164651,195.0
1973,3682,supplementary motor,-0.2611111111111114,235.0
1974,951,important prognostic,-0.26239067055393617,150.0
1975,1086,chemical composition,-0.26372745490982014,188.0
1976,2405,mitral valve,-0.2645616450141959,1025.0
1977,3004,pathological conditions,-0.2649478880965438,161.0
1978,1918,weighted imaging,-0.2658051689860838,191.0
1979,47,axial rotation,-0.26588511137162946,189.0
1980,3146,ventricular function,-0.266568396226415,411.0
1981,2352,detected patients,-0.26670980265285943,458.0
1982,1719,tumor uptake,-0.2685299356076174,200.0
1983,3450,tomography scanning,-0.2687898089171977,211.0
1984,1325,potential applications,-0.2689579923622482,255.0
1985,189,factors affecting,-0.2701149425287347,188.0
1986,3050,femoral component,-0.27026908772697406,213.0
1987,2202,emission tomography,-0.27065914835698973,2610.0
1988,1195,volume measured,-0.2708627238198579,192.0
1989,698,sonographic findings,-0.2711210096510761,166.0
1990,148,without affecting,-0.271232876712329,132.0
1991,2375,within months,-0.27190332326284117,450.0
1992,1231,time min,-0.27346713566452846,325.0
1993,137,acute pancreatitis,-0.2736311239193086,211.0
1994,1463,per cent,-0.274395687206539,388.0
1995,721,root canal,-0.27538593481989754,338.0
1996,3012,medial lateral,-0.2759259259259246,298.0
1997,3222,female patients,-0.2762310973245448,548.0
1998,1795,flow velocity,-0.2777173913043466,511.0
1999,1855,use imaging,-0.27775492212753483,278.0
2000,3154,rates respectively,-0.2786473956913008,393.0
2001,2743,patients studied,-0.27969613259668435,225.0
2002,3300,inverse relationship,-0.2806673209028457,130.0
2003,2026,highlight importance,-0.2819787985865701,133.0
2004,1203,distress syndrome,-0.28292682926829293,174.0
2005,2632,autism spectrum,-0.2830154405086281,266.0
2006,1213,patients isolated,-0.2849721706864564,192.0
2007,3552,mechanism underlying,-0.2853982300884972,215.0
2008,1418,central retinal,-0.28655462184873903,279.0
2009,1132,last years,-0.28659793814432966,278.0
2010,1718,optical imaging,-0.2872586872586865,372.0
2011,1480,knee injury,-0.28775510204081534,141.0
2012,1090,neural activity,-0.289093868692349,666.0
2013,1416,groups control,-0.29009370816599744,197.0
2014,2089,tumor recurrence,-0.2901276024177307,270.0
2015,2344,bone marrow,-0.2912250642516214,1322.0
2016,2763,images showed,-0.29199727952845095,280.0
2017,2727,model parameters,-0.2923076923076939,133.0
2018,1967,lung function,-0.2938775510204071,348.0
2019,2474,included patients,-0.2952789699570863,1978.0
2020,2712,analysed using,-0.29594594594594587,219.0
2021,2751,referral center,-0.29833679833679844,205.0
2022,1157,using standardized,-0.3000000000000004,165.0
2023,723,ultrasound images,-0.300924828076831,405.0
2024,1247,type collagen,-0.301898734177216,159.0
2025,46,underwent functional,-0.3029126213592214,156.0
2026,3526,grade grade,-0.3030965391621128,208.0
2027,3008,data system,-0.3039784221173312,322.0
2028,2332,cortex left,-0.3040149393090574,148.0
2029,2247,aortic root,-0.30469099032017877,341.0
2030,1743,patients died,-0.3072334079045485,515.0
2031,2099,photon emission,-0.308591674047829,268.0
2032,1876,overall accuracy,-0.3087248322147657,230.0
2033,2899,interstitial pneumonia,-0.3093023255813948,133.0
2034,3272,aortic stenosis,-0.3109243697478997,545.0
2035,1804,whole body,-0.31135531135531186,425.0
2036,3460,patients normal,-0.3141173499452802,691.0
2037,2371,matter hyperintensities,-0.3144671996495462,293.0
2038,3446,areas involved,-0.3148936170212763,148.0
2039,1392,local control,-0.31571685662867466,277.0
2040,3294,wall motion,-0.3157520726411373,279.0
2041,637,left inferior,-0.3163841807909585,448.0
2042,2174,total resection,-0.3187066974595847,210.0
2043,1782,participants aged,-0.3190812720848054,129.0
2044,2840,comprised patients,-0.31909456005841497,230.0
2045,2437,multidisciplinary team,-0.31935483870967907,132.0
2046,2302,patients treated,-0.32243346007604595,2438.0
2047,115,mineral density,-0.32312765855756537,1252.0
2048,2901,green fluorescent,-0.3242269588712093,200.0
2049,1495,antibacterial activity,-0.32486583184257456,227.0
2050,1143,survival rates,-0.32527173913043467,399.0
2051,1756,artery aneurysms,-0.325686591276252,144.0
2052,3657,tomography images,-0.3257198952879582,474.0
2053,2299,examination revealed,-0.3257497414684579,450.0
2054,1082,protein levels,-0.32585110362888164,335.0
2055,674,mr angiography,-0.3263513513513503,161.0
2056,3273,diabetic patients,-0.32846757778423985,353.0
2057,2254,better performance,-0.3326446280991719,161.0
2058,3052,right inferior,-0.3327645051194536,325.0
2059,1966,factor vegf,-0.33388429752066107,202.0
2060,2895,healthy adult,-0.3351874244256344,154.0
2061,2716,least months,-0.3359236537150646,224.0
2062,1041,patients recurrent,-0.33707250341997336,224.0
2063,2273,remain unclear,-0.33817427385892185,326.0
2064,930,conducted prospective,-0.3382716049382721,137.0
2065,2339,higher accuracy,-0.3395807644882867,153.0
2066,2752,neuroimaging data,-0.3395833333333333,163.0
2067,797,arthritis ra,-0.34025974025974026,262.0
2068,80,difficult diagnose,-0.3412322274881486,120.0
2069,382,mean maximum,-0.3429752066115701,166.0
2070,3364,information available,-0.34346289752650117,162.0
2071,1882,retrospectively studied,-0.3443793911007032,173.0
2072,1700,retinal ganglion,-0.34447274579724835,147.0
2073,2550,visual assessment,-0.3458262350936958,203.0
2074,3259,diffusion weighted,-0.34713478611783655,253.0
2075,2877,patients recruited,-0.347720364741642,156.0
2076,1,vs patients,-0.348790322580645,173.0
2077,3131,core needle,-0.34949832775919787,209.0
2078,1223,data set,-0.34949968946242543,367.0
2079,761,cancer screening,-0.35003915426781346,745.0
2080,1409,subarachnoid hemorrhage,-0.3507109004739291,370.0
2081,924,emergency department,-0.35283474065138565,900.0
2082,2327,automatic segmentation,-0.3532467532467534,192.0
2083,1435,ventricular tachycardia,-0.355056179775283,158.0
2084,1020,recently introduced,-0.35545023696682654,125.0
2085,2900,pressure iop,-0.3565337001375521,144.0
2086,124,different types,-0.35665634674922597,512.0
2087,2237,early stage,-0.35684248468100305,594.0
2088,1188,vector machine,-0.35755813953488336,205.0
2089,298,body fat,-0.3580488132406747,586.0
2090,3439,participants performed,-0.3595212187159924,236.0
2091,3324,liver spleen,-0.35994410805775484,184.0
2092,1055,mtt assay,-0.36126760563380267,171.0
2093,1968,patients pulmonary,-0.3636138613861382,226.0
2094,1559,lateral wall,-0.3636363636363632,170.0
2095,3487,patients prior,-0.36405266170578165,212.0
2096,294,years surgery,-0.36455938697317963,173.0
2097,684,imaging characteristics,-0.3675086107921922,291.0
2098,2923,metastases patients,-0.36762589928057476,146.0
2099,1569,longer duration,-0.3678861788617884,181.0
2100,520,tomography revealed,-0.36870925684484956,202.0
2101,1214,simulation results,-0.36914600550964294,134.0
2102,1318,tomography oct,-0.37059881778462733,1030.0
2103,1332,total patients,-0.3711804438726362,2885.0
2104,1789,test results,-0.3723404255319163,350.0
2105,1367,exact test,-0.37377367654200955,296.0
2106,719,flow rate,-0.3738771295818276,213.0
2107,1688,quantitative analysis,-0.375462398126006,652.0
2108,1723,k trans,-0.37622377622377573,269.0
2109,3453,main coronary,-0.3776595744680855,142.0
2110,3393,measurements made,-0.37782340862423086,184.0
2111,251,days range,-0.37825618945102224,251.0
2112,2938,basilar artery,-0.3795423956931366,188.0
2113,739,determine factors,-0.3798165137614689,138.0
2114,919,imaging imaging,-0.3806173725771709,241.0
2115,231,cervical cancer,-0.3807189542483673,466.0
2116,130,echocardiography performed,-0.38107457898957353,216.0
2117,2287,systolic pressure,-0.3815028901734104,220.0
2118,1694,pathological changes,-0.38306451612903214,190.0
2119,3200,data show,-0.3831031681559693,262.0
2120,2988,brain tumors,-0.3843750000000032,369.0
2121,3571,retrospective observational,-0.38487972508591123,224.0
2122,730,learning memory,-0.3849397590361444,142.0
2123,570,working memory,-0.3865421764327103,667.0
2124,1613,wide spectrum,-0.3884678747940685,131.0
2125,3134,least squares,-0.38936605316973494,238.0
2126,2333,graft failure,-0.39250493096646966,199.0
2127,2033,squamous cell,-0.3928157589803017,565.0
2128,1034,years sd,-0.3935633966653746,175.0
2129,1989,filtered back,-0.3936507936507929,124.0
2130,106,data including,-0.39509536784741145,145.0
2131,2692,using vivo,-0.39569892473118184,138.0
2132,869,performed cases,-0.3964601769911494,224.0
2133,1062,single photon,-0.3967462608239293,280.0
2134,2002,cancer patients,-0.3971544184832274,1383.0
2135,481,current knowledge,-0.39769452449567694,138.0
2136,1678,patients results,-0.3985374771480794,218.0
2137,2361,revealed presence,-0.39879154078549073,220.0
2138,2231,executive control,-0.3988668555240792,176.0
2139,2631,plays critical,-0.39999999999999986,142.0
2140,2709,stroke volume,-0.4003690036900373,310.0
2141,601,lower limb,-0.4010282776349614,468.0
2142,360,volume ml,-0.4015099519560738,234.0
2143,3698,needle aspiration,-0.40203665987780063,329.0
2144,2374,predictive factors,-0.4025220680958387,304.0
2145,2153,function tests,-0.40265980265980283,247.0
2146,3090,coronary plaque,-0.40357142857142897,226.0
2147,1017,times higher,-0.40396341463414626,318.0
2148,1942,alternative treatment,-0.40555555555554496,146.0
2149,1821,areas curve,-0.4060091443500972,148.0
2150,1050,treated patients,-0.4061382921104889,304.0
2151,2206,higher sensitivity,-0.4075408462505253,256.0
2152,84,cell wall,-0.4086233446258076,428.0
2153,3406,patients symptoms,-0.41269841269841184,130.0
2154,3599,immunohistochemical staining,-0.4132295719844343,177.0
2155,2462,tested whether,-0.41415929203539653,198.0
2156,437,precentral gyrus,-0.41416256157635484,177.0
2157,2402,procedures performed,-0.41443375277572375,509.0
2158,1939,images using,-0.4158381645491564,344.0
2159,59,showed low,-0.41612903225806414,172.0
2160,2964,right heart,-0.4165467625899282,386.0
2161,1582,treatment planning,-0.41709401709401667,732.0
2162,91,muscle mass,-0.41717540655709123,623.0
2163,2666,male mice,-0.4173441734417343,154.0
2164,774,nuclear medicine,-0.41760904684975714,495.0
2165,2401,early treatment,-0.4181818181818163,322.0
2166,2199,patients female,-0.4181818181818186,299.0
2167,2102,left superior,-0.41843971631205645,236.0
2168,76,right atrial,-0.418949909474955,267.0
2169,3385,time patients,-0.4189573459715645,234.0
2170,3144,coefficient variation,-0.4189573459715646,272.0
2171,2945,alkaline phosphatase,-0.4204488778054868,281.0
2172,2068,histological findings,-0.4223660977045322,156.0
2173,1215,volume left,-0.4230769230769221,165.0
2174,524,features patients,-0.4237162519851767,174.0
2175,1386,independent predictor,-0.4250170055173471,907.0
2176,2223,microscopy used,-0.4251592356687901,178.0
2177,1162,dual energy,-0.4253609051892321,237.0
2178,2812,total cholesterol,-0.4255234297108678,194.0
2179,3673,per day,-0.4265120132560058,234.0
2180,367,followed years,-0.4277777777777771,143.0
2181,2847,help identify,-0.4279375513557928,252.0
2182,434,cancer detection,-0.42894924946390306,353.0
2183,1362,visual areas,-0.4303886925795053,203.0
2184,1366,surgical findings,-0.43240223463687155,129.0
2185,1929,models using,-0.4324324324324317,128.0
2186,2258,used identify,-0.43349337430381885,594.0
2187,2394,superior vena,-0.4367573570238756,207.0
2188,372,cbct imaging,-0.43750000000000105,140.0
2189,266,anterior cingulate,-0.4381786140640092,820.0
2190,389,matter gm,-0.43851132686084066,271.0
2191,2354,thyroid gland,-0.4386329866270431,164.0
2192,2397,thickness μm,-0.4389794472005656,163.0
2193,3201,found associated,-0.4394736842105262,167.0
2194,2434,grip strength,-0.44057971014492786,152.0
2195,2430,patients available,-0.44109589041095937,138.0
2196,1083,associated severe,-0.44166666666666515,159.0
2197,274,five cases,-0.4451882845188289,228.0
2198,1397,hip score,-0.44554259735125484,230.0
2199,60,imaging data,-0.4461043142305198,866.0
2200,2017,medline embase,-0.4468388245770253,193.0
2201,3251,dynamic changes,-0.44715871979098676,163.0
2202,3340,cm respectively,-0.4472222222222216,161.0
2203,1486,could useful,-0.4475138121546982,270.0
2204,810,activation patterns,-0.44814965433102905,190.0
2205,994,medical records,-0.4481569303729205,945.0
2206,2592,b c,-0.44918236389981364,350.0
2207,3367,benign tumors,-0.44924623115577883,149.0
2208,686,dorsal anterior,-0.4498620055197783,163.0
2209,2295,thickness measured,-0.4509911894273119,273.0
2210,3435,descending artery,-0.45183887915936916,215.0
2211,1074,needle biopsy,-0.4535669586983728,302.0
2212,2942,radiation oncology,-0.45384907091391796,352.0
2213,1824,microscopy tem,-0.4545886828340475,478.0
2214,1948,cardiac catheterization,-0.4550913838120102,166.0
2215,97,could improve,-0.45509838998211166,318.0
2216,2560,index suspicion,-0.455590062111801,163.0
2217,947,cerebral microbleeds,-0.45578231292516974,201.0
2218,1356,time reduced,-0.4558303886925803,129.0
2219,3327,cells cultured,-0.45714285714285613,160.0
2220,1536,low cytotoxicity,-0.4582881906825557,141.0
2221,2569,pulse wave,-0.4584772455740189,346.0
2222,197,heart disease,-0.458584337349398,1305.0
2223,958,males females,-0.458618012422363,1074.0
2224,3185,weight loss,-0.45863026376677374,561.0
2225,3570,widespread use,-0.458918050348152,204.0
2226,3478,internal carotid,-0.45948816996619923,732.0
2227,336,lesions identified,-0.46008583690987326,134.0
2228,1780,cerebral arteries,-0.460901563937443,167.0
2229,1164,vessel wall,-0.4611353711790393,396.0
2230,42,lesions showed,-0.46153846153846206,140.0
2231,3160,analysis using,-0.4630277583391667,397.0
2232,3032,vaginal delivery,-0.4632054176072234,171.0
2233,2510,children hospital,-0.46398963730569937,199.0
2234,647,needed determine,-0.46438213914849585,172.0
2235,1185,images images,-0.46513157894736806,202.0
2236,1971,metastatic disease,-0.46543504171632916,355.0
2237,441,surface area,-0.4671334036635649,1188.0
2238,1811,internal capsule,-0.467781155015197,243.0
2239,340,preliminary results,-0.46788447296963737,243.0
2240,1524,nineteen patients,-0.4680173661360336,147.0
2241,2951,information processing,-0.469072164948453,195.0
2242,1395,respectively sensitivity,-0.470149253731344,135.0
2243,1212,parietal lobe,-0.47052168447517306,197.0
2244,3315,tyrosine kinase,-0.4716577540106955,147.0
2245,2424,approach used,-0.47205686361617144,253.0
2246,1244,observed among,-0.47234042553191435,148.0
2247,940,communicating artery,-0.4724637681159438,163.0
2248,3353,blot analysis,-0.4725103258375413,156.0
2249,1044,selected cases,-0.4728070175438594,154.0
2250,67,acute kidney,-0.4734054292650632,325.0
2251,988,epithelium rpe,-0.4734982332155465,134.0
2252,683,mild moderate,-0.47522236340533525,374.0
2253,2062,target volume,-0.4787234042553251,450.0
2254,2575,respectively patients,-0.48013569543912527,579.0
2255,912,newly diagnosed,-0.48177710843373556,457.0
2256,2249,inversion recovery,-0.4821188340807164,564.0
2257,3281,brain responses,-0.484725050916497,170.0
2258,1647,therapy treatment,-0.48474576271186454,143.0
2259,1448,mortality rate,-0.48503740648379023,389.0
2260,1750,muscle cells,-0.4858447488584471,228.0
2261,1142,parietal lobule,-0.4858447488584482,266.0
2262,743,longitudinal fasciculus,-0.48653846153846014,297.0
2263,2612,findings show,-0.4884892086330926,194.0
2264,2472,colorectal cancer,-0.49037372593431433,433.0
2265,288,associated better,-0.4911504424778764,185.0
2266,2792,whether patients,-0.49136490250696246,126.0
2267,426,fisher exact,-0.4931234465617232,372.0
2268,2720,within week,-0.4946356275303648,181.0
2269,1985,chest wall,-0.49478417266187014,262.0
2270,3464,performed patients,-0.49620706924273006,1776.0
2271,860,resonance imaging,-0.49681204772145865,11724.0
2272,390,effective dose,-0.49751243781094534,500.0
2273,3209,atrial fibrillation,-0.4976828531130366,950.0
2274,1863,subtraction angiography,-0.4977400316683451,339.0
2275,1628,cells results,-0.49911894273127755,206.0
2276,3199,myocardial fibrosis,-0.4994864269992651,296.0
2277,3636,medical record,-0.5009009009008997,139.0
2278,567,spectral domain,-0.5019305019305009,400.0
2279,2340,patients benefit,-0.5021645021645016,145.0
2280,3345,used image,-0.5051051051051053,203.0
2281,2501,could help,-0.5059561128526618,269.0
2282,2683,applications including,-0.5063829787234009,119.0
2283,1054,found patients,-0.5068445068445079,760.0
2284,1623,replacement therapy,-0.5074118113357112,173.0
2285,2191,techniques including,-0.5081967213114751,155.0
2286,2133,patients aim,-0.5090909090909153,112.0
2287,1570,available data,-0.5094908862350719,193.0
2288,3680,right anterior,-0.5094908862350733,193.0
2289,408,recruited patients,-0.5095785440613029,190.0
2290,1958,models used,-0.5096622661375229,456.0
2291,1266,regression used,-0.5102964471599905,275.0
2292,488,therapy patients,-0.5103448275862086,370.0
2293,407,frontal lobe,-0.5109131403118051,341.0
2294,2802,patients poor,-0.5112781954887221,170.0
2295,1534,corticospinal tract,-0.5131832797427652,228.0
2296,3479,available patients,-0.5147424511545272,207.0
2297,2464,objective present,-0.5164974619289338,185.0
2298,2887,multiple comparisons,-0.517520215633424,160.0
2299,1768,female gender,-0.5175202156334241,160.0
2300,1449,noted patients,-0.5178082191780826,147.0
2301,2165,high affinity,-0.5201151493342907,219.0
2302,1724,bone quality,-0.520652785593698,257.0
2303,1980,determine effect,-0.5218508997429309,203.0
2304,416,duration months,-0.5227467811158802,203.0
2305,1730,liver transplantation,-0.524123805188893,329.0
2306,3660,repeated measures,-0.5241970021413261,136.0
2307,55,children adolescents,-0.5254994551398473,391.0
2308,950,tomography magnetic,-0.5260411680229783,666.0
2309,3357,spectroscopy ftir,-0.5267654751525728,159.0
2310,440,obese patients,-0.526838966202783,265.0
2311,3103,patients randomized,-0.52687385740402,262.0
2312,3622,respiratory distress,-0.5268817204301067,245.0
2313,2699,weeks surgery,-0.5273885350318452,138.0
2314,1101,females males,-0.5283338373147879,416.0
2315,1810,nerve injury,-0.5289666395443448,197.0
2316,827,presence absence,-0.5295983086680764,501.0
2317,1375,ages years,-0.5313725490196072,271.0
2318,3522,la volume,-0.5326500732064405,214.0
2319,3177,doppler imaging,-0.5329839502129046,339.0
2320,2337,however studies,-0.533011272141705,331.0
2321,218,good excellent,-0.5335820895522386,143.0
2322,1147,achieved using,-0.5362810417928531,233.0
2323,1910,angiography mra,-0.5367647058823537,146.0
2324,1182,negatively charged,-0.5370843989769826,150.0
2325,2043,imaging technology,-0.5371146732429095,242.0
2326,2833,bifurcation lesions,-0.5421319796954314,178.0
2327,3091,patients ms,-0.5438756855575868,238.0
2328,3534,sleep apnea,-0.5443548387096757,225.0
2329,1344,overall mortality,-0.54572864321608,181.0
2330,3447,pulmonary hypertension,-0.5467181467181471,708.0
2331,1517,μm μm,-0.5476218266705566,383.0
2332,1498,showed greater,-0.5476896251089776,349.0
2333,500,cell division,-0.5485355648535574,207.0
2334,1662,studies show,-0.5492537313432836,184.0
2335,2504,mass spectrometry,-0.5517974800601081,468.0
2336,1242,facial nerve,-0.5538152610441767,197.0
2337,649,mouse model,-0.5542846333312316,656.0
2338,3645,unclear whether,-0.5575682382134004,321.0
2339,178,receiver operating,-0.5600777511961669,2081.0
2340,2108,recently developed,-0.561346488682531,372.0
2341,2956,prognostic factors,-0.561425576519917,412.0
2342,1542,using linear,-0.5628040057224654,281.0
2343,2208,exhibited higher,-0.5641791044776134,243.0
2344,590,patients small,-0.5645181092694898,242.0
2345,81,interventional radiology,-0.5677419354838708,268.0
2346,2980,prospective included,-0.5703630034808552,155.0
2347,2255,response assessment,-0.5714182605557555,203.0
2348,741,test performed,-0.5717213114754096,155.0
2349,2429,objective determine,-0.5720430107526897,336.0
2350,3145,side branch,-0.5728395061728389,174.0
2351,3226,january july,-0.5731559854897236,158.0
2352,756,used functional,-0.5761496492595471,264.0
2353,757,quantitative measurements,-0.5770992366412205,168.0
2354,2422,ventral striatum,-0.5795828759604822,264.0
2355,584,artery occlusion,-0.580249280920423,306.0
2356,3000,complications included,-0.5833333333333331,160.0
2357,165,treatment groups,-0.5836228287841203,294.0
2358,3434,could identified,-0.5860433604336047,173.0
2359,1572,gyrus left,-0.5865197666882692,181.0
2360,506,back projection,-0.5890109890109891,134.0
2361,2497,future research,-0.5912790697674403,339.0
2362,223,exclusion criteria,-0.5927977839335193,214.0
2363,1953,vas score,-0.5935760171306217,126.0
2364,2385,arthroplasty tka,-0.5945553539019974,182.0
2365,3161,conducted retrospective,-0.5953878406708591,284.0
2366,2506,fibrillation af,-0.5959966168593162,302.0
2367,1961,performed better,-0.5962410887880745,184.0
2368,1638,genetic testing,-0.5964167219641681,214.0
2369,3162,data sets,-0.5964924002004347,576.0
2370,2832,median months,-0.5968428017771059,770.0
2371,3425,force spectroscopy,-0.5971223021582731,166.0
2372,1324,data suggest,-0.5972884698342235,989.0
2373,896,method proposed,-0.5975103734439825,180.0
2374,1872,analysis confirmed,-0.5983713355048876,167.0
2375,1169,et al,-0.6033092914722095,630.0
2376,3109,respectively mean,-0.6034344590726958,502.0
2377,597,therapeutic response,-0.603592814371257,168.0
2378,599,chest radiographs,-0.6045300113250281,157.0
2379,2958,patients scheduled,-0.6054116737533831,191.0
2380,1568,injury patients,-0.6061875604253947,171.0
2381,3564,findings including,-0.6067892503536059,143.0
2382,2176,present work,-0.6068965517241364,304.0
2383,2271,potential use,-0.6079002079002067,258.0
2384,3476,diagnostic value,-0.6079540009583142,488.0
2385,3085,tissue samples,-0.6080275229357808,241.0
2386,3196,matter tracts,-0.6087689713322084,285.0
2387,672,respiratory failure,-0.6099447513812174,184.0
2388,532,mean deviation,-0.6109979633401289,500.0
2389,778,fracture healing,-0.6120967741935476,207.0
2390,1944,immediate postoperative,-0.6127819548872191,163.0
2391,2241,cardiomyopathy hcm,-0.6132743362831841,189.0
2392,1160,vertebral bodies,-0.6148514851485148,138.0
2393,255,image contrast,-0.6153172866520793,148.0
2394,2924,provide valuable,-0.621584699453553,175.0
2395,788,cerebral small,-0.6219512195121956,153.0
2396,650,aim develop,-0.6222222222222238,182.0
2397,2096,studies investigated,-0.6246941045606239,208.0
2398,1442,prognostic value,-0.6251738684300538,703.0
2399,3233,less invasive,-0.6272069464544128,197.0
2400,3484,mouse brain,-0.6277873070325907,183.0
2401,1932,procedure performed,-0.6278195488721818,167.0
2402,3508,median interquartile,-0.6281420765027315,209.0
2403,2146,total number,-0.6285846224890331,332.0
2404,1292,cardiac imaging,-0.629044498102794,194.0
2405,541,published data,-0.6311750599520385,188.0
2406,1035,operating characteristics,-0.6315457413249193,182.0
2407,3362,present novel,-0.6315789473684177,240.0
2408,1683,woman presented,-0.6319573901464711,339.0
2409,3159,fatty liver,-0.6324058919803605,414.0
2410,628,therapeutic option,-0.632822540781019,173.0
2411,3205,visual loss,-0.6337662337662339,122.0
2412,858,cmr imaging,-0.6363288718929265,128.0
2413,1206,physicochemical properties,-0.6387411828540421,218.0
2414,1299,outflow tract,-0.6391131092265248,417.0
2415,2875,often used,-0.6416107382550347,239.0
2416,530,percentage change,-0.6418952618453874,143.0
2417,1245,radiological findings,-0.6424242424242371,318.0
2418,256,strain strain,-0.6442489851150195,207.0
2419,856,mechanisms involved,-0.6448979591836739,158.0
2420,33,prognostic factor,-0.6456968773800462,314.0
2421,2796,detection limit,-0.6471698113207509,343.0
2422,36,fmri studies,-0.6481751824817518,148.0
2423,2837,performed identify,-0.6493827160493831,263.0
2424,2219,outcomes evaluated,-0.6500445235975069,146.0
2425,420,serum albumin,-0.6502383571690474,286.0
2426,1159,major role,-0.6532994923857863,143.0
2427,877,pivotal role,-0.6551130933418285,194.0
2428,1625,using combination,-0.6553968781135849,253.0
2429,3408,elderly patients,-0.6555555555555556,295.0
2430,2396,structural brain,-0.6555555555555559,236.0
2431,120,surgery patients,-0.6564430244941426,536.0
2432,111,element analysis,-0.6571038251366111,185.0
2433,2774,high rates,-0.6573248407643304,172.0
2434,1608,images reconstructed,-0.6574645129711224,292.0
2435,398,enrolled patients,-0.6607356992383742,703.0
2436,352,degeneration amd,-0.6611665790856538,233.0
2437,1000,brain tumor,-0.6613701236917233,331.0
2438,325,iliac vein,-0.6621266427718043,163.0
2439,3063,multivariable analysis,-0.6634799235181661,347.0
2440,1330,high level,-0.6642642642642622,316.0
2441,3065,median years,-0.6652102145839374,1105.0
2442,2315,patients low,-0.6668414154652698,424.0
2443,2668,surgical procedure,-0.6672413793103446,387.0
2444,1849,aortic dissection,-0.6673867681355093,394.0
2445,1136,reviewed retrospectively,-0.6689189189189184,198.0
2446,1465,groups results,-0.6695417789757399,138.0
2447,2898,dynamic light,-0.6718249563976537,214.0
2448,1711,cord injury,-0.6725075528700888,318.0
2449,1540,multimodal imaging,-0.6731234866828087,278.0
2450,2740,adc value,-0.6735347651983993,319.0
2451,1516,nucleic acids,-0.6746113989637313,186.0
2452,1049,patients advanced,-0.6751937984496139,402.0
2453,414,bone health,-0.6761268781302147,225.0
2454,3558,development novel,-0.6767220902612818,259.0
2455,631,coronary heart,-0.6783123612139159,158.0
2456,3532,abdominal aorta,-0.6783347028211437,203.0
2457,3184,analysis revealed,-0.683435494339072,1634.0
2458,609,similar groups,-0.6836734693877539,670.0
2459,2800,arteriovenous malformations,-0.6857142857142842,168.0
2460,2000,mechanical ventilation,-0.6873563218390804,184.0
2461,15,healthy controls,-0.692397832137106,3260.0
2462,3028,matched control,-0.6933962264150955,147.0
2463,2791,type diabetes,-0.6941439195195459,1104.0
2464,2997,option patients,-0.6951672862453531,170.0
2465,2948,patients confirmed,-0.6958368734069674,195.0
2466,1399,imaging analysis,-0.6958579881656821,147.0
2467,2547,renal disease,-0.6962025316455704,275.0
2468,3082,tumor progression,-0.6968510187880389,231.0
2469,268,reconstructed images,-0.6999832523865354,258.0
2470,1230,common carotid,-0.700791177175737,395.0
2471,2218,showed differences,-0.70244363439989,473.0
2472,2489,fluorescence spectroscopy,-0.7026615969581744,154.0
2473,1499,brain damage,-0.7076923076923102,138.0
2474,2718,four cases,-0.7079537729435763,254.0
2475,670,finite element,-0.7105590062111813,702.0
2476,1144,histological analysis,-0.7108433734939782,236.0
2477,1699,moyamoya disease,-0.7120082107423888,242.0
2478,604,surgical approach,-0.7120364862185206,382.0
2479,826,cardiac output,-0.7123595505618001,317.0
2480,1152,blood glucose,-0.7132911392405051,161.0
2481,3545,optic nerve,-0.715365871668019,723.0
2482,622,relatively low,-0.7158176943699716,267.0
2483,2628,among groups,-0.716501738432735,705.0
2484,2897,approach based,-0.717221828490432,220.0
2485,3519,cell types,-0.7173913043478223,396.0
2486,1651,length hospital,-0.7173913043478232,165.0
2487,1401,ten healthy,-0.7214682981090098,141.0
2488,1319,however differences,-0.7215250675472829,197.0
2489,2171,treatment however,-0.7245136186770403,147.0
2490,3625,ventricular outflow,-0.7253936444317214,369.0
2491,461,valve disease,-0.7260643821391501,152.0
2492,2257,well understood,-0.7277654867256607,387.0
2493,1349,data analyzed,-0.7278149450051024,479.0
2494,2092,controlled trials,-0.7294117647058822,310.0
2495,1441,however difference,-0.729418017539196,292.0
2496,213,different stages,-0.7306921463528301,257.0
2497,177,cerebral ischemia,-0.7317952415284776,203.0
2498,2726,superior temporal,-0.7323512080141436,478.0
2499,71,plays important,-0.7333884753239589,532.0
2500,1252,fetal growth,-0.735042735042736,215.0
2501,3695,range years,-0.7353541241620554,1682.0
2502,946,superior longitudinal,-0.736842105263156,210.0
2503,180,noninvasive imaging,-0.7377563329312429,278.0
2504,2282,spectroscopy nirs,-0.7378091872791532,174.0
2505,3563,ultrasound findings,-0.7382812499999998,270.0
2506,766,patients achieved,-0.7385297377170296,196.0
2507,820,conservative treatment,-0.740625,316.0
2508,1053,different time,-0.7408239700374519,207.0
2509,607,memory performance,-0.7425591098748264,281.0
2510,645,data obtained,-0.7430975545621886,628.0
2511,971,proposed approach,-0.7432744978697506,284.0
2512,1093,quality assessed,-0.7448275862069007,144.0
2513,3266,sensitive specific,-0.7457037780006683,272.0
2514,2492,cases cases,-0.7464837049742707,256.0
2515,3501,used monitor,-0.7482587064676617,188.0
2516,2954,cerebral venous,-0.7494252873563226,163.0
2517,2496,monoclonal antibody,-0.7509529860228729,197.0
2518,3498,patients met,-0.7522601110229981,306.0
2519,1999,temporomandibular joint,-0.7525951557093434,261.0
2520,1578,healthy subjects,-0.7531576726522587,1373.0
2521,2625,used treatment,-0.753564899451559,229.0
2522,2710,knee joint,-0.7536231884057967,286.0
2523,767,sudden cardiac,-0.754379426015655,184.0
2524,3656,ko mice,-0.7576616474756422,182.0
2525,236,however use,-0.7576642335766407,173.0
2526,639,symptoms patients,-0.7599221789883234,217.0
2527,3022,discriminant analysis,-0.7606382978723408,195.0
2528,1543,left atrium,-0.7629310344827559,354.0
2529,5,morphological features,-0.7640135797812159,247.0
2530,3630,patients total,-0.764708490356906,352.0
2531,2826,feasible safe,-0.7654676258992812,228.0
2532,1064,hospital stay,-0.7657587548638144,552.0
2533,3104,therapy pdt,-0.7666666666666677,138.0
2534,143,neuroimaging studies,-0.7677941877084319,474.0
2535,884,currently used,-0.7682948490230904,211.0
2536,1032,visual cortex,-0.7693153423288347,537.0
2537,2307,digital subtraction,-0.7705532693187017,383.0
2538,2131,cortex right,-0.7714285714285695,135.0
2539,784,total hip,-0.7716884143930381,714.0
2540,227,potential therapeutic,-0.7733134550875894,182.0
2541,3219,short axis,-0.7736240913811012,149.0
2542,2121,developed new,-0.7740614334470989,189.0
2543,2537,rate complications,-0.7756906077348029,156.0
2544,3323,provide insights,-0.7763527054108207,149.0
2545,968,compare performance,-0.7784090909090916,137.0
2546,3349,used control,-0.779697351828501,229.0
2547,2163,contrast medium,-0.7798458356833985,340.0
2548,2925,present findings,-0.7828715365239289,148.0
2549,394,remains poorly,-0.7841491841491831,174.0
2550,3069,connectivity patterns,-0.7858179787828015,227.0
2551,3118,angiography dsa,-0.7865546218487371,156.0
2552,626,temporal resolution,-0.7871242805371983,362.0
2553,2187,younger years,-0.7897647344166857,243.0
2554,661,regions including,-0.7921182266009832,201.0
2555,2090,cbct scans,-0.7942386831275711,193.0
2556,1193,carcinoma hcc,-0.7943616777446677,403.0
2557,754,idiopathic pulmonary,-0.7944444444444434,143.0
2558,891,longitudinal changes,-0.7947368421052626,151.0
2559,3097,data analysis,-0.7980420594633816,355.0
2560,1121,resonance medicine,-0.7988696463756106,497.0
2561,3496,important role,-0.7998247151621373,1352.0
2562,675,severe aortic,-0.8033018867924538,262.0
2563,681,based analysis,-0.8035010940919043,153.0
2564,1946,second trimester,-0.8039848197343467,223.0
2565,2320,days days,-0.8052946199829196,205.0
2566,1018,able detect,-0.808163265306124,198.0
2567,1210,total participants,-0.8124999999999993,143.0
2568,1002,venous sinus,-0.8126649076517165,140.0
2569,2050,sagittal plane,-0.8135292846336725,319.0
2570,1377,collected data,-0.8145695364238413,205.0
2571,3585,different patients,-0.8149779735682797,185.0
2572,3640,overall results,-0.8163498098859315,226.0
2573,3370,photoelectron spectroscopy,-0.817490494296576,215.0
2574,3013,pooled sensitivity,-0.8272727272727265,182.0
2575,1656,disease patients,-0.8274924746875865,677.0
2576,128,testing performed,-0.8287560581583214,135.0
2577,668,preoperative imaging,-0.8289156626506039,264.0
2578,576,recent advances,-0.8294507575757577,461.0
2579,3652,tube current,-0.832081911262797,159.0
2580,937,tertiary referral,-0.8323427248166723,263.0
2581,1740,ventricular systolic,-0.8327044025157254,331.0
2582,2660,retinal pigment,-0.8328063241106711,301.0
2583,2039,preoperative computed,-0.8329286061194765,175.0
2584,3325,magnetic stimulation,-0.8330794341675738,232.0
2585,2811,cell migration,-0.8349230381024497,352.0
2586,978,new species,-0.8364769187199091,208.0
2587,2689,potentially used,-0.838356164383562,136.0
2588,1579,brachial artery,-0.8433847592332874,220.0
2589,560,pressure bp,-0.846473029045644,204.0
2590,470,small intestine,-0.8465346534653464,180.0
2591,2746,additional information,-0.8506097560975607,279.0
2592,1061,retrospectively analysed,-0.8546365914786953,155.0
2593,1176,blood oxygenation,-0.8576271186440679,138.0
2594,2966,seventeen patients,-0.8581261950286806,132.0
2595,3633,assess diagnostic,-0.8594594594594589,159.0
2596,1211,blue light,-0.8602739726027387,157.0
2597,2736,patients brain,-0.8619893428063953,211.0
2598,3337,bone grafting,-0.8621815806662314,200.0
2599,1513,vocal fold,-0.8636010218815943,311.0
2600,1216,trabecular bone,-0.86416861826698,615.0
2601,3132,treatment plans,-0.8676753782668464,166.0
2602,993,complication rate,-0.8678908007539375,479.0
2603,1523,endoscopic retrograde,-0.8713816988698502,323.0
2604,1263,mesenchymal stem,-0.8720149253731361,399.0
2605,1917,brain connectivity,-0.8750437172120903,278.0
2606,1521,new insights,-0.8788732394366201,312.0
2607,1618,imaging dwi,-0.8789878700926045,416.0
2608,1239,processing speed,-0.8806641300588038,190.0
2609,2913,studies needed,-0.8808362369337973,632.0
2610,897,imaging provides,-0.8822335025380718,158.0
2611,3005,schizophrenia patients,-0.882661996497374,180.0
2612,2314,node dissection,-0.8836438923395435,194.0
2613,2356,cell survival,-0.8837743384922627,167.0
2614,1467,different sizes,-0.8857142857142809,124.0
2615,837,interventional procedures,-0.8884945621064688,199.0
2616,1497,left posterior,-0.8913494809688587,184.0
2617,3110,promising results,-0.8934612031386214,244.0
2618,939,remaining patients,-0.8938154138915376,427.0
2619,1807,infrared spectroscopy,-0.894197952218431,655.0
2620,717,reson med,-0.898816207372238,495.0
2621,2203,substantia nigra,-0.9023386342376049,182.0
2622,2591,disorders including,-0.905096262740658,148.0
2623,2999,carlo simulations,-0.9055441478439434,147.0
2624,793,society magnetic,-0.9060955518945645,450.0
2625,3703,consecutive patients,-0.9068308476195568,3164.0
2626,801,cell adhesion,-0.9071322436849897,407.0
2627,1190,imaging studies,-0.909298780487801,1193.0
2628,2088,uptake values,-0.9094339622641476,241.0
2629,105,complication rates,-0.911949685534595,377.0
2630,3122,previous reports,-0.9141891891891882,246.0
2631,277,results reveal,-0.9149606299212594,249.0
2632,545,showed good,-0.9169251517194984,523.0
2633,2912,functional fmri,-0.9170984455958526,177.0
2634,1440,monte carlo,-0.9179415855354666,528.0
2635,3212,brain magnetic,-0.9181347150259022,443.0
2636,925,pulsatility index,-0.9191489361702142,216.0
2637,351,quantitative evaluation,-0.9201101928374666,167.0
2638,2952,eight patients,-0.9218106995884733,672.0
2639,527,ultrasound ivus,-0.922083805209512,177.0
2640,1446,associated factors,-0.9225806451612886,156.0
2641,2200,optic neuritis,-0.9233215547703152,201.0
2642,1992,microscopy afm,-0.9240641711229944,432.0
2643,617,stress disorder,-0.924354657687991,142.0
2644,3057,seven patients,-0.9250777136331905,634.0
2645,573,joint space,-0.9285091543156049,213.0
2646,2460,patients severe,-0.9294250978776015,930.0
2647,2028,respectively differences,-0.931034482758624,261.0
2648,1473,present aimed,-0.9321009243067703,352.0
2649,1011,ischemic attack,-0.9353474320241749,172.0
2650,1394,potential role,-0.9369458128078824,317.0
2651,1092,system using,-0.9395929087327639,159.0
2652,2480,spatial temporal,-0.9402985074626854,225.0
2653,3415,mortality patients,-0.9424778761061964,355.0
2654,523,assessed whether,-0.9436435124508517,144.0
2655,1158,used characterize,-0.9441624365482226,210.0
2656,2466,surgical correction,-0.9451664025356581,142.0
2657,3263,bone mineral,-0.9459213663838485,1479.0
2658,263,death myocardial,-0.9462254395036187,183.0
2659,1728,pedicle screw,-0.9464745809668923,269.0
2660,125,first evidence,-0.9470852017937228,176.0
2661,2124,differential scanning,-0.9499999999999996,190.0
2662,949,superior frontal,-0.9514731369150775,366.0
2663,3129,scanning microscopy,-0.9519832985386228,240.0
2664,2418,diffusivity md,-0.952112676056337,169.0
2665,3009,disease severity,-0.9523396343352976,394.0
2666,2148,chest computed,-0.954545454545456,280.0
2667,3051,field view,-0.9545878693623665,279.0
2668,910,pediatric patients,-0.9550561797752803,925.0
2669,399,patients higher,-0.9553278688524605,441.0
2670,2563,estimated glomerular,-0.9585811537083478,273.0
2671,1518,spinal cord,-0.9608248776803582,2100.0
2672,1674,filtration rate,-0.9621273166800977,398.0
2673,3679,improve understanding,-0.962818590704648,169.0
2674,2378,whole brain,-0.9638744121011827,426.0
2675,747,tracking echocardiography,-0.9678249678249662,240.0
2676,629,pain relief,-0.9681371171677431,236.0
2677,451,serum creatinine,-0.9686203240951087,283.0
2678,2329,energy absorptiometry,-0.9693251533742349,158.0
2679,3452,inferior frontal,-0.9693747910397956,763.0
2680,3402,paper propose,-0.9694404591104744,233.0
2681,3346,electronic medical,-0.9699481865284972,144.0
2682,652,fluorescent probe,-0.9733191035218757,240.0
2683,3481,associated changes,-0.982658959537573,200.0
2684,2549,assess feasibility,-0.9829479768786112,179.0
2685,945,right hemisphere,-0.9840830449826973,237.0
2686,3359,early visual,-0.9863013698630146,120.0
2687,3089,combination therapy,-0.9897280966767372,182.0
2688,1438,image guidance,-0.9909909909909885,286.0
2689,1183,western blotting,-0.9915547024951991,287.0
2690,2505,small bowel,-0.9915754001684909,535.0
2691,2213,important factor,-0.9944584382871549,282.0
2692,2451,based results,-0.9945145364783313,259.0
2693,737,patients acute,-0.9968907379023411,1084.0
2694,1382,limit detection,-0.9971098265895973,150.0
2695,160,enzyme activity,-1.0000000000000018,120.0
2696,2820,healthy male,-1.0033994334277614,161.0
2697,1979,patients type,-1.0037735849056617,532.0
2698,2845,control subjects,-1.0064274391122612,1343.0
2699,2593,structure function,-1.0114230396902224,653.0
2700,2366,score improved,-1.011790079079799,227.0
2701,669,idiopathic scoliosis,-1.0151279199110104,169.0
2702,3149,results revealed,-1.0159895150720868,456.0
2703,2442,diabetes mellitus,-1.016229676285343,1119.0
2704,2555,artery ica,-1.01639344262295,186.0
2705,3500,linear regression,-1.016781761422765,1378.0
2706,2343,med international,-1.0220862846104313,407.0
2707,1434,principal component,-1.0296363225660738,321.0
2708,547,cell line,-1.036175023274372,735.0
2709,2345,chronic kidney,-1.0368203974503218,446.0
2710,953,patients assessed,-1.036830835117772,269.0
2711,1282,renal cell,-1.037195121951215,243.0
2712,3530,dti parameters,-1.0396744659206514,146.0
2713,2644,included analysis,-1.040818065615685,394.0
2714,733,showed excellent,-1.0435845213849289,244.0
2715,3038,using proposed,-1.0445859872611476,140.0
2716,432,remains unknown,-1.0449760765550273,312.0
2717,2211,authors present,-1.0502793296089379,188.0
2718,3213,abdominal computed,-1.0526315789473673,132.0
2719,1469,scanning calorimetry,-1.0527704485488116,190.0
2720,1068,number patients,-1.0534351145038159,460.0
2721,770,postoperative complications,-1.054423592493297,437.0
2722,1571,characterized using,-1.0551724137931022,204.0
2723,3691,complete remission,-1.0559748427672975,146.0
2724,158,overall findings,-1.0560747663551338,113.0
2725,2943,middle frontal,-1.0627698277952942,327.0
2726,3410,healthy control,-1.066635171843628,636.0
2727,475,tube voltage,-1.0671619613670147,189.0
2728,1341,values respectively,-1.0674225245653772,307.0
2729,589,function assessed,-1.069084821428572,309.0
2730,314,executive function,-1.0694485842026842,414.0
2731,580,lesion revascularization,-1.0705225368966902,189.0
2732,2729,spectrum disorder,-1.0718749999999986,301.0
2733,832,controls patients,-1.071952428146679,416.0
2734,632,autosomal recessive,-1.073684210526316,222.0
2735,3358,subclinical atherosclerosis,-1.0741989881956162,245.0
2736,2152,months treatment,-1.075539568345325,260.0
2737,98,day day,-1.0759259259259277,166.0
2738,443,transgenic mice,-1.0790598290598281,202.0
2739,2914,left main,-1.0803118908382068,326.0
2740,1746,epithelial cells,-1.0804597701149385,530.0
2741,186,mouse models,-1.0815642458100572,242.0
2742,3060,rat model,-1.0823977164605154,316.0
2743,2594,investigate role,-1.0824034334763954,194.0
2744,3503,cardiogenic shock,-1.0825870646766178,136.0
2745,1374,vertebral body,-1.0835936129145471,401.0
2746,2694,lesion glycolysis,-1.0843373493975867,150.0
2747,2445,leg pain,-1.08557457212714,148.0
2748,1881,methods using,-1.0862533692722367,155.0
2749,3278,patients excluded,-1.0887337986041885,156.0
2750,23,total subjects,-1.091216216216216,190.0
2751,870,pathological findings,-1.0917968750000007,215.0
2752,3482,results indicated,-1.0925507900677194,605.0
2753,2639,using approach,-1.0937500000000022,200.0
2754,2695,brachial plexus,-1.0959387875220714,190.0
2755,768,chinese patients,-1.0975308641975299,127.0
2756,3214,matter volume,-1.1005603513554465,559.0
2757,2797,lung nodules,-1.1026833631484758,134.0
2758,3611,anal sphincter,-1.1027932960893856,141.0
2759,651,emission computed,-1.1066014669926643,511.0
2760,2041,higher rate,-1.1136363636363646,315.0
2761,3279,present results,-1.1144508670520252,241.0
2762,995,motor cortex,-1.1149914821124363,385.0
2763,2435,effective safe,-1.11556886227545,207.0
2764,1180,associated mortality,-1.1185142193847968,292.0
2765,3492,difference groups,-1.1224627875507465,395.0
2766,2473,malignant benign,-1.126639582124201,422.0
2767,418,months respectively,-1.1272202998846566,337.0
2768,883,tomography imaging,-1.1272604131391792,684.0
2769,3235,effective treatment,-1.1281105990783424,544.0
2770,1629,patients ischemic,-1.1292517006802756,166.0
2771,666,genetic analysis,-1.1300353356890476,123.0
2772,1264,studies found,-1.1307692307692292,147.0
2773,3033,coefficient adc,-1.132702112163145,576.0
2774,1708,metabolic tumor,-1.1342211928199193,166.0
2775,3171,test whether,-1.1344202898550722,202.0
2776,2318,stem cell,-1.1345129642606886,753.0
2777,1930,lower extremity,-1.1388927431663667,432.0
2778,3448,data patients,-1.141707556427852,831.0
2779,2868,resistive index,-1.1424528301886816,173.0
2780,2962,underwent successful,-1.1427018633540384,223.0
2781,2581,transcranial magnetic,-1.1432748538011686,230.0
2782,504,retrospective analysis,-1.1440245148110182,800.0
2783,2770,moderate severe,-1.1440936863543811,642.0
2784,2362,imaging contrast,-1.1471893491124225,235.0
2785,2645,computed tomographic,-1.1485454678683953,719.0
2786,2048,period months,-1.1541706615532272,463.0
2787,1296,time point,-1.1543859649122798,423.0
2788,2882,cystic fibrosis,-1.1562499999999984,222.0
2789,237,μm respectively,-1.1586206896551732,168.0
2790,1460,paediatric patients,-1.1587235155636946,207.0
2791,975,central venous,-1.1624020887728441,424.0
2792,2635,transient ischemic,-1.1651053864168635,199.0
2793,1950,invasive procedures,-1.1657028913260241,158.0
2794,2578,proposed method,-1.1662945533585183,1616.0
2795,3612,used predict,-1.1668893838158882,271.0
2796,3058,method using,-1.1672321861366952,344.0
2797,3328,diagnosed patients,-1.1684523809523788,151.0
2798,1139,carotid artery,-1.17191780821916,1711.0
2799,348,fluorescence microscopy,-1.1734412470023998,851.0
2800,561,fibroblast growth,-1.1735294117647068,133.0
2801,1024,aims investigate,-1.174879227053141,152.0
2802,234,coronary flow,-1.178446909667197,286.0
2803,1531,light microscopy,-1.1789473684210567,448.0
2804,2051,stress testing,-1.1814671814671835,170.0
2805,1596,component analysis,-1.1883552911177233,451.0
2806,2389,screw fixation,-1.1891566265060232,329.0
2807,834,imaged using,-1.1902390438247004,239.0
2808,3037,network dmn,-1.1913669064747845,276.0
2809,259,showed highest,-1.1923416789396177,253.0
2810,1052,particularly useful,-1.1925058548009382,134.0
2811,2471,cervical length,-1.1953333767842025,524.0
2812,3474,nihss score,-1.195406360424031,199.0
2813,353,drug release,-1.196143715098516,477.0
2814,1983,imaging technique,-1.1975966410887509,701.0
2815,1023,international society,-1.1976480711315074,584.0
2816,1115,microscopy images,-1.2018518518518502,236.0
2817,2538,using novel,-1.2020725388601035,290.0
2818,528,ssc patients,-1.203370786516853,153.0
2819,1900,poorly understood,-1.2041730519863278,681.0
2820,487,years ago,-1.205381165919279,192.0
2821,893,contralateral side,-1.2064516129032257,187.0
2822,1707,cases respectively,-1.2085240726124737,264.0
2823,1527,developed novel,-1.2105263157894768,240.0
2824,2919,many studies,-1.2121212121212124,200.0
2825,992,bone loss,-1.2130592503022966,760.0
2826,1111,pulmonary arteries,-1.2136929460580927,225.0
2827,96,information obtained,-1.220058997050147,188.0
2828,21,chronic hepatitis,-1.220338983050848,160.0
2829,2977,active surveillance,-1.2215568862275448,136.0
2830,600,method evaluated,-1.2222222222222237,170.0
2831,2181,within normal,-1.2248520710059159,207.0
2832,1844,knee arthroplasty,-1.2257383966244735,415.0
2833,3066,higher values,-1.2262411347517743,247.0
2834,2749,ms patients,-1.2266013564431038,397.0
2835,3541,image acquisition,-1.229738412115649,406.0
2836,2128,findings support,-1.2301698301698312,393.0
2837,2238,brain mapp,-1.23054573016675,573.0
2838,2034,hum brain,-1.23054573016675,573.0
2839,191,using ultrasound,-1.2314049586776852,447.0
2840,2905,treatment decisions,-1.2330383480826004,190.0
2841,1291,mitral annular,-1.2363636363636397,204.0
2842,2293,dose reduction,-1.2455043697230046,462.0
2843,2120,recent years,-1.2470712030866276,613.0
2844,1556,h e,-1.2516733601070928,187.0
2845,3181,alzheimer disease,-1.251704126199072,1593.0
2846,2528,functional connectivity,-1.2521236439473882,2892.0
2847,3040,used calculate,-1.259077171065887,292.0
2848,64,patients among,-1.2608695652173902,145.0
2849,931,liver metastases,-1.262468513853899,358.0
2850,3551,artery calcification,-1.2675078864353324,147.0
2851,2084,scanned using,-1.2679060665362019,209.0
2852,3659,general anesthesia,-1.2693586698337243,334.0
2853,397,image noise,-1.270561909497761,501.0
2854,635,failure patients,-1.2737864077669925,164.0
2855,373,using various,-1.274131274131266,150.0
2856,39,nuclear magnetic,-1.2758314855875834,137.0
2857,479,bone tissue,-1.2758691206543982,367.0
2858,799,morphological characteristics,-1.2814371257485047,214.0
2859,1551,cell growth,-1.283268482490271,323.0
2860,2706,patients retrospectively,-1.2853260869565233,215.0
2861,735,symptom severity,-1.2887700534759385,241.0
2862,568,tissue engineering,-1.297240148290539,487.0
2863,3644,crohn disease,-1.2980753443400521,402.0
2864,1007,results demonstrate,-1.30021413276229,1012.0
2865,1166,multiple regression,-1.3009005556620041,409.0
2866,1417,imaging parameters,-1.304109589041096,238.0
2867,2060,glomerular filtration,-1.3063797659494165,429.0
2868,935,years women,-1.306735751295338,291.0
2869,2023,fraction ef,-1.3101005684302605,211.0
2870,1897,randomized groups,-1.3150357995226714,145.0
2871,2296,used model,-1.3172932330827056,219.0
2872,2872,circumferential strain,-1.3175299614056444,287.0
2873,3654,results provide,-1.3175339217494377,633.0
2874,800,patients average,-1.3245947850598996,254.0
2875,854,drug resistance,-1.3266331658291444,120.0
2876,1249,patients males,-1.329387331256492,346.0
2877,2281,quality control,-1.3295024526979689,186.0
2878,3163,pigment epithelium,-1.3296037296037275,276.0
2879,2586,neural networks,-1.3302752293577995,290.0
2880,1612,heart rate,-1.3303476354525563,951.0
2881,824,results patients,-1.332954545454551,391.0
2882,3114,positron emission,-1.336378900542964,2575.0
2883,3178,texture features,-1.3372770769899966,244.0
2884,87,nsclc patients,-1.3376668601276855,172.0
2885,1487,twelve patients,-1.338053097345136,252.0
2886,56,factor receptor,-1.3386243386243393,345.0
2887,2172,curve analysis,-1.3397182093811313,529.0
2888,3624,visceral fat,-1.3401574803149638,253.0
2889,2576,provide additional,-1.3472891566265082,213.0
2890,3696,images obtained,-1.3476635514018735,721.0
2891,2382,mean number,-1.3479843953185968,219.0
2892,1829,address issue,-1.3528336380255894,148.0
2893,2673,analysis demonstrated,-1.3554848966613664,406.0
2894,1884,score patients,-1.3555785123966915,243.0
2895,1037,colon cancer,-1.3573487031700286,157.0
2896,328,student test,-1.3638205499276417,152.0
2897,2922,included mean,-1.368684759916497,298.0
2898,3555,assess whether,-1.3843843843843884,461.0
2899,926,thoracic aortic,-1.389473684210529,198.0
2900,2093,mean arterial,-1.390407673860913,223.0
2901,3102,subjects using,-1.39118028534371,173.0
2902,2765,patients eyes,-1.400000000000003,215.0
2903,2713,studies patients,-1.400000000000004,266.0
2904,1123,propose novel,-1.4015824710894682,202.0
2905,614,treatment results,-1.4022246941045624,191.0
2906,1081,right coronary,-1.4023154848046269,285.0
2907,2194,force microscopy,-1.4029260577303295,887.0
2908,157,ventromedial prefrontal,-1.405172413793103,163.0
2909,467,used determine,-1.4052040634468024,773.0
2910,2535,samples obtained,-1.4052095130237834,188.0
2911,2849,molecular weight,-1.408550702268871,270.0
2912,3423,disease progression,-1.4087149692412875,877.0
2913,3468,imaging system,-1.4105005790760536,485.0
2914,3427,great arteries,-1.4123484013230403,183.0
2915,244,patients mean,-1.4145889850579172,1729.0
2916,3617,patients rheumatoid,-1.4150943396226336,125.0
2917,1726,small number,-1.4175267770204487,251.0
2918,3455,well characterized,-1.4179104477611955,152.0
2919,979,tertiary care,-1.4210526315789498,255.0
2920,542,function patients,-1.422433288104929,425.0
2921,2212,assessment patients,-1.4262206148282108,239.0
2922,1110,pulmonary artery,-1.429428785767863,1170.0
2923,3261,controls respectively,-1.4327621658670306,156.0
2924,2170,development new,-1.4328022492970953,364.0
2925,1156,showed difference,-1.4341364443317224,422.0
2926,2989,low contrast,-1.4343137254901974,133.0
2927,247,tumor necrosis,-1.4350515463917501,232.0
2928,3663,correlations found,-1.4359752670039347,241.0
2929,3329,system cns,-1.436681222707427,235.0
2930,2467,adverse event,-1.4444924406047501,209.0
2931,471,general population,-1.4461538461538483,512.0
2932,2167,total knee,-1.4467525116739794,469.0
2933,3686,patients major,-1.4511882998171852,189.0
2934,9,data acquired,-1.452572964669741,425.0
2935,3306,patients used,-1.4545454545454517,160.0
2936,1587,patients breast,-1.4571855392889115,274.0
2937,982,tumor cell,-1.4606060606060458,241.0
2938,2239,medical management,-1.4657314629258509,159.0
2939,86,white blood,-1.4678949431595454,237.0
2940,1854,anterior insula,-1.4694576593720294,198.0
2941,1874,functional imaging,-1.470802919708028,455.0
2942,1425,high incidence,-1.4714285714285738,206.0
2943,1616,total lesion,-1.4769230769230832,192.0
2944,1063,motor function,-1.4778957528957546,251.0
2945,22,fourier transform,-1.48551645641658,693.0
2946,1175,generalized estimating,-1.4883720930232562,128.0
2947,3092,diagnostic criteria,-1.4905660377358487,395.0
2948,89,patients good,-1.4926470588235319,145.0
2949,1852,live cells,-1.4935763503000647,314.0
2950,1130,investigated effect,-1.4941094941094943,196.0
2951,563,radiation doses,-1.5024390243902428,308.0
2952,1906,epidermal growth,-1.5069452980946498,299.0
2953,3544,apparent diffusion,-1.5089434072915655,830.0
2954,836,tetralogy fallot,-1.5192825112107642,242.0
2955,3026,without evidence,-1.5206896551724085,189.0
2956,1661,macular degeneration,-1.527458492975736,460.0
2957,1745,might useful,-1.5277777777777772,200.0
2958,219,hepatitis b,-1.5337539432176677,187.0
2959,863,patients without,-1.535476302205544,2517.0
2960,1889,alternative method,-1.5359281437125727,171.0
2961,873,carotid thickness,-1.5406250000000021,493.0
2962,3326,dose gy,-1.5428571428571427,162.0
2963,2049,however results,-1.5465116279069788,133.0
2964,556,aimed investigate,-1.5504950495049667,783.0
2965,2292,kidney injury,-1.551590173300325,367.0
2966,2775,time series,-1.5553512803676939,252.0
2967,2346,macular edema,-1.555555555555531,385.0
2968,2949,atomic force,-1.556918167312516,962.0
2969,171,immunosorbent assay,-1.5582491582491582,178.0
2970,659,room temperature,-1.563580874872839,265.0
2971,1500,demographic data,-1.5642857142857165,292.0
2972,1871,successfully applied,-1.5703056768558945,186.0
2973,3282,control groups,-1.5711206896551784,729.0
2974,1224,experimental results,-1.5746214852199043,546.0
2975,2226,valve replacement,-1.5770481144343307,770.0
2976,3499,healthy volunteers,-1.5828508840557054,1405.0
2977,3515,vs respectively,-1.585020242914974,522.0
2978,1715,review board,-1.5855186325512278,570.0
2979,2961,fluorescein angiography,-1.5900136177939184,278.0
2980,3348,vitro studies,-1.596742671009775,129.0
2981,1260,family history,-1.5986842105263153,405.0
2982,1114,evaluation patients,-1.5994694960212175,335.0
2983,1641,sickle cell,-1.6019417475728157,165.0
2984,2725,range cm,-1.6030534351145083,175.0
2985,749,patients liver,-1.6066445182724265,186.0
2986,1237,iterative reconstruction,-1.6072644721906932,472.0
2987,1365,type iv,-1.607875307629207,200.0
2988,79,bypass grafting,-1.6106491910710643,348.0
2989,2969,catheter ablation,-1.6143497757847562,200.0
2990,2894,board approval,-1.6148437500000006,159.0
2991,1590,kidney disease,-1.6158707865168567,590.0
2992,1423,advanced imaging,-1.6161707243763155,283.0
2993,3567,techniques used,-1.6188679245283073,429.0
2994,1658,analysis indicated,-1.6260586319218204,312.0
2995,1550,sensitive detection,-1.6272545090180397,140.0
2996,867,linear model,-1.6332195676905548,194.0
2997,706,performed assess,-1.6400442477876123,353.0
2998,923,supplemental material,-1.6405498281786999,341.0
2999,321,online supplemental,-1.6405498281786999,341.0
3000,1520,showed lower,-1.6416309012875527,425.0
3001,2267,ovarian cancer,-1.64312668463612,254.0
3002,1560,lymph node,-1.6433028412188768,1644.0
3003,1357,aortic wall,-1.6435045317220458,160.0
3004,2637,assigned groups,-1.6461095100864553,136.0
3005,2246,show high,-1.6494505494505527,158.0
3006,2164,root mean,-1.6509349955476407,206.0
3007,2284,speckle tracking,-1.6666666666666656,450.0
3008,2595,studies necessary,-1.66767676767677,127.0
3009,1243,vena cava,-1.6683091461356852,668.0
3010,539,harris hip,-1.6687737041719322,200.0
3011,1027,treatment strategies,-1.6697619608767418,288.0
3012,3113,period years,-1.68125,269.0
3013,3351,new imaging,-1.6814207650273219,181.0
3014,1297,patients months,-1.6827250608272497,182.0
3015,2436,transform infrared,-1.6874684608915083,608.0
3016,616,well established,-1.6926136363636293,331.0
3017,1174,total volume,-1.6929674099485443,141.0
3018,881,tissue doppler,-1.6963821706975784,369.0
3019,746,none patients,-1.6966767371601092,351.0
3020,28,limited number,-1.6981256890848988,151.0
3021,2185,diagnostic accuracy,-1.7000661767266914,1863.0
3022,3252,radial diffusivity,-1.7008325624421827,317.0
3023,2733,aim present,-1.712324416758274,694.0
3024,1396,could provide,-1.7203125000000057,367.0
3025,3666,valuable information,-1.7234165067178542,219.0
3026,2982,nerve sheath,-1.7284403669724746,157.0
3027,3,intervention patients,-1.72961373390558,155.0
3028,31,linear mixed,-1.7299559471365675,187.0
3029,3557,materials methods,-1.7321219226260274,394.0
3030,572,insulin resistance,-1.7324161650902805,438.0
3031,1191,complete resection,-1.7326116373477727,194.0
3032,3287,matter lesions,-1.7380597014925363,137.0
3033,1040,experimental conditions,-1.7391442155309078,177.0
3034,744,bile duct,-1.7465091913515585,549.0
3035,2139,motor recovery,-1.7493796526054621,141.0
3036,378,tumor response,-1.7503836317135555,236.0
3037,1675,tomography spect,-1.75355476255833,273.0
3038,986,eligible patients,-1.7566539923954352,210.0
3039,3095,due high,-1.756965944272444,227.0
3040,818,brain activity,-1.757046114156727,1009.0
3041,2289,respectively results,-1.7650031585596953,254.0
3042,2029,months median,-1.7658767772511863,207.0
3043,3298,studies using,-1.7807199806716563,444.0
3044,3485,grey matter,-1.7827433628318585,612.0
3045,3126,using new,-1.7837837837837758,210.0
3046,3428,adc values,-1.7843271316810185,803.0
3047,1885,cell cycle,-1.789215686274507,365.0
3048,1452,radiation exposure,-1.7893181521880868,1190.0
3049,1202,dice similarity,-1.791943127962085,199.0
3050,3556,purpose present,-1.7948410317936452,272.0
3051,555,light scattering,-1.7978798586572475,318.0
3052,1335,dna damage,-1.8003012048192781,278.0
3053,1424,diastolic blood,-1.8005934718100902,222.0
3054,581,anterior temporal,-1.8081381011097417,188.0
3055,929,mapp periodicals,-1.8087077152918525,533.0
3056,1333,ventricular dysfunction,-1.8117647058823494,224.0
3057,2638,frontal gyrus,-1.8199234509154725,1086.0
3058,775,mean value,-1.8307692307692331,221.0
3059,1858,prostate cancer,-1.8308412973922519,1895.0
3060,1205,treatment choice,-1.8328767123287617,223.0
3061,3491,enrolled prospective,-1.8358208955223887,123.0
3062,734,sd years,-1.8374437443744374,346.0
3063,2776,thickness imt,-1.8396121883656538,229.0
3064,161,improve diagnostic,-1.844382022471912,268.0
3065,991,imaging patients,-1.848878394332945,522.0
3066,583,brain imaging,-1.8493670886075853,487.0
3067,1677,measurements using,-1.8500000000000048,148.0
3068,65,using images,-1.8520547945205532,156.0
3069,94,remains unclear,-1.8591737005775333,775.0
3070,714,resonance spectroscopy,-1.864864864864855,345.0
3071,678,clinically important,-1.8649681528662436,183.0
3072,374,used examine,-1.8772455089820328,285.0
3073,2928,evidence suggests,-1.8835978835978915,356.0
3074,2476,participants completed,-1.8859649122807054,172.0
3075,112,across subjects,-1.887744593202888,195.0
3076,566,general linear,-1.8903474903474888,144.0
3077,1400,lupus erythematosus,-1.8917763157894734,243.0
3078,2477,analysis data,-1.8941711451012846,290.0
3079,518,past years,-1.8944606413994207,361.0
3080,3409,potential improve,-1.9061898211829469,169.0
3081,1869,correlated positively,-1.9063763608087076,227.0
3082,755,sinus thrombosis,-1.9067796610169527,125.0
3083,3597,levels measured,-1.9084594835262727,188.0
3084,781,range days,-1.9164248403946575,254.0
3085,3584,patients however,-1.9212765957446731,344.0
3086,776,imaging scans,-1.9218035824583033,331.0
3087,1187,disorder characterized,-1.9222551928783356,237.0
3088,1710,plaque rupture,-1.9236641221374078,168.0
3089,2934,median iqr,-1.9263157894736838,183.0
3090,2785,elastic modulus,-1.9357142857142902,271.0
3091,2091,cancer cells,-1.9407459784337897,1307.0
3092,1702,head trauma,-1.942035398230082,231.0
3093,3603,functional neuroimaging,-1.94444444444445,175.0
3094,1512,material available,-1.9538961038961067,354.0
3095,1337,folic acid,-1.9552238805970172,131.0
3096,2573,many years,-1.9565217391304375,150.0
3097,229,retrospectively evaluated,-1.9576864535768597,327.0
3098,2322,approved institutional,-1.9593750000000045,266.0
3099,2908,cell lines,-1.961093651791326,761.0
3100,2854,high performance,-1.9703703703703805,133.0
3101,1148,showed strong,-1.9714285714285715,207.0
3102,2103,middle temporal,-1.975810602161603,349.0
3103,1293,ten patients,-1.9820063694267513,461.0
3104,1502,results obtained,-1.9826264690853364,600.0
3105,1851,power doppler,-1.9863636363636332,342.0
3106,3661,species ros,-1.9870967741935426,264.0
3107,1217,could potentially,-1.9888708806050799,233.0
3108,1769,basal cell,-1.9894459102902415,130.0
3109,62,middle ear,-1.9907024793388444,235.0
3110,1359,acquired using,-1.9939849624060144,238.0
3111,918,transmission electron,-1.998098732488331,1619.0
3112,2522,mechanical properties,-1.9987072581043073,1119.0
3113,2902,inflammatory response,-2.0068280571073878,305.0
3114,3689,groups using,-2.0079113924050573,235.0
3115,196,participants underwent,-2.012903225806427,312.0
3116,3054,nine patients,-2.0131323380200072,649.0
3117,1988,remains challenging,-2.014112903225806,270.0
3118,905,reporting data,-2.02857142857143,284.0
3119,2857,waist circumference,-2.035473340587597,199.0
3120,1067,samples collected,-2.037199124726474,245.0
3121,2386,bone thickness,-2.0417910447761156,152.0
3122,3621,high low,-2.04375947448206,321.0
3123,1085,single molecule,-2.0480186480186515,191.0
3124,2585,underwent coronary,-2.054913294797692,237.0
3125,2870,body composition,-2.061101059705346,896.0
3126,1012,gradient echo,-2.06379310344828,228.0
3127,3188,radiographic findings,-2.069724770642203,188.0
3128,2353,cancer imaging,-2.0761523046092205,185.0
3129,3270,radical prostatectomy,-2.0769230769230718,198.0
3130,2220,cardiac death,-2.086708860759498,471.0
3131,2723,examinations performed,-2.086846084064108,426.0
3132,1051,gray matter,-2.0890510948905043,1431.0
3133,1124,patients exhibited,-2.089430894308945,257.0
3134,3509,computational fluid,-2.099999999999985,231.0
3135,3152,cancer underwent,-2.100000000000003,189.0
3136,226,intraclass coefficients,-2.1007496251874116,226.0
3137,2417,mean years,-2.1017524024872443,4290.0
3138,3520,york heart,-2.1052631578947376,200.0
3139,175,malignant transformation,-2.105955006616674,219.0
3140,1927,density bmd,-2.1067256311037372,566.0
3141,1673,novel approach,-2.107142857142863,295.0
3142,2728,commonly used,-2.1120772946859785,1093.0
3143,3604,revision surgery,-2.1133553803103498,322.0
3144,1544,blood vessels,-2.1173764072442514,503.0
3145,2066,drug administration,-2.119665271966537,149.0
3146,682,neck pain,-2.1224489795918386,182.0
3147,3582,newly developed,-2.1268425841674268,377.0
3148,3093,anatomic landmarks,-2.1284796573875844,142.0
3149,2707,endothelial growth,-2.1322274881516563,409.0
3150,3403,high signal,-2.1399267399267443,254.0
3151,3228,using computed,-2.1420454545454506,377.0
3152,423,years average,-2.149898167006118,182.0
3153,2145,measured using,-2.153713544499765,1454.0
3154,2670,high spatial,-2.1616279069767455,338.0
3155,510,body mass,-2.1626100749330064,2081.0
3156,2619,patients females,-2.1673796791443816,193.0
3157,3098,values lower,-2.1681818181818153,159.0
3158,2312,months initial,-2.1753554502369625,135.0
3159,3683,serum levels,-2.1764705882352886,555.0
3160,1853,future studies,-2.184373243395162,670.0
3161,3684,imaging brain,-2.190476190476172,184.0
3162,3296,pregnant women,-2.196817420435512,430.0
3163,1692,analysis used,-2.2004260199901733,722.0
3164,2889,ventricle lv,-2.202631578947374,186.0
3165,943,electron microscopy,-2.2031760686917146,4419.0
3166,1965,man presented,-2.2043844856661083,344.0
3167,2976,pediatric population,-2.2150658078969534,350.0
3168,987,prepared using,-2.215131578947373,182.0
3169,1057,imaging performed,-2.218932038834957,653.0
3170,1087,differences found,-2.218977429755863,777.0
3171,2661,therapeutic effect,-2.2298065984072792,200.0
3172,2364,used analyze,-2.230700778642931,271.0
3173,1059,molecular mechanism,-2.230769230769237,145.0
3174,2158,lymph nodes,-2.23094170403588,1393.0
3175,1376,range motion,-2.2407369912937876,465.0
3176,3333,years median,-2.2412940057088533,302.0
3177,3642,liver cirrhosis,-2.243147656940762,295.0
3178,2119,bipolar disorder,-2.244827586206893,372.0
3179,1955,ethylene glycol,-2.24601366742597,170.0
3180,492,artery bypass,-2.2548915917504004,520.0
3181,502,node metastasis,-2.255036855036857,353.0
3182,3595,intravascular ultrasound,-2.2601694915254322,381.0
3183,3687,systolic diastolic,-2.269921033740129,527.0
3184,3182,subjects years,-2.27835051546391,195.0
3185,13,met inclusion,-2.282665160926034,493.0
3186,1727,myocardial blood,-2.2869409660107385,136.0
3187,270,fully understood,-2.2887608069164216,209.0
3188,3590,tumor location,-2.2920353982300945,185.0
3189,1986,male female,-2.2948717948717947,895.0
3190,1798,corpus callosum,-2.3008117389946934,867.0
3191,2144,purpose assess,-2.3043478260869437,371.0
3192,3174,cardiac cycle,-2.3058823529411745,196.0
3193,3136,mammalian cells,-2.3161764705882324,175.0
3194,3043,patients cerebral,-2.3190184049079763,126.0
3195,537,used assess,-2.322115384615377,1265.0
3196,2879,optic disc,-2.3383177570093445,417.0
3197,1501,experiments performed,-2.3529411764705777,175.0
3198,577,january june,-2.3589743589743657,230.0
3199,1650,malignant tumors,-2.3659284497444664,217.0
3200,250,segmentation method,-2.3693741677762925,217.0
3201,205,used test,-2.3732079905992904,198.0
3202,1384,matter integrity,-2.386074847693647,276.0
3203,1564,congenital heart,-2.390500139703836,586.0
3204,3234,postoperative course,-2.3937219730941766,157.0
3205,1922,analyzed using,-2.394462438616653,947.0
3206,3647,fmri data,-2.399079472230754,471.0
3207,1840,present investigate,-2.4052434456928813,169.0
3208,1603,cutoff value,-2.4062313736114853,367.0
3209,2022,changes associated,-2.4096385542168646,250.0
3210,3236,image features,-2.4135593220339002,178.0
3211,2291,mean difference,-2.418691588785052,647.0
3212,2771,aim analyze,-2.4332103321033167,157.0
3213,2600,males mean,-2.433734939759029,202.0
3214,1778,resonance images,-2.4367346938775536,398.0
3215,2403,patients disease,-2.437499999999997,195.0
3216,3148,survival os,-2.4389483933787823,404.0
3217,499,healthy participants,-2.443690002341377,355.0
3218,490,carotid stenosis,-2.454910714285713,234.0
3219,2519,wound healing,-2.4634435962680246,274.0
3220,2011,images evaluated,-2.4714285714285777,173.0
3221,2918,index bmi,-2.4745071380013646,700.0
3222,952,plasma levels,-2.481081081081083,238.0
3223,444,f f,-2.500803427959296,203.0
3224,1891,various types,-2.517482517482517,200.0
3225,458,molecular imaging,-2.5182860591430254,652.0
3226,2602,last decades,-2.5287009063444086,155.0
3227,880,clin ultrasound,-2.5288256227757966,187.0
3228,2313,periodicals clin,-2.5288256227757966,187.0
3229,2521,left hemisphere,-2.539588688946008,267.0
3230,2891,groups showed,-2.5479099678456576,283.0
3231,3607,brain function,-2.553679653679657,347.0
3232,3497,examined whether,-2.567821782178218,247.0
3233,2143,imaging fmri,-2.585607940446656,1042.0
3234,1693,surrogate marker,-2.5883720930232643,159.0
3235,344,magn reson,-2.5959220097893447,1209.0
3236,685,purpose compare,-2.6,273.0
3237,285,body weight,-2.601483434976104,724.0
3238,466,planning target,-2.6051282051282048,127.0
3239,1413,based upon,-2.6144393241167405,230.0
3240,3135,patients aortic,-2.615384615384614,170.0
3241,866,weeks weeks,-2.6267029972751943,241.0
3242,253,imaging reporting,-2.6332928311057233,252.0
3243,208,images used,-2.634363097757091,249.0
3244,3016,tensor imaging,-2.637313432835838,1178.0
3245,2572,respiratory motion,-2.640901771336557,328.0
3246,1926,without complications,-2.6409266409266348,180.0
3247,1704,subgroup analysis,-2.643814432989687,223.0
3248,1186,cancer pca,-2.6440677966101687,234.0
3249,907,obtained using,-2.645563549160676,788.0
3250,3505,distal radius,-2.6472527472527436,219.0
3251,1039,imaging computed,-2.6492957746478862,198.0
3252,1201,enhancement lge,-2.6526315789473744,168.0
3253,2910,hematoxylin eosin,-2.6590909090909145,130.0
3254,3641,findings indicate,-2.666162570888462,516.0
3255,61,fluoroscopy time,-2.669469835466179,447.0
3256,216,across groups,-2.674384949348766,280.0
3257,548,using scanning,-2.677655677655672,340.0
3258,2262,high rate,-2.679999999999988,335.0
3259,623,studies suggested,-2.6930232558139253,193.0
3260,2544,controls mean,-2.6998027613412177,236.0
3261,110,absorptiometry dxa,-2.7009153318077828,407.0
3262,1481,tomography cbct,-2.7191943127962084,459.0
3263,3271,pancreatic cancer,-2.7282051282051305,448.0
3264,2884,right superior,-2.736431784107938,234.0
3265,1179,retinal nerve,-2.740148698884776,567.0
3266,1455,findings demonstrate,-2.7405289492494704,270.0
3267,3486,scanning electron,-2.743304036943243,2361.0
3268,3274,quality life,-2.745408875244206,928.0
3269,3350,mean preoperative,-2.746835443037979,155.0
3270,2109,maxillary sinus,-2.7553398058252427,396.0
3271,3030,however still,-2.7554502369668312,153.0
3272,2874,male subjects,-2.7603773584905666,154.0
3273,932,physiological conditions,-2.7616580310880843,195.0
3274,63,prospective patients,-2.763636363636359,272.0
3275,3395,intravenous administration,-2.7649667405765004,145.0
3276,2529,strongly associated,-2.7801896733403644,388.0
3277,1300,past decade,-2.7818181818181764,198.0
3278,1436,functional groups,-2.801456310679608,199.0
3279,2450,remained stable,-2.8047023511755858,289.0
3280,1146,excellent agreement,-2.8206642066420664,182.0
3281,2886,quantum dots,-2.826277372262768,242.0
3282,1581,right lateral,-2.828571428571431,154.0
3283,962,imaging systems,-2.828571428571443,176.0
3284,742,patients heart,-2.832167832167839,225.0
3285,2745,mrna expression,-2.8713098535813253,261.0
3286,322,attenuation correction,-2.8713968957871376,175.0
3287,1029,images acquired,-2.876116625310179,653.0
3288,1163,renal function,-2.8770631758679674,674.0
3289,913,region interest,-2.880748246297735,528.0
3290,3308,cholangiopancreatography ercp,-2.8823529411764675,224.0
3291,833,novel technique,-2.8847222222222078,201.0
3292,2703,obstructive sleep,-2.891228070175434,206.0
3293,2627,imaging modality,-2.9310344827586223,850.0
3294,977,novel method,-2.9321266968325754,432.0
3295,2553,subcortical structures,-2.9397683397683334,141.0
3296,3031,forty patients,-2.9493975903614564,204.0
3297,2646,wall thickness,-2.961523676393499,792.0
3298,3561,patients older,-2.962962962962951,200.0
3299,2038,artery aneurysm,-2.990909090909111,188.0
3300,354,signaling pathway,-2.9923566878980954,261.0
3301,2829,commercially available,-2.9947136563876624,561.0
3302,748,although several,-2.995505617977542,129.0
3303,538,brain structures,-2.996341463414622,234.0
3304,3223,parameters measured,-3.0302013422818836,215.0
3305,2511,rsna online,-3.045317220543813,315.0
3306,192,showed association,-3.046280991735534,194.0
3307,3192,analyses revealed,-3.0545454545454556,378.0
3308,2431,imaging sequences,-3.0556962025316463,142.0
3309,2355,new york,-3.0560163154316897,247.0
3310,2816,performed using,-3.056639004149377,1637.0
3311,2192,measurements performed,-3.0605504587155923,417.0
3312,2866,complications patients,-3.0617283950617216,248.0
3313,245,without need,-3.06482910694597,339.0
3314,3062,surgical procedures,-3.094948265368233,339.0
3315,2006,inflammatory cells,-3.1069182389937025,130.0
3316,301,access site,-3.1146245059288535,197.0
3317,1506,patients examined,-3.115883100381201,201.0
3318,3430,locally advanced,-3.1177086541422825,456.0
3319,1667,signal intensity,-3.128063961137536,1198.0
3320,2300,brain areas,-3.1338129496402995,594.0
3321,2607,head injury,-3.1364806866952755,174.0
3322,2388,subjects enrolled,-3.143835616438355,153.0
3323,2860,years patients,-3.144833197721742,773.0
3324,2691,complications associated,-3.156716417910437,141.0
3325,3297,investigate effect,-3.1649514213746013,411.0
3326,3510,metabolic syndrome,-3.167512690355336,360.0
3327,1089,play important,-3.1839930404523744,600.0
3328,2419,patients surgical,-3.206818181818181,166.0
3329,3007,fractional anisotropy,-3.2394313505424632,1237.0
3330,1558,dose escalation,-3.246376811594199,140.0
3331,2514,scans obtained,-3.2470588235294335,216.0
3332,121,identified patients,-3.2661609319967297,763.0
3333,1494,provide useful,-3.278977272727278,199.0
3334,477,operative time,-3.287671232876715,400.0
3335,1289,radiation dose,-3.301295810477775,1585.0
3336,3313,cell imaging,-3.3153439153438957,241.0
3337,997,according presence,-3.317488789237678,137.0
3338,914,middle cerebral,-3.3186018957345844,757.0
3339,280,rheumatoid arthritis,-3.321418949259091,536.0
3340,3180,widely used,-3.323423423423428,1302.0
3341,3533,systemic lupus,-3.3273167777104753,227.0
3342,2383,human brain,-3.3288475654514227,907.0
3343,3175,similar patients,-3.351063829787232,175.0
3344,3577,used investigate,-3.3533519553072626,343.0
3345,147,cortex dlpfc,-3.3629629629629374,227.0
3346,2495,imaging methods,-3.42685589519652,430.0
3347,3363,activity score,-3.4488745980707494,173.0
3348,847,limits agreement,-3.459154929577469,307.0
3349,1737,among patients,-3.4609096625444895,1920.0
3350,3277,brain injury,-3.465353583293791,859.0
3351,463,patients stable,-3.472549019607847,253.0
3352,345,strongly correlated,-3.4733863837312073,322.0
3353,3493,patients classified,-3.4877374784110575,439.0
3354,1509,tumors patients,-3.4960629921259767,148.0
3355,825,previous studies,-3.510835913312659,1296.0
3356,3614,reson imaging,-3.5166524338172565,710.0
3357,1887,controls differences,-3.524999999999987,141.0
3358,1754,using technique,-3.538211382113827,256.0
3359,24,patients undergoing,-3.5520081846506875,2598.0
3360,2568,value accuracy,-3.5714285714285774,125.0
3361,3361,state examination,-3.57647058823534,152.0
3362,2392,improve accuracy,-3.5867768595041354,310.0
3363,3513,important roles,-3.5874999999999897,164.0
3364,602,area receiver,-3.5914772727272775,602.0
3365,2512,motor neuron,-3.5920903954802217,187.0
3366,164,patients grade,-3.5921052631578916,210.0
3367,917,laser scanning,-3.5934959349593507,442.0
3368,1456,adipose tissue,-3.5975446428571534,908.0
3369,3269,provide insight,-3.6124352331606158,249.0
3370,2654,ventricular lv,-3.6175761560376896,971.0
3371,3477,analyses performed,-3.641379310344817,726.0
3372,1009,ventricular volume,-3.654794520547948,174.0
3373,3156,higher levels,-3.6562499999999933,390.0
3374,313,tests performed,-3.697635605006957,211.0
3375,411,fluid dynamics,-3.7347962382445243,259.0
3376,3231,great potential,-3.735042735042733,437.0
3377,1546,visual acuity,-3.7539855072463677,1594.0
3378,3021,investigate whether,-3.7568548387096854,847.0
3379,474,using method,-3.762711864406791,370.0
3380,3121,model used,-3.7640342530922895,460.0
3381,1246,crucial role,-3.813188798554654,346.0
3382,2032,negatively associated,-3.8527131782945663,213.0
3383,2298,univariate analysis,-3.869317329332316,629.0
3384,2657,scan time,-3.873806998939563,281.0
3385,2558,underwent complete,-3.8807017543859406,158.0
3386,830,performed without,-3.8999999999999795,195.0
3387,88,specificity accuracy,-3.9089820359281298,544.0
3388,238,sclerosis ms,-3.9200521682425933,466.0
3389,2076,described literature,-3.926066350710911,218.0
3390,831,left anterior,-3.927683615819201,632.0
3391,1515,past decades,-3.928571428571426,275.0
3392,1935,vast majority,-3.94814814814815,205.0
3393,1732,coronary syndrome,-3.994636015325684,401.0
3394,1388,levels associated,-3.9959390862944084,288.0
3395,828,quantitative imaging,-4.004907975460129,204.0
3396,2228,prenatal ultrasound,-4.012383900928792,144.0
3397,1903,strain rate,-4.021189511831171,447.0
3398,3155,supramarginal gyrus,-4.027190332326296,155.0
3399,2672,bone mass,-4.036144578313242,335.0
3400,3650,image quality,-4.060293309932523,3484.0
3401,3639,weeks postoperatively,-4.066666666666686,122.0
3402,2983,men women,-4.081567305666743,1404.0
3403,2308,aim work,-4.094623655913976,272.0
3404,3331,characteristic curve,-4.1068793619142445,1084.0
3405,1496,high quality,-4.114953271028028,238.0
3406,3101,analyses showed,-4.120438683948157,328.0
3407,2083,prognosis patients,-4.145454545454551,266.0
3408,1120,multiple sclerosis,-4.158186779866597,1001.0
3409,2138,within days,-4.183904109589004,643.0
3410,2973,potential application,-4.223140495867756,219.0
3411,519,increasingly used,-4.24388489208632,347.0
3412,1522,mean sd,-4.26520438683949,1104.0
3413,963,imaging protocol,-4.275167785234891,245.0
3414,3405,interest roi,-4.2847497089639175,239.0
3415,239,diffraction xrd,-4.294618272841058,301.0
3416,1565,prostate biopsy,-4.309307875895013,244.0
3417,2288,metabolic activity,-4.309465020576111,308.0
3418,2871,antibiotic therapy,-4.310447761194034,152.0
3419,2448,single nucleotide,-4.327272727272738,126.0
3420,3368,underwent percutaneous,-4.342268041237101,162.0
3421,134,chain reaction,-4.360123647604338,403.0
3422,1937,near infrared,-4.366990291262122,346.0
3423,2058,treatment modalities,-4.374749498997983,185.0
3424,2449,analysis variance,-4.386477752920711,562.0
3425,1345,reach significance,-4.399999999999977,154.0
3426,1604,examined using,-4.4194346289752735,379.0
3427,2965,effective connectivity,-4.440983606557399,189.0
3428,501,target lesion,-4.447144006436036,333.0
3429,1385,provides evidence,-4.466911764705876,225.0
3430,2933,eleven patients,-4.490196078431354,229.0
3431,1149,subjects without,-4.496124031007754,348.0
3432,1208,years range,-4.533843363041272,1459.0
3433,1303,six patients,-4.558521560574928,740.0
3434,2104,disease cvd,-4.594029850746282,171.0
3435,2080,available article,-4.631007751938032,309.0
3436,225,curve auc,-4.647422680412376,644.0
3437,319,diagnostic performance,-4.6570912841670955,1237.0
3438,3107,cell proliferation,-4.660598179453834,560.0
3439,1155,uric acid,-4.685383502170776,228.0
3440,1447,great promise,-4.712883435582815,167.0
3441,1671,macular hole,-4.714285714285726,198.0
3442,1895,contrast enhancement,-4.72346640701071,539.0
3443,1644,using imaging,-4.724315871774833,364.0
3444,1607,weeks gestation,-4.730759046778469,831.0
3445,3166,purpose article,-4.7547169811320655,168.0
3446,777,fluid csf,-4.773453199365395,373.0
3447,3441,arterial pressure,-4.779039301310051,288.0
3448,2463,cells however,-4.779245283018879,149.0
3449,202,cell membrane,-4.816233090530709,522.0
3450,3631,mean differences,-4.826086956521747,185.0
3451,1679,different techniques,-4.834782608695654,139.0
3452,3608,test showed,-4.840641711229929,146.0
3453,293,confocal laser,-4.867924528301877,430.0
3454,3422,maximum standardized,-4.904587155963302,243.0
3455,494,raman spectroscopy,-4.94464285714285,213.0
3456,692,female mean,-4.973684210526322,210.0
3457,1721,studies showed,-4.99550561797754,429.0
3458,596,identify patients,-5.028021015761857,435.0
3459,1828,total consecutive,-5.0564885496183125,368.0
3460,1189,cerebrovascular disease,-5.066666666666662,192.0
3461,2597,imaging findings,-5.088042687363557,1234.0
3462,1225,images patients,-5.138681948424052,441.0
3463,3047,groups mean,-5.141353383458646,263.0
3464,3554,time points,-5.14877967235041,1000.0
3465,2277,groups according,-5.156962025316489,582.0
3466,1450,cardiac magnetic,-5.167701863354033,832.0
3467,973,results indicate,-5.17391304347827,1470.0
3468,1648,patients schizophrenia,-5.176929072486366,246.0
3469,2221,patients prostate,-5.1858585858585755,151.0
3470,1549,hundred patients,-5.1899581589957915,443.0
3471,711,previously reported,-5.209357118815199,1005.0
3472,2207,investigate relationship,-5.218023255813942,359.0
3473,1514,microscopy imaging,-5.236363636363637,128.0
3474,2844,positively correlated,-5.248879882922459,1027.0
3475,2941,aimed determine,-5.259139326800193,556.0
3476,569,gyrus right,-5.260465116279075,232.0
3477,1923,deviation sd,-5.261851015801355,259.0
3478,3668,women mean,-5.2764132553606125,606.0
3479,3685,lv diastolic,-5.291061452513983,287.0
3480,663,real time,-5.300155520995327,568.0
3481,203,imaging features,-5.307641280775602,791.0
3482,1363,analyses demonstrated,-5.337704918032788,132.0
3483,2210,institutional review,-5.3427179434021115,834.0
3484,2265,relaxation times,-5.346220797068263,358.0
3485,2266,detection rate,-5.371197574532605,516.0
3486,2686,seen patients,-5.399999999999968,426.0
3487,959,protein expression,-5.413953488372074,388.0
3488,2408,systolic blood,-5.416733067729093,412.0
3489,1738,often associated,-5.433333333333315,163.0
3490,849,model showed,-5.4526315789473765,148.0
3491,753,microscopy sem,-5.464523137084532,822.0
3492,3635,benign lesions,-5.499299809038841,363.0
3493,1614,method used,-5.499892588614386,502.0
3494,783,portal vein,-5.501628664495095,563.0
3495,2338,neural correlates,-5.551259519625052,412.0
3496,802,aortic valve,-5.569491525423724,1643.0
3497,1680,poor outcomes,-5.573770491803279,200.0
3498,1161,value suvmax,-5.661455525606448,178.0
3499,1511,low high,-5.721428571428561,267.0
3500,1433,time course,-5.7890625000000275,285.0
3501,2730,head neck,-5.790174854288106,1220.0
3502,176,retrospective series,-5.816122004357321,284.0
3503,821,neuronal activity,-5.822480620155029,259.0
3504,1227,signaling pathways,-5.8327586206897175,199.0
3505,848,cardiovascular mortality,-5.863949843260191,199.0
3506,349,routinely used,-5.9104477611940265,132.0
3507,281,wide range,-5.984888258247575,819.0
3508,2787,type ii,-6.0162354134956795,770.0
3509,1389,mean duration,-6.022388059701444,269.0
3510,3045,mean diffusivity,-6.024031007751936,409.0
3511,3010,values measured,-6.045910290237464,201.0
3512,3035,randomized receive,-6.046927374301664,164.0
3513,3407,reviewed patients,-6.078006500541723,374.0
3514,552,studied using,-6.1093235831809745,341.0
3515,3338,mean period,-6.180459770114931,283.0
3516,1915,lv mass,-6.18807947019867,512.0
3517,3120,new technique,-6.266666666666656,188.0
3518,864,axial diffusivity,-6.29444444444444,206.0
3519,3179,uptake value,-6.332773109243724,471.0
3520,2853,retrospectively reviewed,-6.359876065065864,1346.0
3521,3369,present new,-6.374999999999996,170.0
3522,1761,underlying mechanism,-6.405797101449266,170.0
3523,2664,following treatment,-6.495535714285685,291.0
3524,1408,total body,-6.510902255639099,251.0
3525,2475,delivery system,-6.519834710743782,343.0
3526,736,blood pressure,-6.551906881939581,2128.0
3527,78,patients suffering,-6.555555555555555,295.0
3528,454,hip arthroplasty,-6.5788732394366205,519.0
3529,1419,high levels,-6.580060422960681,330.0
3530,3572,cardiac function,-6.594559879108424,619.0
3531,1537,beneficial effect,-6.599999999999999,132.0
3532,74,pedicle screws,-6.652173913043489,170.0
3533,359,cortical thickness,-6.6986850344395785,1202.0
3534,3027,associated poor,-6.726923076923098,318.0
3535,1808,assess impact,-6.742465753424679,214.0
3536,2126,stent thrombosis,-6.795121951219499,199.0
3537,1909,left atrial,-6.802945657694283,1175.0
3538,2967,arthroplasty tha,-6.805479452054805,216.0
3539,3260,exhibited high,-6.911392405063274,130.0
3540,2665,scan performed,-6.929411764705906,209.0
3541,642,diagnostic therapeutic,-6.931120331950197,288.0
3542,1096,blood loss,-6.9369042215160945,566.0
3543,878,brain networks,-6.955555555555545,626.0
3544,641,subjective image,-7.006249999999973,236.0
3545,2316,used imaging,-7.097316636851491,239.0
3546,712,well known,-7.100917431192626,258.0
3547,2927,objective assess,-7.129032258064501,195.0
3548,1682,spatial distribution,-7.130920060331838,307.0
3549,1622,myocardial perfusion,-7.158225324027933,671.0
3550,2342,iron oxide,-7.187500000000001,391.0
3551,326,liver disease,-7.195588235294132,699.0
3552,2047,mean dose,-7.256250000000007,172.0
3553,2018,fluorescence lifetime,-7.288888888888853,152.0
3554,853,mean square,-7.333333333333316,220.0
3555,1996,perfusion imaging,-7.358906379453221,499.0
3556,361,computerized tomography,-7.368292682926832,318.0
3557,66,first step,-7.399999999999993,243.0
3558,2700,high frequency,-7.479452054794519,210.0
3559,3437,therapeutic options,-7.570616113744088,163.0
3560,108,january january,-7.694117647058816,218.0
3561,3202,aim investigate,-7.82542796691668,1054.0
3562,1567,diffusion coefficient,-7.870183486238529,903.0
3563,752,several studies,-7.873918741808664,323.0
3564,3312,inferior vena,-7.958823529411725,369.0
3565,1585,cell membranes,-8.037795275590662,176.0
3566,2309,resonance mr,-8.054121863799253,977.0
3567,1165,fifteen patients,-8.05934065934067,193.0
3568,3620,healthy children,-8.222784810126573,232.0
3569,276,specificity sensitivity,-8.269070208728653,269.0
3570,1817,male patients,-8.27455621301777,368.0
3571,2819,retrograde cholangiopancreatography,-8.292307692307663,301.0
3572,2589,growth factor,-8.292857142857182,1161.0
3573,813,fluorescence imaging,-8.297397769516726,620.0
3574,1698,frequently associated,-8.299300699300717,138.0
3575,1830,therapeutic potential,-8.312500000000039,133.0
3576,1706,national health,-8.400000000000018,112.0
3577,2168,overall survival,-8.42905405405408,1497.0
3578,845,live cell,-8.446153846153834,183.0
3579,3433,thickness cimt,-8.461538461538384,300.0
3580,3605,different imaging,-8.522851919561255,222.0
3581,2260,heart association,-8.541176470588288,264.0
3582,1621,contrast agent,-8.564765035776478,1002.0
3583,543,present first,-8.653846153846146,225.0
3584,1951,score range,-8.661764705882385,155.0
3585,287,used evaluation,-8.69491525423732,135.0
3586,393,years months,-8.915789473684242,121.0
3587,421,assessed using,-8.993677118424506,1789.0
3588,1952,distal femur,-9.068874172185446,167.0
3589,3081,subjects patients,-9.137764350453239,213.0
3590,894,commonly performed,-9.164705882352987,123.0
3591,347,mass index,-9.266326675166384,2195.0
3592,275,mr imaging,-9.328464318463784,2868.0
3593,1065,early detection,-9.365290900049692,632.0
3594,2876,provide novel,-9.416666666666588,226.0
3595,3169,multivariate analyses,-9.451485148514912,387.0
3596,1774,cardiac events,-9.455421686746984,436.0
3597,3106,f fdg,-9.462962962962976,280.0
3598,1327,using test,-9.528169014084531,205.0
3599,364,gleason score,-9.595238095238146,310.0
3600,151,findings reveal,-9.666666666666673,145.0
3601,1351,cerebral artery,-9.68963749542289,888.0
3602,1118,patients congenital,-9.835294117647045,132.0
3603,1311,tuberculosis tb,-9.83529411764705,132.0
3604,1177,provide first,-9.84999999999992,197.0
3605,1842,brain structure,-9.873134328358164,441.0
3606,822,showed high,-9.904830917874413,609.0
3607,2310,qualitative quantitative,-9.910791366906478,287.0
3608,342,groups respectively,-9.92230483271376,651.0
3609,3119,results suggest,-10.002272727272729,2934.0
3610,2245,diastolic function,-10.192885375494129,614.0
3611,3068,ultrasound scan,-10.202739726027357,196.0
3612,3390,regression analyses,-10.218750000000039,654.0
3613,2311,reported cases,-10.226804123711375,310.0
3614,122,multivariate analysis,-10.330843255586418,1852.0
3615,3227,patients diagnosed,-10.398239254272552,1035.0
3616,2566,preoperative postoperative,-10.438016528925614,421.0
3617,283,eighteen patients,-10.480645161290285,171.0
3618,1888,magnetic resonance,-10.55917355783617,16119.0
3619,885,right ventricular,-10.618782249742052,1416.0
3620,2603,higher incidence,-10.643795620437997,317.0
3621,829,using different,-10.697205346294142,603.0
3622,1800,using single,-10.864285714285742,169.0
3623,1990,basal ganglia,-10.872636815920407,892.0
3624,557,biomedical applications,-11.041067761806948,283.0
3625,2027,imaging using,-11.105474452554752,483.0
3626,2468,patients analyzed,-11.141479099678428,275.0
3627,338,taking account,-11.157575757575838,263.0
3628,3197,right middle,-11.347394540942904,269.0
3629,1796,contrast enhanced,-11.611111111111123,228.0
3630,671,patients renal,-11.65970149253729,186.0
3631,1005,showed similar,-11.70652173913043,359.0
3632,3568,diffusion tensor,-11.747490347490375,1383.0
3633,1781,criteria included,-11.854545454545484,163.0
3634,299,five different,-12.000000000000014,160.0
3635,3075,lower patients,-12.162499999999968,417.0
3636,2367,cervical spine,-12.451546391752565,671.0
3637,2341,stem cells,-12.504925677645081,1078.0
3638,1001,adult patients,-12.630395136777986,789.0
3639,1030,adverse events,-12.817625458996293,1309.0
3640,2019,specificity respectively,-12.863157894736872,282.0
3641,513,expression levels,-12.864565425023873,446.0
3642,1328,surgical repair,-13.055214723926484,304.0
3643,1370,evaluation performed,-13.288888888888923,184.0
3644,1430,results showed,-13.489481946624622,1868.0
3645,1445,article reviews,-13.502425876010705,253.0
3646,2175,analysis included,-13.5479452054794,215.0
3647,1878,nanoparticles nps,-13.600000000000062,224.0
3648,3542,patients underwent,-13.99692660165973,6540.0
3649,3459,improve quality,-14.100000000000149,141.0
3650,2979,left middle,-14.18808933002486,253.0
3651,16,four patients,-14.222544642857235,951.0
3652,838,failure hf,-14.506249999999978,211.0
3653,3086,however data,-14.53846153846152,135.0
3654,1712,imaging techniques,-14.617361111111123,1302.0
3655,603,matched controls,-14.95081967213118,285.0
3656,3581,ml ml,-14.983333333333233,186.0
3657,3115,fat mass,-15.031879194630793,527.0
3658,2478,previously described,-15.211111111111022,444.0
3659,493,demonstrate feasibility,-15.334939759036047,172.0
3660,1643,results show,-15.531631431990562,1609.0
3661,920,differences observed,-15.54487632508832,468.0
3662,2873,patients associated,-15.802898550724676,232.0
3663,3623,subjects mean,-15.916666666666604,191.0
3664,2407,assessed patients,-15.933333333333218,239.0
3665,2986,spatial resolution,-16.14017672494838,1216.0
3666,3208,likert scale,-16.214814814815004,199.0
3667,702,data acquisition,-16.39899497487432,259.0
3668,3248,radiation therapy,-16.52080344332865,1175.0
3669,217,polymerase chain,-16.521739130434803,380.0
3670,7,per second,-17.30909090909104,136.0
3671,2584,temporal gyrus,-17.446153846153877,546.0
3672,2747,years males,-17.48148148148163,236.0
3673,2256,analysis showed,-17.483142229812184,1731.0
3674,3116,technique used,-17.851256281407125,428.0
3675,2803,antimicrobial activity,-20.267716535433355,198.0
3676,862,percent patients,-20.341176470588287,182.0
3677,1940,months years,-20.716564417177736,268.0
3678,332,image registration,-20.831506849315172,411.0
3679,805,lumbar puncture,-21.878260869565462,148.0
3680,2624,liver biopsy,-24.28442211055269,331.0
3681,876,femoral neck,-25.36923076923079,731.0
3682,1411,hypertrophic cardiomyopathy,-25.803625377643467,365.0
3683,2107,mr images,-26.381401617250734,1125.0
3684,2590,provide better,-27.01860465116305,157.0
3685,1773,western blot,-28.266666666666545,424.0
3686,1119,studied patients,-28.9443037974686,309.0
3687,43,whereas patients,-29.399999999999935,189.0
3688,1267,previous work,-30.993197278911545,268.0
3689,1304,indocyanine green,-31.698591549295106,363.0
3690,1753,performed determine,-32.71578947368407,336.0
3691,1066,performed within,-32.88214285714305,279.0
3692,630,standardized uptake,-35.92737430167587,545.0
3693,1801,premotor cortex,-36.17777777777786,176.0
3694,3559,morbidity mortality,-38.17894736842097,819.0
3695,1008,angular gyrus,-38.37037037037032,148.0
3696,3087,right posterior,-41.651162790697555,199.0
3697,3056,determined using,-44.94146341463395,666.0
3698,658,appropriate treatment,-49.15384615384683,213.0
3699,2243,imaging modalities,-50.37083333333376,1099.0
3700,2069,cancer nsclc,-54.73239436619666,290.0
3701,1635,patients performed,-66.76923076923129,248.0
3702,155,published periodicals,-79.91666666666724,274.0
3703,2846,differences groups,-87.51176470588321,522.0
3704,2649,patients asymptomatic,-107.63636363636581,160.0
